nct_id,dropout_percentage_all,Clinical Title,Overall Status,Trial Phase,Allocation,Start Date,Completion Date,Primary Purpose,City,State,Zipcode,Gender,Minimum Age,Maximum Age,New Completion Date,New Start Date,length_of_trial
NCT00001596,17.39130435,Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome,Completed,Phase 2,Randomized,September 2005,"May 9, 2016",Treatment,Bethesda,Maryland,20892,All,18 Years,,2016-05-01,2005-09-01,3895.0
NCT00001723,8.0,Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases,Completed,Phase 2,Randomized,May 1998,October 2011,Treatment,Bethesda,Maryland,20892,All,12 Years,17 Years,2011-10-01,1998-05-01,4901.0
NCT00003869,21.87789084,Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer,Completed,Phase 3,Randomized,April 1999,May 2008,Treatment,Rochester,Minnesota,55905,All,18 Years,,2008-05-01,1999-04-01,3318.0
NCT00003901,0.8595988539,"Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery",Completed,Phase 3,,July 1999,October 2011,Diagnostic,Mobile,Alabama,36608,All,18 Years,,2011-10-01,1999-07-01,4475.0
NCT00045162,24.43651603,S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer,Completed,Phase 3,Randomized,November 2002,December 2009,Treatment,Anniston,Alabama,36202,All,18 Years,120 Years,2009-12-01,2002-11-01,2587.0
NCT00047385,1.406735931,National Lung Screening Trial (NLST) Screening,Completed,Phase 3,Randomized,August 2002,October 2010,Screening,Birmingham,Alabama,35233,All,55 Years,74 Years,2010-10-01,2002-08-01,2983.0
NCT00047463,13.63636364,Effects of Treating Obstructive Sleep Apnea in Epilepsy,Completed,Phase 2,Randomized,September 2002,July 2008,Treatment,Ann Arbor,Michigan,48109,All,18 Years,,2008-07-01,2002-09-01,2130.0
NCT00048997,7.975460123,Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,September 2002,December 2016,Treatment,Phoenix,Arizona,85013,All,18 Years,,2016-12-01,2002-09-01,5205.0
NCT00049543,0.0,"Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery",Completed,Phase 3,Randomized,September 2002,April 2011,Treatment,Kingston,Ontario,K7L 3N6,All,18 Years,,2011-04-01,2002-09-01,3134.0
NCT00050960,40.19607843,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",Completed,Phase 3,Randomized,May 2002,March 2005,Treatment,Montgomery,Alabama,36106,All,,,2005-03-01,2002-05-01,1035.0
NCT00051363,22.62039077,Apnea Positive Pressure Long-Term Efficacy Study,Completed,Phase 3,Randomized,September 2002,September 2008,Treatment,Tucson,Arizona,85724,All,18 Years,,2008-09-01,2002-09-01,2192.0
NCT00053846,12.92056595,Buspirone in Reducing Shortness of Breath in Patients With Cancer,Completed,Phase 2/Phase 3,Randomized,November 2002,January 2011,Supportive Care,Chicago,Illinois,60612-7323,All,18 Years,120 Years,2011-01-01,2002-11-01,2983.0
NCT00057746,0.5050505051,Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,February 2003,November 2013,Treatment,Birmingham,Alabama,35294,All,,120 Years,2013-11-01,2003-02-01,3926.0
NCT00057837,20.45454545,Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,"July 14, 2004",August 2012,Treatment,Lewes,Delaware,19958,All,18 Years,,2012-08-01,2004-07-01,2953.0
NCT00062010,0.0,"Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer",Completed,Phase 2,,"May 26, 2004",August 2012,Treatment,Decatur,Georgia,30033,All,18 Years,,2012-08-01,2004-05-01,3014.0
NCT00063154,25.58139535,"Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy",Completed,Phase 2,,July 2003,April 2005,Treatment,Scottsdale,Arizona,85258,All,18 Years,,2005-04-01,2003-07-01,640.0
NCT00065429,4.87804878,Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer,Completed,Phase 1/Phase 2,Non-Randomized,April 2003,December 2008,Treatment,Denver,Colorado,80218,All,18 Years,,2008-12-01,2003-04-01,2071.0
NCT00066222,1.408450704,"Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer",Completed,Phase 2,,June 2003,November 2013,Treatment,Birmingham,Alabama,35294,All,18 Years,,2013-11-01,2003-06-01,3806.0
NCT00069823,2.246453945,Study of Acid Reflux in Asthma,Completed,Phase 3,Randomized,September 2003,May 2008,Treatment,Birmingham,Alabama,35294,All,18 Years,,2008-05-01,2003-09-01,1704.0
NCT00071032,0.8433040077,Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease,Completed,Phase 3,Randomized,July 2003,May 2009,Treatment,New Brunswick,New Jersey,08903,All,50 Years,,2009-05-01,2003-07-01,2131.0
NCT00078312,46.64634146,"Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder",Completed,Phase 3,Non-Randomized,January 2004,July 2006,Treatment,Peoria,Arizona,85381,All,18 Years,65 Years,2006-07-01,2004-01-01,912.0
NCT00079040,1.587301587,"Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer",Completed,Phase 2,,January 2006,January 2009,Treatment,Boston,Massachusetts,02215,All,18 Years,,2009-01-01,2006-01-01,1096.0
NCT00079937,14.96609178,"Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma",Completed,Phase 3,Randomized,April 2004,March 2008,Treatment,Birmingham,Alabama,35209,All,6 Years,11 Years,2008-03-01,2004-04-01,1430.0
NCT00080223,54.21686747,Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis,Completed,Phase 2,,"August 31, 2003","April 30, 2015",Other,Phoenix,Arizona,85006,All,40 Years,85 Years,2015-04-01,2003-08-01,4261.0
NCT00080938,52.38095238,Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer,Completed,Phase 2,,"December 20, 2005",February 2009,Treatment,,,,All,18 Years,,2009-02-01,2005-12-01,1158.0
NCT00087438,0.0,Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer,Completed,Phase 2,,May 2004,December 2016,Treatment,Rochester,New York,14642,All,18 Years,,2016-12-01,2004-05-01,4597.0
NCT00087698,18.18181818,Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma,Completed,Phase 2,Non-Randomized,September 2003,February 2008,Treatment,San Francisco,California,,All,18 Years,,2008-02-01,2003-09-01,1614.0
NCT00090142,7.258064516,Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275),Completed,Phase 3,Randomized,May 2004,October 2004,Prevention,,,,All,15 Years,45 Years,2004-10-01,2004-05-01,153.0
NCT00092118,7.378878606,The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265),Completed,Phase 3,Randomized,October 2003,May 2004,Treatment,,,,All,15 Years,85 Years,2004-05-01,2003-10-01,213.0
NCT00092131,1.960784314,Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270),Completed,Phase 3,Randomized,June 2003,November 2003,Prevention,,,,All,15 Years,45 Years,2003-11-01,2003-06-01,153.0
NCT00094094,21.875,Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,,February 2005,July 2007,Treatment,Irvine,California,92612,All,18 Years,,2007-07-01,2005-02-01,880.0
NCT00094861,20.25288376,Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,January 2005,January 2014,Treatment,,,,All,18 Years,,2014-01-01,2005-01-01,3287.0
NCT00095199,18.6503884,Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,January 2005,July 2011,Treatment,Birmingham,Alabama,35294,All,18 Years,,2011-07-01,2005-01-01,2372.0
NCT00096226,26.31578947,"Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,September 2004,"May 16, 2016",Treatment,Phoenix,Arizona,85013,All,18 Years,,2016-05-01,2004-09-01,4260.0
NCT00096486,6.477732794,Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer,Completed,Phase 1/Phase 2,,May 2004,July 2010,Treatment,New York,New York,10021,All,18 Years,120 Years,2010-07-01,2004-05-01,2252.0
NCT00097773,6.25,Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis,Completed,Phase 2,Randomized,September 2004,August 2009,Prevention,Birmingham,Alabama,35233,All,1 Year,12 Years,2009-08-01,2004-09-01,1795.0
NCT00098254,5.405405405,BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,December 2004,January 2011,Treatment,Bethesda,Maryland,20892,All,18 Years,,2011-01-01,2004-12-01,2222.0
NCT00100932,21.97802198,"Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy",Completed,Phase 2,Non-Randomized,December 2004,,Treatment,Gilroy,California,,All,18 Years,,,2004-12-01,
NCT00102804,12.79340565,Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,March 2005,December 2013,Treatment,Minneapolis,Minnesota,55455,All,18 Years,,2013-12-01,2005-03-01,3197.0
NCT00103259,13.95881007,Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck,Completed,Phase 2,Randomized,July 2005,November 2011,Treatment,Boston,Massachusetts,02215,All,18 Years,,2011-11-01,2005-07-01,2314.0
NCT00104520,52.59259259,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa,Completed,Phase 3,Randomized,February 2005,September 2006,Treatment,Phoenix,Arizona,,All,6 Years,,2006-09-01,2005-02-01,577.0
NCT00105183,5.188943886,EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection,Completed,Phase 3,Randomized,January 2005,January 2011,Prevention,Los Angeles,California,90048,All,18 Years,,2011-01-01,2005-01-01,2191.0
NCT00107952,5.361968834,Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus,Completed,Phase 3,Randomized,February 2005,July 2007,Treatment,Springfield,Massachusetts,01199,All,18 Years,,2007-07-01,2005-02-01,880.0
NCT00111839,26.26866917,Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer,Completed,Phase 2,Randomized,"May 31, 2005","March 31, 2009",Treatment,Tucson,Arizona,85715,All,18 Years,,2009-03-01,2005-05-01,1400.0
NCT00112294,0.0,Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,December 2004,August 2008,Treatment,Birmingham,Alabama,,All,18 Years,,2008-08-01,2004-12-01,1339.0
NCT00112359,24.19642857,International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa,Completed,Phase 3,Randomized,May 2005,April 2007,Treatment,Birmingham,Alabama,,All,6 Years,,2007-04-01,2005-05-01,700.0
NCT00113516,26.19047619,A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,September 2005,March 2009,Treatment,Los Angeles,California,90048,All,18 Years,,2009-03-01,2005-09-01,1277.0
NCT00117325,6.25181645,Study Of Adults And Adolescents With Vasomotor Rhinitis,Completed,Phase 3,Randomized,"July 11, 2005","February 9, 2006",Treatment,Beverly Hills,California,90212,All,12 Years,,2006-02-01,2005-07-01,215.0
NCT00117338,2.524348513,A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301),Completed,Phase 3,Randomized,July 2005,March 2008,Treatment,,,,All,6 Years,14 Years,2008-03-01,2005-07-01,974.0
NCT00117572,4.396135266,Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE),Completed,Phase 3,Randomized,November 2004,December 2016,Treatment,Los Angeles,California,90033,All,18 Years,,2016-12-01,2004-11-01,4413.0
NCT00118703,4.031293602,Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis,Completed,Phase 3,Randomized,"July 1, 2005","February 9, 2006",Treatment,Birmingham,Alabama,35209,All,12 Years,,2006-02-01,2005-07-01,215.0
NCT00124020,5.416724836,Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus,Completed,Phase 3,Randomized,January 2005,May 2007,Treatment,Tel Hashomer,,52621,All,18 Years,,2007-05-01,2005-01-01,850.0
NCT00124618,0.0,Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer,Completed,Phase 2,,January 2006,March 2015,Treatment,Scottsdale,Arizona,85259-5499,All,18 Years,,2015-03-01,2006-01-01,3346.0
NCT00125359,11.9047619,Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer,Completed,Phase 2,,August 2005,March 2014,Treatment,Lebanon,New Hampshire,03756,All,18 Years,,2014-03-01,2005-08-01,3134.0
NCT00127166,4.520917679,Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911),Completed,Phase 3,Randomized,December 2005,November 2008,Treatment,,,,All,6 Years,14 Years,2008-11-01,2005-12-01,1066.0
NCT00127855,2.207317073,Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine,Completed,Phase 2,Randomized,"March 1, 2003","February 12, 2004",Prevention,North Adelaide,South Australia,5006,All,6 Weeks,12 Weeks,2004-02-01,2003-03-01,337.0
NCT00128492,25.13849984,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA),Completed,Phase 3,Non-Randomized,August 2005,January 2009,Treatment,Birmingham,Alabama,,All,6 Years,,2009-01-01,2005-08-01,1249.0
NCT00129116,3.096903097,"3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age",Completed,Phase 2,Randomized,"March 1, 2003","December 16, 2003",Prevention,Asse,Bayern,1730,All,6 Weeks,12 Weeks,2003-12-01,2003-03-01,275.0
NCT00129766,1.62806476,Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children,Completed,Phase 3,Randomized,November 2004,May 2006,Prevention,Birmingham,Alabama,35233,All,,24 Months,2006-05-01,2004-11-01,546.0
NCT00138658,34.56790123,A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 1/Phase 2,,November 2004,March 2010,Treatment,Los Angeles,California,90033,All,18 Years,,2010-03-01,2004-11-01,1946.0
NCT00139659,19.38453318,A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma,Completed,Phase 3,Randomized,January 2003,October 2008,Treatment,Glendale,Arizona,85306,All,18 Years,77 Years,2008-10-01,2003-01-01,2100.0
NCT00143455,26.38508416,Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer,Completed,Phase 3,Randomized,June 2002,December 2008,Treatment,Wels,,A-4600,All,18 Years,75 Years,2008-12-01,2002-06-01,2375.0
NCT00144339,40.99070223,Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients,Completed,Phase 3,,December 2002,,Treatment,Anniston,Alabama,,All,40 Years,,,2002-12-01,
NCT00147537,41.98247536,"Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer",Completed,Phase 1/Phase 2,Randomized,February 2005,August 2011,Treatment,Tucson,Arizona,85719,All,18 Years,,2011-08-01,2005-02-01,2372.0
NCT00157196,0.0,Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease,Completed,Phase 2,,April 2005,April 2012,Treatment,,,,All,18 Years,,2012-04-01,2005-04-01,2557.0
NCT00157209,0.0,Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer),Completed,Phase 2,Randomized,August 2000,July 2012,Treatment,Darmstadt,,,All,18 Years,,2012-07-01,2000-08-01,4352.0
NCT00159822,35.41666667,Voriconazole For Chronic Bronchopulmonary Aspergillosis,Completed,Phase 2/Phase 3,Non-Randomized,July 2005,December 2008,Treatment,Nantes,Cedex,44093,All,18 Years,,2008-12-01,2005-07-01,1249.0
NCT00159913,2.673160173,"A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.",Completed,Phase 3,Randomized,August 2003,June 2008,Treatment,Palo Alto,California,94304,All,1 Year,17 Years,2008-06-01,2003-08-01,1766.0
NCT00168831,25.35410676,Tiotropium / Respimat One-Year Study,Completed,Phase 3,Randomized,February 2003,,Treatment,Birmingham,Alabama,,All,40 Years,,,2003-02-01,
NCT00168844,20.55305863,Tiotropium / Respimat One-Year Study,Completed,Phase 3,Randomized,January 2003,,Treatment,Los Angeles,California,,All,40 Years,,,2003-01-01,
NCT00171834,45.71428571,"Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer",Completed,Phase 1/Phase 2,Non-Randomized,August 2003,September 2008,Treatment,Louisville,Kentucky,40232-5070,All,18 Years,,2008-09-01,2003-08-01,1858.0
NCT00172042,33.68703603,A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,March 2005,June 2010,Prevention,Jette,,,All,18 Years,,2010-06-01,2005-03-01,1918.0
NCT00182689,32.25146199,Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,,July 2005,October 2008,Treatment,Portland,Oregon,97239,All,18 Years,,2008-10-01,2005-07-01,1188.0
NCT00191139,21.875,"Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)",Completed,Phase 2,Randomized,March 2003,February 2009,Treatment,Denver,Colorado,80218,All,18 Years,,2009-02-01,2003-03-01,2164.0
NCT00191191,28.24074074,To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,October 2004,October 2008,Treatment,Chiba,,,All,20 Years,75 Years,2008-10-01,2004-10-01,1461.0
NCT00191308,3.333333333,Molecular Profiling in Lung Cancer Patients,Completed,Phase 2,Non-Randomized,May 2005,December 2010,Treatment,Bystra Slaska,,43-360,All,18 Years,,2010-12-01,2005-05-01,2040.0
NCT00192036,28.57142857,Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,August 2004,November 2009,Treatment,Aalst,,9300,All,18 Years,,2009-11-01,2004-08-01,1918.0
NCT00197106,3.75,Treatment Of Symptomatic Asthma In Children,Completed,Phase 4,Randomized,June 2005,October 2008,Treatment,Almere,,1315 RA,All,6 Years,12 Years,2008-10-01,2005-06-01,1218.0
NCT00200967,13.96825397,Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE),Completed,Phase 3,Randomized,December 2004,February 2008,Treatment,San Diego,California,92103,All,18 Years,90 Years,2008-02-01,2004-12-01,1157.0
NCT00207740,23.05019542,A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma,Completed,Phase 2,Randomized,August 2004,July 2007,Treatment,Los Angeles,California,,All,18 Years,,2007-07-01,2004-08-01,1064.0
NCT00216203,6.060606061,Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer,Completed,Phase 1/Phase 2,,May 2005,December 2008,Treatment,Galesburg,Illinois,61401,All,18 Years,,2008-12-01,2005-05-01,1310.0
NCT00227539,4.0,"Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,July 2005,November 2013,Treatment,Seattle,Washington,98109-1023,All,18 Years,120 Years,2013-11-01,2005-07-01,3045.0
NCT00228553,47.60601915,Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness,Completed,Phase 3,Non-Randomized,May 2004,July 2006,Treatment,Birmingham,Alabama,35213,All,18 Years,65 Years,2006-07-01,2004-05-01,791.0
NCT00228566,21.05263158,Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome,Completed,Phase 3,Non-Randomized,October 2005,July 2006,Treatment,Birmingham,Alabama,35213,All,18 Years,65 Years,2006-07-01,2005-10-01,273.0
NCT00231465,4.545454545,Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer,Completed,Phase 2,,July 2003,August 2012,Treatment,Tampa,Florida,33612,All,70 Years,,2012-08-01,2003-07-01,3319.0
NCT00232557,5.958829902,Telecommunications System in Asthma,Completed,Phase 3,Randomized,August 2004,December 2009,,Boston,Massachusetts,02130,All,18 Years,,2009-12-01,2004-08-01,1948.0
NCT00243074,21.27659574,S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery,Completed,Phase 2,,November 2005,December 2011,Treatment,San Antonio,Texas,78245,All,18 Years,,2011-12-01,2005-11-01,2221.0
NCT00244725,7.650205539,Odiparcil For The Prevention Of Venous Thromboembolism,Completed,Phase 2,Randomized,September 2005,September 2006,Prevention,Birmingham,Alabama,35209,All,35 Years,,2006-09-01,2005-09-01,365.0
NCT00245570,0.3546099291,Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316),Completed,Phase 3,Randomized,December 2005,September 2006,Prevention,,,,All,15 Years,45 Years,2006-09-01,2005-12-01,274.0
NCT00247416,5.225806452,Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer,Completed,Phase 2,Randomized,August 2005,July 2009,Treatment,Danville,Kentucky,40422,All,18 Years,,2009-07-01,2005-08-01,1430.0
NCT00248495,2.631578947,"Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,"June 8, 2005","April 5, 2017",Treatment,Buffalo,New York,14263-0001,All,18 Years,120 Years,2017-04-01,2005-06-01,4322.0
NCT00250679,27.30371791,Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,October 2005,October 2007,Treatment,Birmingham,Alabama,33744,All,35 Years,,2007-10-01,2005-10-01,730.0
NCT00254566,8.838383838,A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB),Completed,Phase 3,Randomized,February 2006,August 2008,Treatment,Guangzhou,Guangdong,510080,All,50 Years,,2008-08-01,2006-02-01,912.0
NCT00255047,8.861391361,Safety and Immune Response of Different Pediatric Combination Vaccines.,Completed,Phase 3,Randomized,November 2005,February 2009,Prevention,Tuscaloosa,Alabama,35401,All,42 Days,89 Days,2009-02-01,2005-11-01,1188.0
NCT00257608,14.27432795,A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS),Completed,Phase 3,Randomized,January 2006,November 2014,Treatment,Mobile,Alabama,36608,All,18 Years,,2014-11-01,2006-01-01,3226.0
NCT00258895,1.952619971,Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®,Completed,Phase 3,Non-Randomized,March 2005,April 2007,Prevention,Fayetteville,Arkansas,15213,All,4 Years,6 Years,2007-04-01,2005-03-01,761.0
NCT00261833,11.80941787,Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency,Completed,Phase 4,Randomized,March 2006,September 2012,Treatment,Denver,Colorado,80206,All,18 Years,65 Years,2012-09-01,2006-03-01,2376.0
NCT00263887,6.477732794,Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE),Completed,Phase 2,Randomized,December 2003,January 2007,Treatment,Hellerup,England,2900,All,18 Years,,2007-01-01,2003-12-01,1127.0
NCT00264576,0.3262720886,Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults,Completed,Phase 2,Randomized,October 2005,May 2006,Prevention,Bardstown,Kentucky,40004,All,18 Years,49 Years,2006-05-01,2005-10-01,212.0
NCT00264849,10.89154412,Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma,Completed,Phase 4,Randomized,November 2005,September 2008,Treatment,Bruxelles,,,All,12 Years,75 Years,2008-09-01,2005-11-01,1035.0
NCT00265317,19.72445465,A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone,Completed,Phase 2,Randomized,June 2006,January 2012,Treatment,Birmingham,Alabama,35233,All,18 Years,,2012-01-01,2006-06-01,2040.0
NCT00266877,14.98778999,Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,December 2005,January 2009,Treatment,Los Angeles,California,90033,All,18 Years,,2009-01-01,2005-12-01,1127.0
NCT00267202,21.11722387,Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma,Completed,Phase 4,Randomized,December 2005,April 2008,Treatment,East Hanover,New Jersey,,All,18 Years,55 Years,2008-04-01,2005-12-01,852.0
NCT00269152,18.63061609,Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,December 2005,July 2013,Treatment,Bordeaux,,33076,All,18 Years,,2013-07-01,2005-12-01,2769.0
NCT00279916,13.21256039,Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays,Completed,Phase 3,Randomized,"September 1, 2005",March 2009,Treatment,Rochester,Minnesota,55905,All,6 Years,100 Years,2009-03-01,2005-09-01,1277.0
NCT00280735,20.83333333,Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC,Completed,Phase 2,,May 2004,July 2011,Treatment,Chapel Hill,North Carolina,27599,All,18 Years,120 Years,2011-07-01,2004-05-01,2617.0
NCT00282295,2.088680709,"US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease",Completed,Phase 4,Randomized,"January 25, 2006","August 8, 2006",Prevention,Chandler,Arizona,85224,All,11 Years,18 Years,2006-08-01,2006-01-01,212.0
NCT00283244,24.70291147,"Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC",Completed,Phase 2,Randomized,March 2006,October 2014,Treatment,Fayetteville,Arkansas,72703,All,70 Years,120 Years,2014-10-01,2006-03-01,3136.0
NCT00284141,32.65306122,Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma,Completed,Phase 2,Non-Randomized,January 2006,July 2008,Treatment,Bridgewater,New Jersey,08807,All,18 Years,,2008-07-01,2006-01-01,912.0
NCT00284856,14.72685376,Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED),Completed,Phase 3,Randomized,May 2006,April 2010,Treatment,,,,All,18 Years,55 Years,2010-04-01,2006-05-01,1431.0
NCT00285012,33.04202545,Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).,Completed,Phase 3,Randomized,May 2006,April 2009,Treatment,Birmingham,Alabama,35249-2181,All,35 Years,,2009-04-01,2006-05-01,1066.0
NCT00289198,19.20529801,Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,"February 7, 2006","July 4, 2006",Treatment,San Diego,California,92123,All,12 Years,,2006-07-01,2006-02-01,150.0
NCT00289783,10.46572005,Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine,Completed,Phase 3,Randomized,"February 22, 2006","February 26, 2008",Prevention,Birmingham,Alabama,35216,All,6 Weeks,15 Months,2008-02-01,2006-02-01,730.0
NCT00289874,3.066389479,Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED),Completed,Phase 3,Randomized,March 2006,July 2007,Treatment,,,,All,6 Years,14 Years,2007-07-01,2006-03-01,487.0
NCT00291642,1.017022193,A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen,Completed,Phase 2,Randomized,"January 1, 2006","April 1, 2006",Treatment,Kingston,Ontario,,All,16 Years,,2006-04-01,2006-01-01,90.0
NCT00294762,4.19600939,Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC,Completed,Phase 2,Randomized,January 2006,March 2009,Treatment,Alhambra,California,91801,All,18 Years,,2009-03-01,2006-01-01,1155.0
NCT00295022,1.598150611,Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects,Completed,Phase 4,Randomized,"July 29, 2006","October 1, 2006",Treatment,Kingston,Ontario,,All,18 Years,,2006-10-01,2006-07-01,92.0
NCT00296491,13.23477627,Study Of Allergic Rhinitis In Patients Who Also Have Asthma,Completed,Phase 4,Randomized,September 2005,October 2007,Treatment,Birmingham,Alabama,35209,All,15 Years,,2007-10-01,2005-09-01,760.0
NCT00298896,7.272727273,Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer,Completed,Phase 2,,February 2006,June 2008,Treatment,Sacramento,California,95817,All,18 Years,,2008-06-01,2006-02-01,851.0
NCT00301366,2.631578947,The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency,Completed,Phase 3,Non-Randomized,June 2006,March 2007,Treatment,Denver,Colorado,80206,All,18 Years,,2007-03-01,2006-06-01,273.0
NCT00301808,17.24137931,"Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,November 2005,October 2012,Treatment,Detroit,Michigan,48201-1379,All,18 Years,120 Years,2012-10-01,2005-11-01,2526.0
NCT00303316,1.094751297,Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants,Completed,Phase 3,Non-Randomized,February 2006,September 2007,Prevention,Cordoba,Provincia de Córdoba,5000,All,510 Days,578 Days,2007-09-01,2006-02-01,577.0
NCT00303459,24.40790656,Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH),Completed,Phase 4,Randomized,May 2006,December 2013,Treatment,La Jolla,California,92037-7381,All,12 Years,,2013-12-01,2006-05-01,2771.0
NCT00306527,0.9048473415,"Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly",Completed,Phase 3,Randomized,September 2005,April 2006,Prevention,Ul. Langiewicza 2,Kielce,25-381,All,18 Years,,2006-04-01,2005-09-01,212.0
NCT00309907,10.25641026,Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant,Completed,Phase 2,,April 2006,September 2011,Treatment,Birmingham,Alabama,35294,All,1 Year,17 Years,2011-09-01,2006-04-01,1979.0
NCT00309946,1.960784314,Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery,Completed,Phase 2,,December 2005,September 2010,Treatment,Chicago,Illinois,60637-1470,All,18 Years,,2010-09-01,2005-12-01,1735.0
NCT00310804,0.4166666667,Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60),Completed,Phase 3,Randomized,September 2005,April 2006,Prevention,Panevezys,,,All,18 Years,60 Years,2006-04-01,2005-09-01,212.0
NCT00312377,6.396598845,ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer,Completed,Phase 3,Randomized,May 2006,March 2014,Treatment,Fullerton,California,,All,18 Years,,2014-03-01,2006-05-01,2861.0
NCT00312728,49.56521739,A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT),Completed,Phase 2,,March 2006,June 2009,Treatment,,,,All,18 Years,,2009-06-01,2006-03-01,1188.0
NCT00313911,6.082981716,"Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.",Completed,Phase 3,Randomized,July 2006,February 2008,Prevention,Mexico DF,,,All,50 Days,71 Days,2008-02-01,2006-07-01,580.0
NCT00314574,16.15730362,A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA),Completed,Phase 3,Randomized,December 2005,November 2009,Treatment,,,,All,12 Years,75 Years,2009-11-01,2005-12-01,1431.0
NCT00315055,2.580645161,Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule,Completed,Phase 3,Randomized,July 2006,February 2008,Prevention,Ankara,,,All,50 Days,71 Days,2008-02-01,2006-07-01,580.0
NCT00316186,24.24242424,First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin,Completed,Phase 2,Non-Randomized,June 2005,May 2009,Treatment,Tucson,Arizona,85712,All,18 Years,,2009-05-01,2005-06-01,1430.0
NCT00316225,16.12903226,Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen,Completed,Phase 2,Non-Randomized,December 2006,March 2009,Treatment,Kobenhavn,,2100,All,18 Years,,2009-03-01,2006-12-01,821.0
NCT00316264,6.534741115,Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season,Completed,Phase 2,Randomized,April 2006,February 2007,Prevention,Garran,Australian Capital Territory,2605,All,,24 Months,2007-02-01,2006-04-01,306.0
NCT00317044,13.84869562,Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma,Completed,Phase 2,Randomized,April 2006,July 2008,Treatment,Birmingham,Alabama,,All,18 Years,70 Years,2008-07-01,2006-04-01,822.0
NCT00318149,0.4444444444,Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population,Completed,Phase 2,Randomized,"October 10, 2005","May 14, 2006",Prevention,Gent,,9000,All,18 Years,,2006-05-01,2005-10-01,212.0
NCT00319020,38.0952381,Bosentan in Children With Pulmonary Arterial Hypertension Extension Study,Completed,Phase 3,,"August 23, 2005","October 28, 2011",Treatment,Denver,Colorado,80218,All,2 Years,11 Years,2011-10-01,2005-08-01,2252.0
NCT00319111,21.85430464,Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH),Completed,Phase 3,Non-Randomized,January 2006,April 2009,Treatment,La Jolla,California,92037-1300,All,18 Years,80 Years,2009-04-01,2006-01-01,1186.0
NCT00319553,1.242248006,"Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®",Completed,Phase 4,Randomized,May 2006,December 2008,Prevention,Annapolis,Maryland,21401,All,11 Years,18 Years,2008-12-01,2006-05-01,945.0
NCT00320255,24.10511364,A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer,Completed,Phase 2,Randomized,June 2006,January 2009,Prevention,Tucson,Arizona,85724,All,18 Years,90 Years,2009-01-01,2006-06-01,945.0
NCT00321373,0.4095004095,Study to Evaluate an Influenza Vaccine Candidate,Completed,Phase 2,Randomized,"May 11, 2006","July 18, 2006",Prevention,Helsinki,,00100,All,60 Years,,2006-07-01,2006-05-01,61.0
NCT00321763,0.6302363914,Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate,Completed,Phase 2,Randomized,"April 27, 2006","July 7, 2006",Prevention,Tartu,Bayern,50417,All,60 Years,,2006-07-01,2006-04-01,91.0
NCT00321893,18.81188119,Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer,Completed,Phase 2,Randomized,January 2006,September 2008,Prevention,Milan,,20141,All,50 Years,,2008-09-01,2006-01-01,974.0
NCT00322452,5.917811771,First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia,Completed,Phase 3,Randomized,March 2006,June 2010,Treatment,Fuzhou,Fujian,,All,18 Years,,2010-06-01,2006-03-01,1553.0
NCT00323297,26.37735849,Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension,Completed,Phase 4,Randomized,September 2006,August 2013,Treatment,Los Angeles,California,90073,All,18 Years,,2013-08-01,2006-09-01,2526.0
NCT00323869,0.0,"Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer",Completed,Phase 2,,June 2006,October 2013,Treatment,Palo Alto,California,94304-1290,All,18 Years,,2013-10-01,2006-06-01,2679.0
NCT00325130,4.601152406,"Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)",Completed,Phase 3,Randomized,April 2006,April 2007,Prevention,,,,All,11 Years,17 Years,2007-04-01,2006-04-01,365.0
NCT00326599,20.68965517,Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,June 2007,February 2010,Treatment,Scottsdale,Arizona,85259-5499,All,18 Years,,2010-02-01,2007-06-01,976.0
NCT00336505,8.934707904,Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP),Completed,Phase 3,Randomized,December 2005,October 2007,Treatment,Woodridge,Illinois,60517,All,18 Years,,2007-10-01,2005-12-01,669.0
NCT00336544,5.376510463,Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia,Completed,Phase 3,Randomized,June 2006,May 2007,Treatment,Woodridge,Illinois,60517,All,18 Years,,2007-05-01,2006-06-01,334.0
NCT00337428,0.7117688116,"Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)",Completed,Phase 3,Randomized,May 2006,May 2007,Prevention,,,,All,11 Years,17 Years,2007-05-01,2006-05-01,365.0
NCT00337675,12.93089993,Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED),Completed,Phase 3,Randomized,October 2006,August 2009,Treatment,,,,All,6 Months,5 Years,2009-08-01,2006-10-01,1035.0
NCT00343291,33.89344262,A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC,Completed,Phase 2,Randomized,December 2006,December 2010,Treatment,Decatur,Alabama,35601,All,18 Years,,2010-12-01,2006-12-01,1461.0
NCT00343889,1.054023949,"Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine",Completed,Phase 3,Randomized,August 2006,April 2008,Prevention,Manila,,,All,42 Days,50 Days,2008-04-01,2006-08-01,609.0
NCT00344773,6.52173913,First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation,Completed,Phase 2,Non-Randomized,March 2006,December 2007,Treatment,Seongnam-Si,,,All,19 Years,,2007-12-01,2006-03-01,640.0
NCT00345579,5.421561259,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age",Completed,Phase 3,Randomized,September 2006,March 2008,Prevention,Birmingham,Alabama,35235,All,6 Weeks,12 Weeks,2008-03-01,2006-09-01,547.0
NCT00346073,2.921715108,Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years,Completed,Phase 3,Randomized,"July 13, 2006","March 7, 2007",Prevention,Huntsville,Alabama,35802,All,19 Years,64 Years,2007-03-01,2006-07-01,243.0
NCT00346398,9.846153846,Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study,Completed,Phase 2,Randomized,May 2006,July 2011,Prevention,New York,New York,10029,All,12 Months,30 Months,2011-07-01,2006-05-01,1887.0
NCT00346775,3.608247423,Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q),Completed,Phase 3,Randomized,"May 1, 2006","June 29, 2006",Treatment,Fresno,California,93720,All,18 Years,,2006-06-01,2006-05-01,31.0
NCT00347958,0.7352941176,"Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine",Completed,Phase 4,Non-Randomized,August 2006,October 2008,Prevention,Jonesboro,Arkansas,72401,All,15 Years,69 Years,2008-10-01,2006-08-01,792.0
NCT00348881,1.443172454,"Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants",Completed,Phase 3,Randomized,June 2006,June 2008,Prevention,Alabang,Muntinlupa City,,All,42 Days,50 Days,2008-06-01,2006-06-01,731.0
NCT00350207,4.638205303,Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg,Completed,Phase 2,,July 2006,,Treatment,Graz,,,All,18 Years,65 Years,,2006-07-01,
NCT00350792,27.41935484,Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients,Completed,Phase 2,Non-Randomized,August 2006,November 2009,Treatment,Bobigny,,93009,All,70 Years,,2009-11-01,2006-08-01,1188.0
NCT00353873,1.980392157,Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids,Completed,Phase 4,Randomized,"November 18, 2005","October 26, 2006",Treatment,Brugge,Campania,8000,All,4 Years,11 Years,2006-10-01,2005-11-01,334.0
NCT00355121,5.673816269,Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®,Completed,Phase 2,Randomized,October 2006,July 2009,Prevention,Little Rock,Arkansas,72205,All,4 Years,7 Years,2009-07-01,2006-10-01,1004.0
NCT00355342,37.62719704,Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.,Completed,Phase 4,Randomized,"April 28, 2004","September 6, 2007",Treatment,Berkeley,California,94705,All,40 Years,,2007-09-01,2004-04-01,1248.0
NCT00356122,43.39622642,Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Non-Randomized,July 2006,August 2010,Treatment,Bridgewater,New Jersey,08807,All,18 Years,,2010-08-01,2006-07-01,1492.0
NCT00358436,21.92156863,Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD),Completed,Phase 3,Randomized,August 2006,June 2008,Treatment,Jasper,Alabama,35501,All,40 Years,,2008-06-01,2006-08-01,670.0
NCT00359788,10.61974514,A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.,Completed,Phase 4,,July 2006,,Treatment,Birmingham,Alabama,,All,40 Years,,,2006-07-01,
NCT00362336,3.065856448,Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV,Completed,Phase 3,Randomized,August 2006,August 2009,Prevention,Soweto,Johannesburg,2013,All,,3 Days,2009-08-01,2006-08-01,1096.0
NCT00363415,8.149819276,Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer,Completed,Phase 3,Randomized,August 2006,June 2008,Treatment,Huntsville,Alabama,35805,All,18 Years,,2008-06-01,2006-08-01,670.0
NCT00363480,7.239819005,Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data,Completed,Phase 4,Non-Randomized,"May 17, 2006","September 14, 2007",Treatment,Erlangen,Bayern,91052,All,18 Years,,2007-09-01,2006-05-01,488.0
NCT00363766,46.875,Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer,Completed,Phase 2,,September 2006,October 2008,Treatment,Gauting,,D-82131,All,18 Years,,2008-10-01,2006-09-01,761.0
NCT00363896,15.08838384,A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,July 2006,May 2008,Treatment,Escaldes,,8036,All,40 Years,,2008-05-01,2006-07-01,670.0
NCT00364351,16.59846354,Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy,Completed,Phase 3,Randomized,August 2006,November 2016,Treatment,Berkeley,California,,All,18 Years,,2016-11-01,2006-08-01,3745.0
NCT00365105,3.969742436,"Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer",Completed,Phase 3,Randomized,"July 11, 2006","February 27, 2017",Supportive Care,Mobile,Alabama,36608,All,18 Years,,2017-02-01,2006-07-01,3868.0
NCT00365508,45.63862928,Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking,Completed,Phase 4,Randomized,February 2006,August 2009,Treatment,Washington,District of Columbia,20060,All,18 Years,,2009-08-01,2006-02-01,1277.0
NCT00365547,4.347826087,Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy,Completed,Phase 2,,September 2006,September 2011,Treatment,Minneapolis,Minnesota,55455,All,18 Years,,2011-09-01,2006-09-01,1826.0
NCT00367770,5.405405405,BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology,Completed,Phase 4,Non-Randomized,January 2004,December 2005,Treatment,Boston,Massachusetts,02115,All,12 Years,,2005-12-01,2004-01-01,700.0
NCT00368927,11.4516129,Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,Completed,Phase 2,Randomized,August 2006,December 2010,Prevention,Scottsdale,Arizona,85259,All,40 Years,79 Years,2010-12-01,2006-08-01,1583.0
NCT00368992,37.25490196,"S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,,August 2006,October 2010,Treatment,San Antonio,Texas,78245,All,18 Years,,2010-10-01,2006-08-01,1522.0
NCT00371683,10.07902025,Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery,Completed,Phase 3,Randomized,November 2006,May 2008,Prevention,Birmingham,Alabama,35205,All,18 Years,,2008-05-01,2006-11-01,547.0
NCT00372775,28.125,Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases,Completed,Phase 2,Non-Randomized,March 2007,December 2009,Treatment,Norwalk,Connecticut,06856,All,18 Years,,2009-12-01,2007-03-01,1006.0
NCT00373425,29.49845161,A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors,Completed,Phase 3,Randomized,September 2006,June 2014,Treatment,Birmingham,Alabama,35294,All,18 Years,,2014-06-01,2006-09-01,2830.0
NCT00374140,5.0,Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer,Completed,Phase 2,,October 2006,June 2012,Treatment,Steubenville,Ohio,43952,All,18 Years,,2012-06-01,2006-10-01,2070.0
NCT00377403,6.673928831,Treatment of Acute Sinusitis,Completed,Phase 4,Randomized,October 2006,August 2010,Treatment,St. Louis,Missouri,63110,All,18 Years,70 Years,2010-08-01,2006-10-01,1400.0
NCT00377611,1.872743392,"Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™",Completed,Phase 4,Non-Randomized,"October 5, 2006","June 20, 2007",Prevention,Mobile,Alabama,36608,All,50 Years,,2007-06-01,2006-10-01,243.0
NCT00380068,25.89285714,Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension,Completed,Phase 3,Non-Randomized,August 2006,May 2009,Treatment,Birmingham,Alabama,35294,All,18 Years,,2009-05-01,2006-08-01,1004.0
NCT00380718,3.03030303,Chemotherapy for Patients With Non-Small Cell Lung Cancer,Completed,Phase 4,Non-Randomized,November 2006,November 2009,Treatment,Taichung,,407,All,18 Years,,2009-11-01,2006-11-01,1096.0
NCT00383123,6.177832483,Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children,Completed,Phase 3,Randomized,"November 2, 2006","October 19, 2007",Prevention,Antioch,California,94509,All,6 Months,17 Years,2007-10-01,2006-11-01,334.0
NCT00383240,10.70461758,Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED),Completed,Phase 3,Randomized,September 2006,September 2008,Treatment,,,,All,12 Years,,2008-09-01,2006-09-01,731.0
NCT00383435,19.62157883,Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED),Completed,Phase 3,Randomized,October 2006,July 2010,Treatment,,,,All,40 Years,,2010-07-01,2006-10-01,1369.0
NCT00383552,13.61546255,Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED),Completed,Phase 3,Randomized,September 2006,August 2008,Treatment,,,,All,12 Years,,2008-08-01,2006-09-01,700.0
NCT00383721,20.62470445,Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED),Completed,Phase 3,Randomized,September 2006,July 2010,Treatment,,,,All,40 Years,,2010-07-01,2006-09-01,1399.0
NCT00384189,20.19240277,A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma,Completed,Phase 3,Randomized,September 2006,August 2008,Treatment,Plovdiv,,4000,All,6 Years,11 Years,2008-08-01,2006-09-01,700.0
NCT00385840,2.788163068,Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate,Completed,Phase 2,Randomized,"October 20, 2006","February 5, 2007",Prevention,Elverum,,2408,All,60 Years,,2007-02-01,2006-10-01,123.0
NCT00387088,15.21453823,Tiotropium / Respimat One Year Study in COPD.,Completed,Phase 3,,September 2006,,Treatment,Birmingham,Alabama,,All,40 Years,,,2006-09-01,
NCT00388505,11.51742994,Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis,Completed,Phase 3,Randomized,February 2006,March 2009,Treatment,Hartford,Connecticut,06102,All,6 Years,,2009-03-01,2006-02-01,1124.0
NCT00388583,0.6195786865,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects",Completed,Phase 2,Randomized,September 2006,September 2008,Prevention,Alabaster,Alabama,,All,65 Years,,2008-09-01,2006-09-01,731.0
NCT00390806,9.322033898,Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer,Completed,Phase 3,Randomized,December 2006,September 2013,Treatment,Birmingham,Alabama,35294,All,18 Years,,2013-09-01,2006-12-01,2466.0
NCT00390884,2.61645493,Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.,Completed,Phase 4,Non-Randomized,October 2006,September 2008,Prevention,Layton,Utah,84041,All,11 Months,14 Months,2008-09-01,2006-10-01,701.0
NCT00391053,0.5485229896,"Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly",Completed,Phase 3,Randomized,October 2006,February 2008,Prevention,Mesa,Arizona,,All,65 Years,,2008-02-01,2006-10-01,488.0
NCT00391274,5.742271747,Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,October 2006,June 2010,Treatment,Beijing,,101149,All,18 Years,,2010-06-01,2006-10-01,1339.0
NCT00391391,11.40476765,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children",Completed,Phase 2,Randomized,October 2006,October 2007,Prevention,Harrisburg,Arkansas,72432,All,6 Months,8 Years,2007-10-01,2006-10-01,365.0
NCT00391768,12.86231884,Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza,Completed,Phase 1/Phase 2,Non-Randomized,January 2007,April 2010,Treatment,Birmingham,Alabama,35117,All,,23 Months,2010-04-01,2007-01-01,1186.0
NCT00392288,11.03480837,Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.,Completed,Phase 3,Randomized,September 2006,February 2008,Treatment,Bridgewater,New Jersey,08807,All,4 Years,11 Years,2008-02-01,2006-09-01,518.0
NCT00393367,5.076173826,Budesonide Inhalation Suspension for Acute Asthma in Children,Completed,Phase 4,Randomized,December 2006,November 2007,Treatment,Philadelphia,Pennsylvania,19104,All,2 Years,18 Years,2007-11-01,2006-12-01,335.0
NCT00393458,18.81108423,"Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control",Completed,Phase 3,Randomized,October 2006,July 2008,Treatment,Buenos Aires,,,All,40 Years,,2008-07-01,2006-10-01,639.0
NCT00394914,4.51443461,Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295),Completed,Phase 2,Randomized,August 2006,April 2007,Prevention,,,,All,6 Years,65 Years,2007-04-01,2006-08-01,243.0
NCT00396162,5.128205128,Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis,Completed,Phase 4,Randomized,November 2006,February 2008,Treatment,,,,All,15 Years,70 Years,2008-02-01,2006-11-01,457.0
NCT00397215,8.29496156,Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age,Completed,Phase 2,Randomized,"November 17, 2006","September 14, 2009",Prevention,Dour,Liguria,7370,All,60 Years,,2009-09-01,2006-11-01,1035.0
NCT00400153,7.400428183,Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,November 2006,,Treatment,Birmingham,Alabama,,All,40 Years,,,2006-11-01,
NCT00401531,4.611650485,"Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants",Completed,Phase 3,Randomized,October 2006,August 2008,Prevention,Bangkok,,,All,50 Days,71 Days,2008-08-01,2006-10-01,670.0
NCT00402051,20.76923077,Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,November 2006,May 2009,Treatment,Coswig,,D-01640,All,18 Years,,2009-05-01,2006-11-01,912.0
NCT00402649,5.714285714,Open-Label Study of H5 Vaccine in Participants of Protocol 04-077,Completed,Phase 1/Phase 2,Non-Randomized,February 2007,December 2007,Prevention,Torrance,California,90502,All,2 Years,10 Years,2007-12-01,2007-02-01,303.0
NCT00403845,2.0,Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,December 2006,October 2007,Treatment,Kasukabe,,,All,40 Years,75 Years,2007-10-01,2006-12-01,304.0
NCT00404547,9.943413125,Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102),Completed,Phase 4,Randomized,November 2006,December 2008,Treatment,Abbotsford,,V2T 3S4,All,18 Years,,2008-12-01,2006-11-01,761.0
NCT00404651,11.37076003,Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants,Completed,Phase 3,Randomized,November 2006,July 2008,Prevention,Estado de Mexico,,56613,All,2 Months,,2008-07-01,2006-11-01,608.0
NCT00404924,17.21316235,ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures,Completed,Phase 3,Randomized,November 2006,November 2014,Treatment,Tucson,Arizona,,All,18 Years,,2014-11-01,2006-11-01,2922.0
NCT00405964,12.85580524,Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684),Completed,Phase 3,Randomized,September 2006,April 2008,Treatment,,,,All,12 Years,,2008-04-01,2006-09-01,578.0
NCT00406783,4.387935184,Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683),Completed,Phase 3,Randomized,August 2006,November 2007,Treatment,,,,All,12 Years,,2007-11-01,2006-08-01,457.0
NCT00408317,8.064516129,Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI),Completed,Phase 3,Randomized,November 2006,April 2007,Treatment,Grand Rapids,Michigan,49503,All,7 Years,,2007-04-01,2006-11-01,151.0
NCT00409006,11.57981803,Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers,Completed,Phase 2,Randomized,February 2007,May 2010,Treatment,Fujian,,350014,All,18 Years,,2010-05-01,2007-02-01,1185.0
NCT00409188,0.0,Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START),Completed,Phase 3,Randomized,January 2007,April 2015,Treatment,Fort Smith,Arkansas,72901,All,18 Years,,2015-04-01,2007-01-01,3012.0
NCT00411671,17.14285714,BATTLE Program: Sorafenib in Patients With NSCLC,Completed,Phase 2,,November 2006,November 2012,Treatment,Houston,Texas,77030,All,18 Years,,2012-11-01,2006-11-01,2192.0
NCT00412737,4.425061164,A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants,Completed,Phase 4,Randomized,January 2007,May 2008,Prevention,Birmingham,Alabama,35233,All,1 Year,,2008-05-01,2007-01-01,486.0
NCT00416455,3.08326229,"Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer",Completed,Phase 1/Phase 2,,September 2007,"July 16, 2016",Diagnostic,Los Angeles,California,90095,Female,18 Years,,2016-07-01,2007-09-01,3226.0
NCT00419263,2.336728701,Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.,Completed,Phase 2,Randomized,January 2007,September 2007,Treatment,Birmingham,Alabama,35209,All,18 Years,,2007-09-01,2007-01-01,243.0
NCT00419744,28.49988412,A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD,Completed,Phase 3,Randomized,January 2007,August 2009,Treatment,Jasper,Alabama,,All,40 Years,,2009-08-01,2007-01-01,943.0
NCT00419757,10.79636387,"An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma",Completed,Phase 3,Randomized,January 2007,June 2008,Treatment,Anaheim,California,,All,12 Years,,2008-06-01,2007-01-01,517.0
NCT00419952,36.20834999,A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.,Completed,Phase 3,Randomized,February 2007,November 2009,Treatment,Birmingham,Alabama,,All,12 Years,,2009-11-01,2007-02-01,1004.0
NCT00423319,8.212523868,Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3),Completed,Phase 3,Randomized,March 2007,September 2009,Prevention,Birmingham,Alabama,35209,All,18 Years,,2009-09-01,2007-03-01,915.0
NCT00423592,19.44444444,Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension,Completed,Phase 2,Non-Randomized,May 2005,March 2009,Treatment,,,,All,12 Years,75 Years,2009-03-01,2005-05-01,1400.0
NCT00424021,34.61538462,Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension,Completed,Phase 2,Non-Randomized,April 2003,December 2009,Treatment,,,,All,18 Years,,2009-12-01,2003-04-01,2436.0
NCT00424528,5.569050832,Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,December 2006,October 2007,Treatment,Jasper,Alabama,35501,All,45 Years,,2007-10-01,2006-12-01,304.0
NCT00425061,11.11111111,Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma,Completed,Phase 2,Randomized,February 2007,August 2008,Treatment,Birmingham,Alabama,35209,All,18 Years,80 Years,2008-08-01,2007-02-01,547.0
NCT00431964,3.852298953,Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa,Completed,Phase 4,Randomized,February 2007,November 2009,Treatment,Phoenix,Arizona,85016,All,6 Years,18 Years,2009-11-01,2007-02-01,1004.0
NCT00433329,16.0,Combination Therapy in Pulmonary Arterial Hypertension,Completed,Phase 4,Non-Randomized,March 2007,August 2010,Treatment,Birmingham,Alabama,35294,All,12 Years,,2010-08-01,2007-03-01,1249.0
NCT00435461,6.091161608,Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine,Completed,Phase 4,Randomized,"December 20, 2006","February 28, 2007",Treatment,Austin,Texas,78731,All,12 Years,,2007-02-01,2006-12-01,62.0
NCT00439725,10.26963992,Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study,Completed,Phase 3,Randomized,February 2007,September 2009,Prevention,Little Rock,Arkansas,72205,All,18 Years,,2009-09-01,2007-02-01,943.0
NCT00439777,10.90768157,Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study,Completed,Phase 3,Randomized,March 2007,December 2011,Treatment,Little Rock,Arkansas,72205,All,18 Years,,2011-12-01,2007-03-01,1736.0
NCT00441012,5.700797371,Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED),Completed,Phase 3,Randomized,December 2006,June 2008,Prevention,,,,All,40 Days,80 Days,2008-06-01,2006-12-01,548.0
NCT00441441,6.280003919,A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma,Completed,Phase 3,Randomized,February 2007,January 2008,Treatment,Huntington Beach,California,92647,All,4 Years,11 Years,2008-01-01,2007-02-01,334.0
NCT00445848,27.05882353,S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer,Completed,Phase 2,,July 2007,January 2014,Treatment,Antioch,California,94531,All,18 Years,120 Years,2014-01-01,2007-07-01,2376.0
NCT00449033,54.6460177,"A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)",Completed,Phase 3,Randomized,February 2007,June 2011,Treatment,Innsbruck,Bahia,6020,All,18 Years,,2011-06-01,2007-02-01,1581.0
NCT00449072,25.42061929,"Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)",Completed,Phase 4,Randomized,March 2007,October 2011,Treatment,Bridgewater,New Jersey,08807,All,3 Years,9 Years,2011-10-01,2007-03-01,1675.0
NCT00451906,36.97053407,A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.,Completed,Phase 4,,August 2006,June 2009,Treatment,Buenos Aires,New South Wales,1272,All,18 Years,,2009-06-01,2006-08-01,1035.0
NCT00452348,22.92148509,A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma,Completed,Phase 4,Randomized,May 2007,April 2009,Treatment,Birmingham,Alabama,35209,All,12 Years,,2009-04-01,2007-05-01,701.0
NCT00452400,3.748459062,Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.,Completed,Phase 2,,March 2007,,Treatment,Birmingham,Alabama,,All,40 Years,,,2007-03-01,
NCT00452530,7.556460781,Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery,Completed,Phase 3,Randomized,June 2007,January 2009,Treatment,Graz,Minas Gerais,8036,All,18 Years,,2009-01-01,2007-06-01,580.0
NCT00452699,23.20728291,A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma,Completed,Phase 4,Randomized,May 2007,May 2009,Treatment,Scottsdale,Arizona,85251,All,12 Years,,2009-05-01,2007-05-01,731.0
NCT00453063,1.408574893,Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED),Completed,Phase 3,Randomized,March 2007,June 2007,Treatment,,,,All,12 Years,,2007-06-01,2007-03-01,92.0
NCT00453362,10.81081081,A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib,Completed,Phase 1/Phase 2,,December 2006,"April 23, 2010",Treatment,,,,All,18 Years,,2010-04-01,2006-12-01,1217.0
NCT00453999,9.500805153,Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza,Completed,Phase 2,Randomized,July 2007,August 2009,Treatment,Mobile,Alabama,36608,All,18 Years,,2009-08-01,2007-07-01,762.0
NCT00454194,37.12974552,Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,September 2007,May 2013,Treatment,Scottsdale,Arizona,85259-5499,All,18 Years,120 Years,2013-05-01,2007-09-01,2069.0
NCT00455923,6.0,SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII),Completed,Phase 4,Randomized,"May 3, 2005","July 31, 2007",Treatment,Luleå,,SE-971 89,All,18 Years,70 Years,2007-07-01,2005-05-01,791.0
NCT00456755,2.380952381,Herbal Treatment for Perennial Allergic Rhinitis,Completed,Phase 2,Randomized,March 2004,April 2006,Treatment,Hong Kong,,,All,18 Years,65 Years,2006-04-01,2004-03-01,761.0
NCT00457002,10.75367647,Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness,Completed,Phase 3,Randomized,June 2007,May 2011,Prevention,Birmingham,Alabama,35294,All,40 Years,,2011-05-01,2007-06-01,1430.0
NCT00457249,0.7685749885,A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older,Completed,Phase 4,Randomized,March 2007,November 2008,Prevention,Chandler,Arizona,85224,All,65 Years,,2008-11-01,2007-03-01,611.0
NCT00457392,22.70833333,A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone,Completed,Phase 3,Randomized,July 2007,December 2012,Treatment,Florence,Alabama,35630,All,18 Years,,2012-12-01,2007-07-01,1980.0
NCT00459342,0.0,"Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",Completed,Phase 2,,March 2007,April 2012,Treatment,Houston,Texas,77030,All,18 Years,,2012-04-01,2007-03-01,1858.0
NCT00461032,6.456037445,Montelukast Back to School Asthma Study (0476-340),Completed,Phase 3,Randomized,June 2006,November 2006,Treatment,,,,All,6 Years,14 Years,2006-11-01,2006-06-01,153.0
NCT00461500,17.64705882,SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults,Completed,Phase 4,Randomized,March 2007,December 2007,Treatment,,,,All,18 Years,40 Years,2007-12-01,2007-03-01,275.0
NCT00461981,19.82352941,A Phase 2 Study to Evaluate Immune Responses of FluMist®,Completed,Phase 2,Randomized,May 2007,February 2008,Treatment,Jonesboro,Arkansas,73401,All,12 Months,35 Months,2008-02-01,2007-05-01,276.0
NCT00463567,15.17252815,"26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 2/Phase 3,Randomized,April 2007,August 2008,Treatment,Anniston,Alabama,36207,All,40 Years,,2008-08-01,2007-04-01,488.0
NCT00464672,0.4402183483,"Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old",Completed,Phase 3,Randomized,April 2007,December 2007,Prevention,Buenos Aires,,,All,3 Years,64 Years,2007-12-01,2007-04-01,244.0
NCT00466947,21.07046827,COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine,Completed,Phase 3,Randomized,"June 28, 2007","July 28, 2011",Prevention,Godoy Cruz,Mendoza,4200,All,6 Weeks,16 Weeks,2011-07-01,2007-06-01,1491.0
NCT00467519,3.568756657,Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age,Completed,Phase 3,Randomized,April 2007,December 2009,Prevention,Birmingham,Alabama,35205,All,4 Years,6 Years,2009-12-01,2007-04-01,975.0
NCT00467740,2.026108075,Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma,Completed,Phase 2,,May 2007,,Treatment,Lakewood,California,,All,18 Years,,,2007-05-01,
NCT00468052,12.29508197,Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy,Completed,Phase 3,Randomized,March 2007,May 2008,Prevention,Newark,New Jersey,07103,All,2 Years,10 Years,2008-05-01,2007-03-01,427.0
NCT00468312,1.626794258,Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED),Completed,Phase 3,Randomized,March 2007,July 2007,Treatment,,,,All,12 Years,,2007-07-01,2007-03-01,122.0
NCT00469898,22.0,Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer,Completed,Phase 2,,December 2003,July 2010,Treatment,Owensboro,Kentucky,42303,All,18 Years,,2010-07-01,2003-12-01,2404.0
NCT00470054,0.0,Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer,Completed,Phase 2,,April 2007,April 2013,Treatment,Chicago,Illinois,60606,All,18 Years,,2013-04-01,2007-04-01,2192.0
NCT00473083,1.0,Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer,Completed,Phase 2,Randomized,January 2009,August 2013,Treatment,Calgary,Alberta,T2N 4N2,All,18 Years,,2013-08-01,2009-01-01,1673.0
NCT00473668,8.7003367,Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib,Completed,Phase 3,Randomized,"June 1, 2007","January 30, 2008",Prevention,Bangalore,,560034,All,6 Weeks,8 Weeks,2008-01-01,2007-06-01,214.0
NCT00477269,18.77880184,Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension,Completed,Phase 2/Phase 3,Randomized,April 2006,January 2014,Treatment,Los Angeles,California,90073,All,18 Years,,2014-01-01,2006-04-01,2832.0
NCT00481065,36.04564518,"Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects",Completed,Phase 2,Randomized,April 2007,December 2008,Prevention,Bogotà,,,All,18 Years,40 Years,2008-12-01,2007-04-01,610.0
NCT00481078,14.89361702,"Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,May 2007,July 2009,Treatment,Duarte,California,91010,All,18 Years,,2009-07-01,2007-05-01,792.0
NCT00482014,16.97324415,"A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer",Completed,Phase 1/Phase 2,Randomized,May 2007,October 2011,Treatment,Los Angeles,California,90095,All,18 Years,,2011-10-01,2007-05-01,1614.0
NCT00486837,22.16216216,Deposition of Inhaled Prolastin in Cystic Fibrosis Patients,Completed,Phase 2,Randomized,December 2003,June 2004,Treatment,,,,All,8 Years,,2004-06-01,2003-12-01,183.0
NCT00488345,19.04761905,"Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age",Completed,Phase 2,,December 2007,September 2009,Treatment,Long Beach,California,90806,All,8 Years,11 Years,2009-09-01,2007-12-01,640.0
NCT00489853,2.102102102,Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD,Completed,Phase 4,Randomized,July 2007,August 2008,Treatment,Berlin,Basel Stadt,,All,40 Years,,2008-08-01,2007-07-01,397.0
NCT00491504,2.901265401,This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED),Completed,Phase 4,Randomized,February 2007,July 2007,Treatment,,,,All,18 Years,65 Years,2007-07-01,2007-02-01,150.0
NCT00492024,3.01234088,BAY12-8039: 5 Days for Sinusitis vs Placebo,Completed,Phase 3,Randomized,January 2005,March 2008,Treatment,Birmingham,Alabama,35209,All,18 Years,,2008-03-01,2005-01-01,1155.0
NCT00492063,1.588148591,Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly,Completed,Phase 3,Randomized,September 2004,May 2005,Prevention,ul. Langiewicza 2,Kielce,25-381,All,18 Years,,2005-05-01,2004-09-01,242.0
NCT00495586,2.516619183,Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,October 2007,July 2011,Treatment,Barcelona,Catalonia,08036,All,40 Years,,2011-07-01,2007-10-01,1369.0
NCT00495612,5.555555556,A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma,Completed,Phase 4,Randomized,September 2007,June 2009,Treatment,,,,All,18 Years,65 Years,2009-06-01,2007-09-01,639.0
NCT00496470,8.332032434,Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.,Completed,Phase 4,Randomized,May 2007,June 2008,Treatment,Concord,New South Wales,,All,40 Years,,2008-06-01,2007-05-01,397.0
NCT00500318,10.2753978,A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,July 2007,September 2010,Treatment,Jasper,Alabama,35501,All,40 Years,,2010-09-01,2007-07-01,1158.0
NCT00502593,9.977324263,Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children,Completed,Phase 2,Randomized,"July 23, 2007","December 4, 2009",Prevention,Blanes (Girona),,17300,All,3 Years,9 Years,2009-12-01,2007-07-01,884.0
NCT00502775,5.008648661,Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine,Completed,Phase 4,Randomized,August 2007,November 2007,Treatment,Little Rock,Arkansas,72205,All,12 Years,,2007-11-01,2007-08-01,92.0
NCT00502801,24.59016393,"An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia",Completed,Phase 2,,August 2007,November 2008,Treatment,Palm Springs,California,,All,18 Years,,2008-11-01,2007-08-01,458.0
NCT00504231,0.3968253968,Intradermal Influenza Vaccine Study in Elders,Completed,Phase 2,Randomized,September 2007,January 2008,Prevention,,,,All,65 Years,,2008-01-01,2007-09-01,122.0
NCT00506350,10.53335856,Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults,Completed,Phase 2,Non-Randomized,"August 1, 2007","October 12, 2009",Prevention,Gent,,9000,All,19 Years,61 Years,2009-10-01,2007-08-01,792.0
NCT00508144,0.0,Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer,Completed,Phase 2,,September 2005,December 2015,Treatment,Houston,Texas,77030,All,18 Years,,2015-12-01,2005-09-01,3743.0
NCT00509028,7.875344353,Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma,Completed,Phase 3,Non-Randomized,December 2006,October 2008,Treatment,Takizawa,Iwate,,All,5 Years,15 Years,2008-10-01,2006-12-01,670.0
NCT00509106,7.229719249,Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia,Completed,Phase 3,Randomized,July 2007,June 2009,Treatment,Durham,North Carolina,27710,All,18 Years,,2009-06-01,2007-07-01,701.0
NCT00510510,9.660887766,Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,August 2007,January 2008,Treatment,Glendale,Arizona,85306,All,40 Years,,2008-01-01,2007-08-01,153.0
NCT00514683,27.13816689,Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis,Completed,Phase 2,Randomized,August 2007,,Treatment,Mendoza,Queensland,,All,40 Years,,,2007-08-01,
NCT00515034,8.92034233,A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia,Completed,Phase 2,Randomized,October 2007,November 2008,Treatment,,,,All,18 Years,99 Years,2008-11-01,2007-10-01,397.0
NCT00517933,12.74848747,Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis,Completed,Phase 3,Randomized,August 2007,October 2009,Treatment,Birmingham,Alabama,35294,All,18 Years,,2009-10-01,2007-08-01,792.0
NCT00518180,13.33485136,A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents,Completed,Phase 3,Randomized,July 2007,October 2008,Prevention,San Jose,,,All,11 Years,18 Years,2008-10-01,2007-07-01,458.0
NCT00518986,18.86774194,Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression,Completed,Phase 4,Randomized,October 2007,March 2009,Treatment,Jasper,Alabama,35501,All,18 Years,65 Years,2009-03-01,2007-10-01,517.0
NCT00519636,5.53710543,Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS,Completed,Phase 4,Randomized,August 2007,November 2007,Treatment,Birmingham,Alabama,35209,All,18 Years,,2007-11-01,2007-08-01,92.0
NCT00520676,16.13207547,Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,October 2007,July 2010,Treatment,Ballarat,Victoria,3350,All,18 Years,,2010-07-01,2007-10-01,1004.0
NCT00521599,6.156716418,A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828),Completed,Phase 4,Randomized,May 2007,March 2009,Treatment,,,,All,18 Years,,2009-03-01,2007-05-01,670.0
NCT00523991,10.46678946,Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).,Completed,Phase 4,Randomized,April 2007,,Treatment,Birmingham,Alabama,,All,40 Years,80 Years,,2007-04-01,
NCT00525512,27.75393525,Tiotropium In Exercise,Completed,Phase 4,Randomized,August 2007,,Treatment,Jasper,Alabama,,All,40 Years,,,2007-08-01,
NCT00527826,18.88740543,Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV,Completed,Phase 4,Randomized,November 2007,July 2009,Treatment,Bruchsal,Baden-Wuerttemberg,76646,All,40 Years,,2009-07-01,2007-11-01,608.0
NCT00528645,13.04347826,AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,,November 2007,May 2013,Treatment,Rochester,Minnesota,55905,All,18 Years,,2013-05-01,2007-11-01,2008.0
NCT00529100,21.21212121,"Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer",Completed,Phase 1/Phase 2,Non-Randomized,December 2005,September 2012,Treatment,Edmonton,Alberta,T6G 1Z2,All,18 Years,,2012-09-01,2005-12-01,2466.0
NCT00529516,0.4624785914,Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults,Completed,Phase 3,Non-Randomized,"October 15, 2007","June 4, 2008",Prevention,Clearwater,Florida,33761,All,18 Years,,2008-06-01,2007-10-01,244.0
NCT00529529,10.31228615,Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma,Completed,Phase 3,Randomized,September 2007,August 2008,Treatment,Glendale,Arizona,85306,All,12 Years,,2008-08-01,2007-09-01,335.0
NCT00531284,36.98717949,"Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma",Completed,Phase 1/Phase 2,Non-Randomized,September 2007,"May 22, 2017",Treatment,Scottsdale,Arizona,85258,All,18 Years,,2017-05-01,2007-09-01,3530.0
NCT00531934,12.22695298,A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.,Completed,Phase 2,Randomized,October 2007,August 2010,Treatment,Antibes,,06600,All,18 Years,75 Years,2010-08-01,2007-10-01,1035.0
NCT00531960,28.98776997,A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.,Completed,Phase 2,Randomized,January 2008,January 2010,Treatment,East Bentleigh,Victoria,VIC 3165,All,18 Years,,2010-01-01,2008-01-01,731.0
NCT00532155,31.55447426,A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer,Completed,Phase 3,Randomized,September 2007,October 2011,Treatment,Bridgewater,New Jersey,08807,All,18 Years,,2011-10-01,2007-09-01,1491.0
NCT00532298,0.4386354591,Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over,Completed,Phase 2,Randomized,"September 20, 2007","November 2, 2007",Prevention,Soeborg,,2860,All,65 Years,,2007-11-01,2007-09-01,61.0
NCT00536731,1.890387054,Symbicort Rapihaler Therapeutic Equivalence Study,Completed,Phase 3,Randomized,September 2007,April 2008,Treatment,Pleven,,,All,12 Years,,2008-04-01,2007-09-01,213.0
NCT00538473,1.515151515,Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults,Completed,Phase 2,Non-Randomized,"October 23, 2007","December 12, 2007",Prevention,Gent,,9000,All,67 Years,,2007-12-01,2007-10-01,61.0
NCT00539006,5.020996,Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS,Completed,Phase 4,Randomized,August 2007,November 2007,Treatment,Scottsdale,Arizona,85251,All,18 Years,,2007-11-01,2007-08-01,92.0
NCT00539864,0.4977924945,"Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV",Completed,Phase 3,Randomized,September 2007,April 2008,Prevention,Fresno,California,93726,All,50 Years,64 Years,2008-04-01,2007-09-01,213.0
NCT00540228,0.401010101,Study to Evaluate an Influenza Vaccine Candidate,Completed,Phase 2,Randomized,"October 5, 2007","May 8, 2008",Prevention,Caen cedex 4,Baden-Wuerttemberg,14052,All,18 Years,64 Years,2008-05-01,2007-10-01,213.0
NCT00540436,16.0,"Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension",Completed,Phase 2,Non-Randomized,August 2007,January 2009,Treatment,Aichi,,470-1192,All,18 Years,,2009-01-01,2007-08-01,519.0
NCT00540514,28.79675114,Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,"November 1, 2007","February 1, 2013",Treatment,Huntsville,Alabama,35805,All,18 Years,,2013-02-01,2007-11-01,1919.0
NCT00540592,0.4955787472,Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A,Completed,Phase 2,Randomized,"October 8, 2007","June 10, 2008",Prevention,Gueglingen,Baden-Wuerttemberg,74363,All,18 Years,,2008-06-01,2007-10-01,244.0
NCT00542880,5.398873528,Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®,Completed,Phase 4,Randomized,September 2007,August 2008,Treatment,Monte Grande,Buenos Aires,,All,40 Years,,2008-08-01,2007-09-01,335.0
NCT00545272,0.7856441274,A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma,Completed,Phase 2,Randomized,October 2007,April 2008,Treatment,Aalst,,,All,12 Years,75 Years,2008-04-01,2007-10-01,183.0
NCT00545532,6.948051948,A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.,Completed,Phase 3,Randomized,"February 4, 2008","May 2, 2017",Treatment,Birmingham,Alabama,35233,All,1 Year,,2017-05-01,2008-02-01,3377.0
NCT00545844,3.833865815,Singulair(R) In Asthma And Allergic Rhinitis (0476-383),Completed,Phase 4,Non-Randomized,"April 1, 2007","January 1, 2008",Treatment,,,,All,15 Years,,2008-01-01,2007-04-01,275.0
NCT00550173,20.39295393,A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,November 2007,January 2012,Treatment,Barretos,Dorset,14784700,All,18 Years,,2012-01-01,2007-11-01,1522.0
NCT00550537,29.31034483,"Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",Completed,Phase 2,,October 2007,December 2013,Treatment,Gainesville,Florida,32610-0232,All,18 Years,120 Years,2013-12-01,2007-10-01,2253.0
NCT00550550,17.41673711,Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED),Completed,Phase 3,Randomized,November 2007,September 2009,Treatment,,,,All,5 Years,17 Years,2009-09-01,2007-11-01,670.0
NCT00551031,0.8298675501,"Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects",Completed,Phase 2,Randomized,October 2007,November 2008,Prevention,Alabaster,Alabama,,All,18 Years,,2008-11-01,2007-10-01,397.0
NCT00552110,2.840482738,Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500),Completed,Phase 2,Randomized,July 2007,February 2008,Treatment,,,,All,12 Years,,2008-02-01,2007-07-01,215.0
NCT00553462,12.0,Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery,Completed,Phase 2,,March 2008,"June 15, 2017",Treatment,Castro Valley,California,94546,All,18 Years,,2017-06-01,2008-03-01,3379.0
NCT00554619,4.761904762,A Study to Evaluate GSK1325760A - a Long-Term Extension Study,Completed,Phase 3,Non-Randomized,February 2008,January 2011,Treatment,Aichi,,470-1192,All,,,2011-01-01,2008-02-01,1065.0
NCT00556322,12.99066046,"A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)",Completed,Phase 3,Randomized,March 2006,June 2012,Treatment,St. Leonards,New South Wales,2065,All,18 Years,,2012-06-01,2006-03-01,2284.0
NCT00556712,8.231327643,"A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)",Completed,Phase 3,Randomized,January 2006,November 2010,Treatment,St. Leonards,New South Wales,2065,All,18 Years,,2010-11-01,2006-01-01,1765.0
NCT00557466,3.783575672,A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,October 2007,May 2008,Treatment,Buenos Aires,,,All,40 Years,,2008-05-01,2007-10-01,213.0
NCT00558285,7.063655651,Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,November 2007,July 2008,Treatment,Adelaide,,,All,40 Years,,2008-07-01,2007-11-01,243.0
NCT00560066,1.552954697,"Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions",Completed,Phase 4,Randomized,November 2007,July 2008,Prevention,Balve,,,All,18 Years,,2008-07-01,2007-11-01,243.0
NCT00562159,15.79655712,Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED),Completed,Phase 3,Randomized,November 2007,September 2009,Treatment,,,,All,18 Years,65 Years,2009-09-01,2007-11-01,670.0
NCT00562484,2.064329202,"A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults",Completed,Phase 4,Randomized,March 2008,January 2010,Prevention,Canberra,Australian Capital Territory,4066,All,18 Years,64 Years,2010-01-01,2008-03-01,671.0
NCT00563381,15.96254109,Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.,Completed,Phase 4,Randomized,January 2008,,Treatment,Feldbach,,,All,40 Years,,,2008-01-01,
NCT00564733,8.695652174,FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer,Completed,Phase 2,,October 2007,March 2012,Treatment,Seattle,Washington,98104,All,18 Years,,2012-03-01,2007-10-01,1613.0
NCT00567476,9.075573549,Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma,Completed,Phase 4,Randomized,November 2007,April 2010,Treatment,São Paulo,,,All,12 Years,75 Years,2010-04-01,2007-11-01,882.0
NCT00567996,10.11438847,Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control,Completed,Phase 3,Randomized,November 2007,,Treatment,Edmonton,,,All,40 Years,,,2007-11-01,
NCT00570401,9.523809524,Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib,Completed,Phase 2,,June 2006,September 2011,Treatment,New York,New York,10065,All,18 Years,120 Years,2011-09-01,2006-06-01,1918.0
NCT00570778,1.470588235,Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,December 2007,September 2008,Treatment,Saint Louis,Missouri,,All,40 Years,,2008-09-01,2007-12-01,275.0
NCT00577655,4.883107089,Albuterol HFA MDI in Pediatric Participants With Asthma,Completed,Phase 3,Randomized,August 2007,July 2008,Treatment,Huntington Beach,California,92647,All,4 Years,11 Years,2008-07-01,2007-08-01,335.0
NCT00578786,31.6101465,A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202),Completed,Phase 3,Randomized,February 2004,March 2010,Treatment,Ciudad Autonoma de Buenos Aires,Buenos Aires,C1115AAB,All,18 Years,,2010-03-01,2004-02-01,2220.0
NCT00579345,0.6912258089,"Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup",Completed,Phase 3,Randomized,October 2007,June 2008,Prevention,Krakow,,25-381,All,18 Years,,2008-06-01,2007-10-01,244.0
NCT00581945,10.90336912,Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 1/Phase 2,Randomized,January 2007,May 2010,Basic Science,Anaheim,California,92801,All,40 Years,80 Years,2010-05-01,2007-01-01,1216.0
NCT00585039,1.754385965,Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED),Completed,Phase 4,Randomized,September 2005,March 2009,Treatment,Phoenix,Arizona,85016,All,6 Years,17 Years,2009-03-01,2005-09-01,1277.0
NCT00585533,0.0,"A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,,June 2004,March 2012,Treatment,Salt Lake City,Utah,84112,All,18 Years,,2012-03-01,2004-06-01,2830.0
NCT00586469,0.1,A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk,Completed,Phase 4,Randomized,"December 14, 2007","January 14, 2008",Prevention,Coquitlam,British Columbia,V3K 3P4,All,18 Years,60 Years,2008-01-01,2007-12-01,31.0
NCT00587288,1.886792453,Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma,Completed,Phase 2,Randomized,April 2008,March 2010,Treatment,Orange,California,92868,All,18 Years,75 Years,2010-03-01,2008-04-01,699.0
NCT00588445,21.53846154,Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene,Completed,Phase 2,,June 2004,September 2010,Treatment,New York,New York,10065,All,18 Years,,2010-09-01,2004-06-01,2283.0
NCT00589121,8.860759494,"Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg",Completed,Phase 2,Non-Randomized,March 2008,"May 21, 2018",Treatment,Newark,Delaware,19713,All,18 Years,,2018-05-01,2008-03-01,3713.0
NCT00590902,0.0,"Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer",Completed,Phase 2,,March 2002,February 2013,Treatment,New York,New York,10065,All,,,2013-02-01,2002-03-01,3990.0
NCT00591591,14.19386535,Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers,Completed,Phase 3,Non-Randomized,August 2007,June 2010,Diagnostic,Orange,California,92868,All,21 Years,55 Years,2010-06-01,2007-08-01,1035.0
NCT00599027,5.923076923,An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma,Completed,Phase 3,Randomized,May 2008,May 2009,Treatment,,,,All,18 Years,75 Years,2009-05-01,2008-05-01,365.0
NCT00600171,2.142075972,Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.,Completed,Phase 2,Randomized,December 2007,September 2008,Treatment,Phoenix,Arizona,85006,All,12 Years,,2008-09-01,2007-12-01,275.0
NCT00600821,10.14367816,A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.,Completed,Phase 2,Randomized,April 2008,October 2012,Treatment,Baton Rouge,Louisiana,70809,All,18 Years,,2012-10-01,2008-04-01,1644.0
NCT00603278,4.20751413,A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.,Completed,Phase 2,Randomized,December 2007,November 2008,Treatment,Phoenix,Arizona,85028,All,12 Years,,2008-11-01,2007-12-01,336.0
NCT00603382,4.148555927,A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.,Completed,Phase 2,Randomized,"December 1, 2007","October 2, 2008",Treatment,Phoenix,Arizona,85028,All,12 Years,,2008-10-01,2007-12-01,305.0
NCT00603746,3.716618084,A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.,Completed,Phase 2,Randomized,"December 1, 2007","September 20, 2008",Treatment,Phoenix,Arizona,85028,All,12 Years,,2008-09-01,2007-12-01,275.0
NCT00604500,3.308823529,A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1),Completed,Phase 3,,"March 1, 2008","November 1, 2008",Treatment,,,,All,12 Years,,2008-11-01,2008-03-01,245.0
NCT00606021,12.63227513,"A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,January 2008,December 2010,Treatment,Assiut,,0000,All,18 Years,,2010-12-01,2008-01-01,1065.0
NCT00606502,1.5,Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment,Completed,Phase 2,Randomized,January 2008,"June 24, 2010",Treatment,Bakersfield,California,93309,All,18 Years,,2010-06-01,2008-01-01,882.0
NCT00606684,8.910891089,A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,February 2008,October 2008,Treatment,Florence,Alabama,35630,All,40 Years,80 Years,2008-10-01,2008-02-01,243.0
NCT00608868,9.420289855,SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients,Completed,Phase 4,Non-Randomized,January 2007,January 2009,Treatment,Daegu,,,All,19 Years,80 Years,2009-01-01,2007-01-01,731.0
NCT00609518,13.64522417,A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,February 2008,June 2010,Treatment,Bankstown,New South Wales,2200,All,18 Years,,2010-06-01,2008-02-01,851.0
NCT00609674,4.445564516,A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis,Completed,Phase 4,Randomized,January 2008,June 2008,Treatment,Baltimore,Maryland,21236,All,12 Years,,2008-06-01,2008-01-01,152.0
NCT00613626,0.0,Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,January 2008,August 2015,Treatment,Newark,Delaware,19713,All,18 Years,,2015-08-01,2008-01-01,2769.0
NCT00615459,1.497005988,"A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control",Completed,Phase 3,Randomized,February 2008,December 2008,Treatment,Camperdown,,,All,40 Years,,2008-12-01,2008-02-01,304.0
NCT00616928,2.110521781,Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years,Completed,Phase 3,Randomized,"January 23, 2008","March 19, 2009",Prevention,Huntsville,Alabama,35802,All,18 Years,,2009-03-01,2008-01-01,425.0
NCT00617305,18.18181818,Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1),Completed,Phase 4,Randomized,April 2008,July 2011,Treatment,Mobile,Alabama,36617,All,16 Years,75 Years,2011-07-01,2008-04-01,1186.0
NCT00617851,11.05990783,Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old,Completed,Phase 3,Randomized,November 2007,June 2008,Prevention,Santo Domingo,,,All,18 Years,49 Years,2008-06-01,2007-11-01,213.0
NCT00619502,7.109181141,Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants,Completed,Phase 3,Non-Randomized,December 2007,July 2008,Prevention,Ankara,,,All,15 Months,18 Months,2008-07-01,2007-12-01,213.0
NCT00619801,1.286054118,Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin,Completed,Phase 3,Randomized,March 2008,July 2008,Treatment,Birmingham,Alabama,,All,2 Years,6 Years,2008-07-01,2008-03-01,122.0
NCT00620022,8.426966292,The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,April 2008,January 2009,Treatment,Torrance,California,,All,40 Years,,2009-01-01,2008-04-01,275.0
NCT00620815,3.648785801,Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above,Completed,Phase 2,Randomized,November 2007,December 2008,Prevention,Holzkirchen,,83607,All,18 Years,,2008-12-01,2007-11-01,396.0
NCT00621504,6.271720066,Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia,Completed,Phase 3,Randomized,January 2008,June 2009,Treatment,Los Angeles,California,90015,All,18 Years,,2009-06-01,2008-01-01,517.0
NCT00621959,2.345852807,A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis,Completed,Phase 4,Randomized,March 2008,June 2008,Treatment,Scottsdale,Arizona,,All,18 Years,65 Years,2008-06-01,2008-03-01,92.0
NCT00624286,6.467460409,Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,February 2008,July 2008,Treatment,Anniston,Alabama,36207-5710,All,40 Years,,2008-07-01,2008-02-01,151.0
NCT00626028,2.205882353,Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing,Completed,Phase 3,Randomized,September 2004,February 2010,Diagnostic,Stanford,California,94304,All,4 Weeks,18 Years,2010-02-01,2004-09-01,1979.0
NCT00626522,5.173402582,Aclidinium/Formoterol Fixed Combination Dose Finding Study,Completed,Phase 2,Randomized,February 2008,November 2008,Treatment,Taichung,,,All,40 Years,80 Years,2008-11-01,2008-02-01,274.0
NCT00628108,5.416666667,Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months,Completed,Phase 3,Randomized,March 2008,September 2008,Treatment,Birmingham,Alabama,,All,6 Months,11 Months,2008-09-01,2008-03-01,184.0
NCT00628758,18.61915175,A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma,Completed,Phase 3,Randomized,December 2005,September 2008,Treatment,Ankara,,,All,18 Years,,2008-09-01,2005-12-01,1005.0
NCT00628862,8.15314749,"Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU",Completed,Phase 3,Randomized,December 2007,April 2009,Treatment,Gabrovo,Aichi,,All,40 Years,,2009-04-01,2007-12-01,487.0
NCT00629239,16.85606061,Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,January 2008,August 2008,Treatment,Hvidovre,,,All,40 Years,,2008-08-01,2008-01-01,213.0
NCT00630331,4.870866646,Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects,Completed,Phase 3,Randomized,October 2007,July 2008,Prevention,Denver,Colorado,80212,All,18 Years,49 Years,2008-07-01,2007-10-01,274.0
NCT00631475,21.09375,Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443,Completed,Phase 3,Non-Randomized,April 2008,May 2010,Treatment,Birmingham,Alabama,35294,All,18 Years,,2010-05-01,2008-04-01,760.0
NCT00632502,13.63636364,"Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)",Completed,Phase 2,Randomized,"May 1, 2008","February 1, 2009",Treatment,,,,All,18 Years,70 Years,2009-02-01,2008-05-01,276.0
NCT00633074,0.1388888889,Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations,Completed,Phase 2,Randomized,"March 3, 2008","April 11, 2008",Prevention,Saku,,75501,All,65 Years,,2008-04-01,2008-03-01,31.0
NCT00633217,13.70523416,Advair HFA For Chronic Obstructive Pulmonary Disease(COPD),Completed,Phase 4,Randomized,March 2008,February 2009,Treatment,Jasper,Alabama,35501,All,40 Years,,2009-02-01,2008-03-01,337.0
NCT00633893,16.2820363,Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism,Completed,Phase 3,Randomized,May 2008,August 2012,Treatment,Birmingham,Alabama,35235,All,18 Years,,2012-08-01,2008-05-01,1553.0
NCT00640926,11.99806483,Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia,Completed,Phase 2,Randomized,October 2007,April 2009,Treatment,San Diego,California,,All,18 Years,65 Years,2009-04-01,2007-10-01,548.0
NCT00642759,2.777777778,"Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,,April 2008,April 2015,Treatment,Boston,Massachusetts,02114,All,18 Years,,2015-04-01,2008-04-01,2556.0
NCT00643201,14.99380056,Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism,Completed,Phase 3,Randomized,July 2008,March 2013,Treatment,Birmingham,Alabama,35235,All,18 Years,,2013-03-01,2008-07-01,1704.0
NCT00645411,5.83433123,Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents,Completed,Phase 2/Phase 3,Randomized,October 2007,July 2008,Prevention,Fayetteville,Arkansas,72703,All,3 Years,17 Years,2008-07-01,2007-10-01,274.0
NCT00645788,11.10244594,Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis,Completed,Phase 2,Randomized,May 2008,January 2011,Treatment,Phoenix,Arizona,85016,All,12 Years,,2011-01-01,2008-05-01,975.0
NCT00650091,12.1333869,"Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF",Completed,Phase 3,Randomized,October 2009,January 2014,Treatment,Birmingham,Alabama,35294,All,35 Years,85 Years,2014-01-01,2009-10-01,1553.0
NCT00651118,4.087815868,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,March 2008,July 2008,Treatment,Scottsdale,Arizona,85251,All,12 Years,,2008-07-01,2008-03-01,122.0
NCT00652340,0.0,APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,April 2008,March 2012,Treatment,Tucson,Arizona,,All,18 Years,,2012-03-01,2008-04-01,1430.0
NCT00652743,5.304420302,Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules,Completed,Phase 3,Randomized,"March 23, 2008","June 8, 2011",Prevention,Hong Kong,,308433,All,19 Years,61 Years,2011-06-01,2008-03-01,1187.0
NCT00653224,1.72432246,A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis,Completed,Phase 4,Randomized,April 2008,July 2008,Treatment,Tucson,Arizona,,All,18 Years,65 Years,2008-07-01,2008-04-01,91.0
NCT00653939,29.6996663,"A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,March 2008,October 2011,Treatment,Campbell,California,95008,All,18 Years,,2011-10-01,2008-03-01,1309.0
NCT00654420,17.38975818,A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007),Completed,Phase 2,Randomized,"March 19, 2008","February 13, 2012",Treatment,,,,All,18 Years,,2012-02-01,2008-03-01,1432.0
NCT00654901,0.5921134858,Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™,Completed,Phase 3,Randomized,March 2008,July 2009,Prevention,Estado de Mexico,,,All,15 Months,18 Months,2009-07-01,2008-03-01,487.0
NCT00655850,2.564102564,Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer,Completed,Phase 2,,March 2008,September 2016,Treatment,Birmingham,Alabama,35294 - 0104,All,19 Years,,2016-09-01,2008-03-01,3106.0
NCT00656136,13.33333333,BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1),Completed,Phase 3,Randomized,April 2008,October 2013,Treatment,Kingman,Arizona,,All,18 Years,,2013-10-01,2008-04-01,2009.0
NCT00659529,25.92592593,Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease,Completed,Phase 1/Phase 2,,August 2008,December 2012,Treatment,Denver,Colorado,80206,All,14 Years,,2012-12-01,2008-08-01,1583.0
NCT00660179,4.030853994,Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,May 2008,April 2012,Treatment,Birmingham,Alabama,35249-0001,All,12 Years,,2012-04-01,2008-05-01,1431.0
NCT00660816,13.06818182,Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,January 2008,July 2015,Treatment,Detroit,Michigan,48202,All,18 Years,,2015-07-01,2008-01-01,2738.0
NCT00660829,6.015037594,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,December 2007,April 2008,Treatment,Austin,Texas,78731,All,12 Years,,2008-04-01,2007-12-01,122.0
NCT00661193,12.93706294,S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,December 2008,December 2016,Treatment,Little Rock,Arkansas,72205,All,18 Years,120 Years,2016-12-01,2008-12-01,2922.0
NCT00661778,54.0,A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,July 2007,July 2011,Treatment,Cádiz,Cadiz,11009,All,18 Years,,2011-07-01,2007-07-01,1461.0
NCT00662038,44.13988658,Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 3,,August 2008,February 2016,Treatment,South San Francisco,California,94080-4990,All,40 Years,84 Years,2016-02-01,2008-08-01,2740.0
NCT00666679,5.993761141,Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386),Completed,Phase 2,Randomized,May 2008,February 2009,Treatment,,,,All,15 Years,85 Years,2009-02-01,2008-05-01,276.0
NCT00669331,20.60274076,Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis,Completed,Phase 3,Randomized,November 2009,January 2014,Treatment,Denver,Colorado,80206,All,18 Years,85 Years,2014-01-01,2009-11-01,1522.0
NCT00669617,0.4494382022,Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,April 2008,August 2008,Treatment,Tamarac,Florida,33321,All,40 Years,,2008-08-01,2008-04-01,122.0
NCT00670007,5.714285714,Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.,Completed,Phase 4,,April 2008,September 2014,Treatment,Adelaide,South Australia,5000,All,18 Years,,2014-09-01,2008-04-01,2344.0
NCT00670930,4.347826087,"Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists",Completed,Phase 4,Randomized,April 2008,November 2011,Treatment,Denver,Colorado,80206,All,18 Years,75 Years,2011-11-01,2008-04-01,1309.0
NCT00674700,24.21369475,Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis,Completed,Phase 2/Phase 3,Randomized,October 2007,February 2010,Treatment,,,,All,18 Years,50 Years,2010-02-01,2007-10-01,854.0
NCT00676052,4.51419033,Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,"May 16, 2008","December 22, 2008",Treatment,Jasper,Alabama,35501,All,40 Years,80 Years,2008-12-01,2008-05-01,214.0
NCT00677365,5.283674363,"Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients",Completed,Phase 2,Randomized,June 2008,June 2009,Treatment,Mobile,Alabama,36608,All,16 Years,,2009-06-01,2008-06-01,365.0
NCT00677807,9.83443397,"Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,May 2008,March 2009,Treatment,Homewood,Alabama,35209-6870,All,40 Years,,2009-03-01,2008-05-01,304.0
NCT00677820,0.2083333333,A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine,Completed,Phase 4,Randomized,June 2008,December 2008,Prevention,Daytona Beach,Florida,32117,All,18 Years,49 Years,2008-12-01,2008-06-01,183.0
NCT00682643,41.27538501,A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis,Completed,Phase 4,Randomized,June 2008,February 2011,Treatment,Oxford,Alabama,36203,All,12 Years,,2011-02-01,2008-06-01,975.0
NCT00686959,0.0,Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,September 2008,November 2014,Treatment,Birmingham,Alabama,35249,All,18 Years,,2014-11-01,2008-09-01,2252.0
NCT00690482,5.137587822,Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,May 2008,December 2008,Treatment,Pleven,,,All,40 Years,,2008-12-01,2008-05-01,214.0
NCT00696020,3.337946335,Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD),Completed,Phase 2,Randomized,June 2008,,Treatment,Riverside,California,,All,40 Years,,,2008-06-01,
NCT00698516,6.0,Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,July 2008,May 2010,Treatment,Jonesboro,Arkansas,72401,All,18 Years,,2010-05-01,2008-07-01,669.0
NCT00698815,12.35368737,Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,"April 15, 2008",,Treatment,Anaheim,California,92807,All,18 Years,,,2008-04-01,
NCT00700180,2.976553648,A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.,Completed,Phase 2,Randomized,September 2008,September 2012,Treatment,St. Leonards,New South Wales,2065,All,18 Years,,2012-09-01,2008-09-01,1461.0
NCT00702325,29.99690867,Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans,Completed,Phase 4,Randomized,June 2008,September 2009,Treatment,Pell City,Alabama,,All,12 Years,,2009-09-01,2008-06-01,457.0
NCT00705406,2.222845437,"A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza",Completed,Phase 2,Randomized,July 2008,October 2009,Treatment,Birmingham,Alabama,35209,All,18 Years,,2009-10-01,2008-07-01,457.0
NCT00709098,24.58333333,Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,September 2008,June 2010,Treatment,La Jolla,California,92037,All,18 Years,,2010-06-01,2008-09-01,638.0
NCT00709956,10.89931574,Iloprost Power 15 in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,July 2008,August 2009,Treatment,La Jolla,California,92037,All,18 Years,,2009-08-01,2008-07-01,396.0
NCT00710866,5.178931452,Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity,Completed,Phase 3,Randomized,August 2008,March 2009,Prevention,Coquitlam,British Columbia,V3C 4J2,All,6 Months,23 Months,2009-03-01,2008-08-01,212.0
NCT00711594,29.03225806,LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib,Completed,Phase 2,Non-Randomized,April 2008,November 2013,Treatment,"Akashi, Hyogo",,,All,20 Years,,2013-11-01,2008-04-01,2040.0
NCT00712166,0.6578947368,"Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa",Completed,Phase 3,Randomized,May 2008,August 2009,Treatment,Phoenix,Arizona,,All,6 Years,,2009-08-01,2008-05-01,457.0
NCT00712335,23.26388889,The Effects of Montelukast on Smokers With Asthma,Completed,Phase 4,Randomized,February 2007,May 2011,Diagnostic,Seoul,,139-707,All,18 Years,45 Years,2011-05-01,2007-02-01,1550.0
NCT00712920,7.608462199,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies,Completed,Phase 3,Randomized,January 2007,,Treatment,Huntington Beach,California,92647,All,12 Years,,,2007-01-01,
NCT00712959,3.000129316,Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose,Completed,Phase 4,Non-Randomized,June 2008,December 2009,Prevention,Coquitlam,British Columbia,V3C 4J2,All,20 Years,,2009-12-01,2008-06-01,548.0
NCT00718315,17.41293532,"A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.",Completed,Phase 3,Randomized,April 2009,June 2012,Treatment,Salvador,BA,40110-150,All,18 Years,,2012-06-01,2009-04-01,1157.0
NCT00719862,2.293562053,A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,August 2007,November 2007,Treatment,Huntington Beach,California,92647,Female,12 Years,,2007-11-01,2007-08-01,92.0
NCT00720226,10.32763533,Efficacy of Losartan in Preventing Progression of COPD,Completed,Phase 4,Randomized,July 2008,August 2016,Treatment,Baltimore,Maryland,21205,All,40 Years,,2016-08-01,2008-07-01,2953.0
NCT00720278,3.237165558,A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies,Completed,Phase 3,Randomized,August 2007,November 2007,Treatment,Oxford,Alabama,36203,All,12 Years,,2007-11-01,2007-08-01,92.0
NCT00720382,27.92325383,A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,March 2007,July 2008,Treatment,Oxford,Alabama,36203,All,12 Years,,2008-07-01,2007-03-01,488.0
NCT00720499,3.546099291,Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,July 2008,,Treatment,Clearwater,Florida,,All,40 Years,,,2008-07-01,
NCT00723957,17.2541744,A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer,Completed,Phase 2,Randomized,December 2008,August 2011,Treatment,La Jolla,California,90237,All,18 Years,,2011-08-01,2008-12-01,973.0
NCT00728416,0.8982683983,Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583),Completed,Phase 3,Randomized,August 2008,October 2008,Treatment,,,,All,12 Years,,2008-10-01,2008-08-01,61.0
NCT00729612,15.87301587,"Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",Completed,Phase 2,,"August 14, 2008","December 16, 2011",Treatment,Columbus,Ohio,43210,All,18 Years,120 Years,2011-12-01,2008-08-01,1217.0
NCT00730756,3.927608779,A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis,Completed,Phase 2,Randomized,March 2008,February 2009,Treatment,Bangkok,,10330,All,12 Years,,2009-02-01,2008-03-01,337.0
NCT00730912,0.0,Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539),Completed,Phase 4,Non-Randomized,June 2008,December 2008,Treatment,,,,All,3 Years,64 Years,2008-12-01,2008-06-01,183.0
NCT00730925,29.26829268,Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients,Completed,Phase 2,Non-Randomized,June 2008,,Treatment,Antwerpen,,,All,18 Years,,,2008-06-01,
NCT00731822,2.5,A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,August 2008,February 2009,Treatment,Bergen,,5053,All,40 Years,80 Years,2009-02-01,2008-08-01,184.0
NCT00732381,0.2840909091,Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529),Completed,Phase 3,Randomized,August 2008,November 2008,Treatment,,,,All,12 Years,,2008-11-01,2008-08-01,92.0
NCT00733005,1.234567901,Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED),Completed,Phase 3,Randomized,July 2008,October 2008,Treatment,,,,All,12 Years,,2008-10-01,2008-07-01,92.0
NCT00735475,1.263102725,A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine,Completed,Phase 4,Randomized,October 2008,June 2009,Prevention,Mountain Home,Arkansas,72635,All,65 Years,,2009-06-01,2008-10-01,243.0
NCT00735696,5.0,A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer,Completed,Phase 2,,January 2009,January 2012,Treatment,Beverly Hills,California,90211,All,18 Years,,2012-01-01,2009-01-01,1095.0
NCT00735904,34.21052632,"Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer",Completed,Phase 2,,December 2008,November 2011,Treatment,Torun,Cluj,87-100,All,18 Years,,2011-11-01,2008-12-01,1065.0
NCT00736489,0.9009009009,Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199,Completed,Phase 2,Randomized,August 2008,December 2008,Treatment,Hvidovre,,,All,18 Years,,2008-12-01,2008-08-01,122.0
NCT00737100,4.120268955,Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis,Completed,Phase 2,Randomized,September 2008,,Treatment,Tucson,Arizona,,All,,,,2008-09-01,
NCT00739648,23.49428868,A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 2,Randomized,October 2008,April 2010,Treatment,Haleyville,Alabama,35565,All,40 Years,,2010-04-01,2008-10-01,547.0
NCT00740636,2.23880597,Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,August 2008,February 2013,Treatment,Basking Ridge,New Jersey,11725,All,18 Years,,2013-02-01,2008-08-01,1645.0
NCT00740792,4.133341155,A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,August 2008,November 2008,Treatment,Scottsdale,Arizona,85251,All,12 Years,,2008-11-01,2008-08-01,92.0
NCT00741819,8.219178082,Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects,Completed,Phase 4,Non-Randomized,September 2008,December 2010,Treatment,Birmingham,Alabama,35294,All,18 Years,75 Years,2010-12-01,2008-09-01,821.0
NCT00741988,7.380952381,Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer,Completed,Phase 2,Non-Randomized,September 2008,September 2012,Treatment,Fort Myers,Florida,33901,All,18 Years,,2012-09-01,2008-09-01,1461.0
NCT00742885,1.0,Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine,Completed,Phase 2,Non-Randomized,"September 1, 2008","March 7, 2009",Prevention,Fukuoka,,813-8588,All,20 Years,64 Years,2009-03-01,2008-09-01,181.0
NCT00743275,0.8196721311,A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination,Completed,Phase 4,,August 2008,November 2008,Prevention,Norfolk,Virginia,23507,All,18 Years,,2008-11-01,2008-08-01,92.0
NCT00745251,11.16600791,A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults,Completed,Phase 1/Phase 2,Randomized,August 2008,December 2009,Treatment,Louisville,Kentucky,40217,All,30 Years,65 Years,2009-12-01,2008-08-01,487.0
NCT00745875,0.0,ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study,Completed,Phase 2,Randomized,August 2008,January 2010,Treatment,Pleven,,,All,18 Years,,2010-01-01,2008-08-01,518.0
NCT00752895,3.748485696,American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL,Completed,Phase 2,Randomized,"September 1, 2008","June 1, 2009",Prevention,Burbank,California,91505,All,18 Years,,2009-06-01,2008-09-01,273.0
NCT00753272,22.63162077,Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older,Completed,Phase 3,Randomized,"September 15, 2008","January 5, 2011",Prevention,Alabaster,Alabama,35007,All,65 Years,,2011-01-01,2008-09-01,852.0
NCT00753714,49.34946656,Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine,Completed,Phase 2,Randomized,October 2008,December 2011,Treatment,Meldola,(fc),,All,70 Years,,2011-12-01,2008-10-01,1156.0
NCT00757237,12.37745098,Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa,Completed,Phase 3,Randomized,August 2008,November 2010,Treatment,Anchorage,Alaska,99508,All,6 Years,,2010-11-01,2008-08-01,822.0
NCT00757848,9.448275862,"A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis",Completed,Phase 2,Randomized,October 2008,August 2009,Basic Science,Kobenhavn,Northern Ireland,,All,16 Years,,2009-08-01,2008-10-01,304.0
NCT00758459,9.413919414,Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 2,Randomized,September 2008,March 2009,Treatment,Russe,,,All,40 Years,,2009-03-01,2008-09-01,181.0
NCT00758589,4.901593449,One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids,Completed,Phase 2,Randomized,September 2008,July 2009,Treatment,Quilmes,Buenos Aires,,All,18 Years,,2009-07-01,2008-09-01,303.0
NCT00758706,14.58885942,A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 2,Randomized,September 2008,May 2009,Treatment,Alborg,,,All,40 Years,,2009-05-01,2008-09-01,242.0
NCT00760617,2.526310988,Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older,Completed,Phase 3,Randomized,"October 6, 2008","May 15, 2009",Prevention,Gueglingen,Baden-Wuerttemberg,74363,All,18 Years,,2009-05-01,2008-10-01,212.0
NCT00760838,5.521885522,AZISAST Study: AZIthromycin in Severe ASThma Study,Completed,Phase 4,Randomized,March 2009,September 2011,Treatment,Aalst,,9300,All,18 Years,75 Years,2011-09-01,2009-03-01,914.0
NCT00762034,28.31746997,"A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer",Completed,Phase 3,Randomized,December 2008,December 2014,Treatment,Fayetteville,Arkansas,72703,All,18 Years,,2014-12-01,2008-12-01,2191.0
NCT00762476,10.22022259,Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses,Completed,Phase 2,Randomized,August 2008,November 2008,Prevention,Paramus,New Jersey,07652,All,18 Years,,2008-11-01,2008-08-01,92.0
NCT00764790,3.285714913,Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children,Completed,Phase 3,Randomized,"October 1, 2008","June 1, 2009",Prevention,Birmingham,Alabama,35205,All,6 Months,35 Months,2009-06-01,2008-10-01,243.0
NCT00765076,1.149758454,Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older,Completed,Phase 3,Randomized,"October 16, 2008","December 4, 2009",Prevention,Houston,Texas,77030,All,18 Years,,2009-12-01,2008-10-01,426.0
NCT00766415,1.923076923,14729-D9831C00002- 1 Month Biopsy Study,Completed,Phase 2,Randomized,November 2008,June 2009,Treatment,Frieburg,,,All,40 Years,,2009-06-01,2008-11-01,212.0
NCT00768755,11.77198482,Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer,Completed,Phase 1/Phase 2,Randomized,January 2009,March 2012,Treatment,Huntsville,Alabama,35805,All,18 Years,,2012-03-01,2009-01-01,1155.0
NCT00769067,4.787234043,A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen,Completed,Phase 2,Randomized,November 2008,August 2014,Treatment,Muscle Shoals,Alabama,35661,All,18 Years,99 Years,2014-08-01,2008-11-01,2099.0
NCT00769119,9.090909091,"A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis",Completed,Phase 2,Randomized,September 2008,April 2009,Basic Science,Chemin Sainte-Foy,Quebec,,All,18 Years,80 Years,2009-04-01,2008-09-01,212.0
NCT00770120,44.06779661,S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery,Completed,Phase 2,,December 2008,April 2014,Treatment,Tucson,Arizona,85724-5024,All,18 Years,120 Years,2014-04-01,2008-12-01,1947.0
NCT00770315,22.73230327,Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234),Completed,Phase 2/Phase 3,Randomized,September 2009,May 2011,Treatment,,,,All,18 Years,50 Years,2011-05-01,2009-09-01,607.0
NCT00770588,5.067567568,"Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)",Completed,Phase 4,Randomized,September 2008,February 2011,Treatment,Beijing,Beijing,,All,18 Years,,2011-02-01,2008-09-01,883.0
NCT00771615,1.603606413,Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years,Completed,Phase 2,Randomized,"October 16, 2008","December 4, 2009",Prevention,Huntsville,Alabama,35802,All,18 Years,64 Years,2009-12-01,2008-10-01,426.0
NCT00771953,16.66666667,0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,November 2008,December 2014,Treatment,Los Angeles,California,90033,All,18 Years,,2014-12-01,2008-11-01,2221.0
NCT00772109,2.087688489,Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults,Completed,Phase 3,Randomized,October 2008,July 2009,Prevention,Hoover,Alabama,35216,All,18 Years,64 Years,2009-07-01,2008-10-01,273.0
NCT00772538,9.778766108,Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I),Completed,Phase 3,Randomized,October 2008,,Treatment,Birmingham,Alabama,,All,18 Years,75 Years,,2008-10-01,
NCT00772889,6.109530912,Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly,Completed,Phase 3,Non-Randomized,"October 9, 2008","December 15, 2009",Prevention,Clearwater,Florida,33761,All,19 Years,,2009-12-01,2008-10-01,426.0
NCT00772928,7.288457747,Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™,Completed,Phase 3,Randomized,October 2003,November 2006,Prevention,Montgomery,Alabama,36106,All,42 Days,89 Days,2006-11-01,2003-10-01,1127.0
NCT00775450,0.4023948056,Influenza Vaccine Revaccination in Ambulatory Elderly Subjects,Completed,Phase 2,Randomized,October 2008,July 2009,Prevention,Hoover,Alabama,35216,All,65 Years,,2009-07-01,2008-10-01,273.0
NCT00776984,11.19014167,Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II),Completed,Phase 3,Randomized,October 2008,,Treatment,Fountain Valley,California,,All,18 Years,75 Years,,2008-10-01,
NCT00777257,2.379903185,Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine,Completed,Phase 4,Randomized,April 2005,September 2007,Prevention,Jonesboro,Arkansas,72401,All,11 Years,17 Years,2007-09-01,2005-04-01,883.0
NCT00778895,8.801738554,"Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control",Completed,Phase 2,Randomized,"November 10, 2008","August 19, 2009",Prevention,Calgary,Alberta,T3B 6A8,All,6 Months,36 Months,2009-08-01,2008-11-01,273.0
NCT00782210,17.70334928,12 / 48 Week Pivotal PFT vs PBO in COPD I,Completed,Phase 3,Randomized,November 2008,,Treatment,Jasper,Alabama,,All,40 Years,,,2008-11-01,
NCT00782509,13.0369879,12 / 48 wk Pivotal PFT vs PBO in COPD II,Completed,Phase 3,Randomized,February 2009,,Treatment,Mobile,Alabama,,All,40 Years,,,2009-02-01,
NCT00783198,24.93343953,Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED),Completed,Phase 2/Phase 3,Randomized,September 2009,May 2011,Treatment,,,,All,18 Years,50 Years,2011-05-01,2009-09-01,607.0
NCT00783224,0.7017630257,A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512),Completed,Phase 3,Randomized,September 2005,December 2005,Treatment,,,,All,16 Years,,2005-12-01,2005-09-01,91.0
NCT00783432,14.22136492,Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis,Completed,Phase 3,Randomized,July 2006,December 2007,Treatment,Somerset,New Jersey,08873,All,12 Years,,2007-12-01,2006-07-01,518.0
NCT00783705,12.91574279,Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,Completed,Phase 2,Randomized,November 2008,May 2014,Prevention,Scottsdale,Arizona,85259,All,45 Years,79 Years,2014-05-01,2008-11-01,2007.0
NCT00784368,18.18181818,A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection,Completed,Phase 3,Non-Randomized,January 2008,May 2009,Treatment,Fukuoka,,,All,18 Years,79 Years,2009-05-01,2008-01-01,486.0
NCT00784550,21.06919315,A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).,Completed,Phase 4,Randomized,December 2008,December 2009,Treatment,Riverside,California,92506,All,40 Years,99 Years,2009-12-01,2008-12-01,365.0
NCT00784784,6.926406926,Zanamivir Versus Trivalent Split Virus Influenza Vaccine,Completed,Phase 3,Randomized,November 2008,June 2009,Prevention,Toronto,Ontario,M5G 1X5,All,18 Years,69 Years,2009-06-01,2008-11-01,212.0
NCT00786422,36.0,Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer,Completed,Phase 2,,May 2009,June 2011,Treatment,Redcliffe,Queensland,4020,All,18 Years,,2011-06-01,2009-05-01,761.0
NCT00789373,14.8029819,A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,November 2008,November 2017,Treatment,Adelaide,South Australia,5000,All,18 Years,,2017-11-01,2008-11-01,3287.0
NCT00789555,15.23110136,Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis,Completed,Phase 4,Randomized,November 2008,January 2011,Treatment,Fort Worth,Texas,76134,All,12 Years,,2011-01-01,2008-11-01,791.0
NCT00790023,5.944279858,Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis,Completed,Phase 3,Randomized,November 2008,February 2009,Treatment,Austin,Texas,78731,All,12 Years,,2009-02-01,2008-11-01,92.0
NCT00791934,23.80952381,Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide,Completed,Phase 3,,August 2008,November 2011,Treatment,Burlington,Massachusetts,01805,All,17 Years,,2011-11-01,2008-08-01,1187.0
NCT00792805,11.05953352,Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,November 2008,February 2010,Treatment,Adelaide,,,All,40 Years,,2010-02-01,2008-11-01,457.0
NCT00793624,19.47723935,Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I,Completed,Phase 3,Randomized,February 2009,,Treatment,Capital Federal,Alberta,,All,40 Years,,,2009-02-01,
NCT00794157,9.48883408,Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,November 2008,October 2009,Treatment,Hong Kong,,,All,40 Years,,2009-10-01,2008-11-01,334.0
NCT00796653,17.30344261,Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II,Completed,Phase 3,Randomized,January 2009,,Treatment,Capital Federal,Alberta,,All,40 Years,,,2009-01-01,
NCT00797511,0.7575757576,Immunogenicity and Safety of Adacel Polio Vaccine,Completed,Phase 3,,November 2008,July 2009,Prevention,Taipei,,100,All,6 Years,8 Years,2009-07-01,2008-11-01,242.0
NCT00798603,53.22580645,"Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer",Completed,Phase 2,,December 2008,May 2013,Treatment,Scottsdale,Arizona,85259-5499,All,70 Years,120 Years,2013-05-01,2008-12-01,1612.0
NCT00800202,21.45522388,A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis,Completed,Phase 2,Non-Randomized,April 2009,October 2012,Treatment,Bordeaux,,33076,All,18 Years,,2012-10-01,2009-04-01,1279.0
NCT00802867,1.31445905,Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™,Completed,Phase 4,Non-Randomized,February 2004,September 2005,Prevention,Jonesboro,Arkansas,72401,All,4 Years,6 Years,2005-09-01,2004-02-01,578.0
NCT00803595,3.902303485,A Multinational Phase III Study of CS-8958 (MARVEL),Completed,Phase 3,Randomized,November 2008,June 2009,Treatment,Hong-Kong,,,All,20 Years,,2009-06-01,2008-11-01,212.0
NCT00805025,53.93258427,Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis,Completed,Phase 2,,December 2008,October 2009,Treatment,Birmingham,Alabama,35209,All,18 Years,,2009-10-01,2008-12-01,304.0
NCT00805194,25.12180148,LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer,Completed,Phase 3,Randomized,"December 3, 2008","November 13, 2017",Treatment,Graz,,8036,All,18 Years,,2017-11-01,2008-12-01,3257.0
NCT00806819,31.9723796,Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC,Completed,Phase 3,Randomized,December 2008,December 2015,Treatment,Downy,California,,All,18 Years,,2015-12-01,2008-12-01,2556.0
NCT00807573,4.545454545,"Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment",Completed,Phase 2,,December 2008,April 2014,Treatment,Basking Ridge,New Jersey,07920,All,18 Years,,2014-04-01,2008-12-01,1947.0
NCT00809094,1.470588235,"NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients",Completed,Phase 2,Randomized,November 2008,February 2011,Treatment,Birmingham,Alabama,35294,All,7 Years,,2011-02-01,2008-11-01,822.0
NCT00809328,10.78431373,The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP),Completed,Phase 3,Non-Randomized,February 2009,March 2010,Treatment,Seto-shi,Aichi-ken,,All,16 Years,80 Years,2010-03-01,2009-02-01,393.0
NCT00809757,11.32538485,"A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma",Completed,Phase 3,Randomized,December 2008,June 2013,Treatment,Little Rock,Arkansas,72205,All,,48 Months,2013-06-01,2008-12-01,1643.0
NCT00810693,12.0130817,A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH),Completed,Phase 3,Randomized,"December 17, 2008","May 14, 2012",Treatment,Tucson,Arizona,85724,All,18 Years,80 Years,2012-05-01,2008-12-01,1247.0
NCT00812981,0.3125,A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.,Completed,Phase 3,Randomized,"November 15, 2008","June 7, 2009",Prevention,Taipei,,100,All,18 Years,59 Years,2009-06-01,2008-11-01,212.0
NCT00818441,8.389513109,Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung,Completed,Phase 2,Non-Randomized,"March 11, 2009","April 30, 2015",Treatment,Orange,California,92868-3298,All,18 Years,,2015-04-01,2009-03-01,2222.0
NCT00818454,1.659292035,4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma,Completed,Phase 2,,December 2008,,Treatment,Birmingham,Alabama,,All,18 Years,,,2008-12-01,
NCT00820755,19.55403087,Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,January 2009,June 2013,Treatment,Darmstadt,,,All,18 Years,,2013-06-01,2009-01-01,1612.0
NCT00821093,6.157411239,Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,January 2009,October 2009,Treatment,Anniston,Alabama,36207-5710,All,40 Years,,2009-10-01,2009-01-01,273.0
NCT00824382,3.649841597,Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD,Completed,Phase 2,Randomized,January 2009,,Treatment,"Asahikawa, Hokkaido",,,All,40 Years,,,2009-01-01,
NCT00824408,25.51274679,Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC,Completed,Phase 2,Randomized,March 2009,August 2015,Treatment,Nassau,Alberta,,All,18 Years,,2015-08-01,2009-03-01,2344.0
NCT00824473,4.750290178,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,December 2008,February 2009,Treatment,Austin,Texas,78731,All,12 Years,,2009-02-01,2008-12-01,62.0
NCT00825162,2.51362426,Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years,Completed,Phase 4,Non-Randomized,March 2009,February 2010,Prevention,Garran,Australian Capital Territory,2606,All,6 Months,17 Years,2010-02-01,2009-03-01,337.0
NCT00826449,2.127659574,Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 1/Phase 2,,February 2009,June 2014,Treatment,Houston,Texas,77030,All,16 Years,,2014-06-01,2009-02-01,1946.0
NCT00831311,2.083333333,Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants,Completed,Phase 2,Randomized,October 2004,March 2007,Prevention,Córdoba,,,All,50 Days,70 Days,2007-03-01,2004-10-01,881.0
NCT00832455,15.95238095,"Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)",Completed,Phase 4,Non-Randomized,June 2006,October 2008,Treatment,,,,All,2 Years,14 Years,2008-10-01,2006-06-01,853.0
NCT00836953,6.060606061,Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®,Completed,Phase 4,Non-Randomized,September 2003,July 2004,Prevention,Norfolk,Virginia,23510,All,6 Months,36 Months,2004-07-01,2003-09-01,304.0
NCT00837967,4.0,Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients,Completed,Phase 3,Randomized,January 2009,July 2009,Treatment,Ibaragi,,,All,16 Years,65 Years,2009-07-01,2009-01-01,181.0
NCT00839800,8.801317039,Study to Investigate the Efficacy of Symbicort® SMART.,Completed,Phase 3,Randomized,February 2009,February 2011,Treatment,Capital Federal,Buenos Aires,,All,16 Years,,2011-02-01,2009-02-01,730.0
NCT00841763,1.577070762,"Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects",Completed,Phase 3,Randomized,October 2008,November 2009,Prevention,Tampere,,33100,All,18 Years,,2009-11-01,2008-10-01,396.0
NCT00842712,2.240896359,Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,February 2009,July 2013,Treatment,Antwerpen (Edegem),,,All,18 Years,,2013-07-01,2009-02-01,1611.0
NCT00843193,8.080808081,Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma,Completed,Phase 2,Randomized,"December 9, 2008","July 25, 2010",Treatment,Medford,Oregon,97504,All,18 Years,75 Years,2010-07-01,2008-12-01,577.0
NCT00845429,6.71949754,"Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects",Completed,Phase 2,Randomized,October 2007,November 2008,Prevention,Hoover,Alabama,35216,All,18 Years,49 Years,2008-11-01,2007-10-01,397.0
NCT00845728,16.71925384,Exacerbation Study,Completed,Phase 3,Randomized,March 2009,July 2012,Treatment,Capital Federal,Buenos Aires,C1424BSF,All,40 Years,,2012-07-01,2009-03-01,1218.0
NCT00846586,5.477999812,Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,March 2009,March 2010,Treatment,Birmingham,Alabama,32509,All,40 Years,,2010-03-01,2009-03-01,365.0
NCT00846768,0.5319148936,BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD,Completed,Phase 2,,February 2009,,Treatment,Genk,,,All,40 Years,,,2009-02-01,
NCT00854308,12.37212276,"A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)",Completed,Phase 2,Randomized,April 2009,January 2012,Treatment,,,,All,18 Years,,2012-01-01,2009-04-01,1005.0
NCT00854360,2.848860456,Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR,Completed,Phase 2,Randomized,March 2009,May 2009,Treatment,Mission Viejo,California,92691,All,12 Years,,2009-05-01,2009-03-01,61.0
NCT00855465,6.906857593,A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.,Completed,Phase 3,Randomized,"February 23, 2009","June 27, 2012",Treatment,La Jolla,California,92093,All,18 Years,80 Years,2012-06-01,2009-02-01,1216.0
NCT00855894,2.43902439,A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,March 2009,March 2012,Treatment,Los Angeles,California,90033,All,18 Years,,2012-03-01,2009-03-01,1096.0
NCT00856193,1.515151515,A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,February 2009,May 2009,Treatment,Spartanburg,South Carolina,29303,All,40 Years,,2009-05-01,2009-02-01,89.0
NCT00857766,22.5029036,A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,March 2009,March 2010,Treatment,Birmingham,Alabama,35294,All,50 Years,,2010-03-01,2009-03-01,365.0
NCT00862641,0.9049629411,A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,April 2009,October 2009,Diagnostic,Montgomery,Alabama,36117,All,18 Years,,2009-10-01,2009-04-01,183.0
NCT00863746,17.66086605,A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).,Completed,Phase 3,Randomized,April 2009,April 2013,Treatment,Fayetteville,Arkansas,72703,All,18 Years,,2013-04-01,2009-04-01,1461.0
NCT00864721,53.96825397,Sunitinib Non Small Cell Lung Cancer Patients Over 70,Completed,Phase 2,,February 2009,July 2012,Treatment,Ocala,Florida,34471,All,70 Years,,2012-07-01,2009-02-01,1246.0
NCT00867009,26.54867257,A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,April 2009,September 2014,Treatment,Graz,,8036,All,18 Years,,2014-09-01,2009-04-01,1979.0
NCT00870584,9.221132898,Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma,Completed,Phase 4,Randomized,March 2009,March 2010,Treatment,Jasper,Alabama,35501,All,12 Years,,2010-03-01,2009-03-01,365.0
NCT00870870,15.17241379,A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before,Completed,Phase 2,Randomized,March 2009,May 2012,Treatment,Anniston,Alabama,36207,All,18 Years,,2012-05-01,2009-03-01,1157.0
NCT00871403,25.87557604,Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,July 2009,March 2011,Treatment,Herlev,Surrey,2730,All,18 Years,,2011-03-01,2009-07-01,608.0
NCT00873860,3.553921569,Study to Evaluate the Safety and Efficacy of CAT-354,Completed,Phase 2,Randomized,June 2009,August 2010,Treatment,Burgas,Manchester,8000,All,18 Years,65 Years,2010-08-01,2009-06-01,426.0
NCT00873912,0.625,A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine,Completed,Phase 4,Randomized,May 2009,December 2009,Prevention,Daytona Beach,Florida,32117,All,18 Years,49 Years,2009-12-01,2009-05-01,214.0
NCT00874848,31.58971362,Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,August 2009,August 2015,Treatment,Augusta,Georgia,30912,All,18 Years,75 Years,2015-08-01,2009-08-01,2191.0
NCT00876694,16.63606557,Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,March 2009,October 2010,Treatment,Asahikawa,,,All,40 Years,,2010-10-01,2009-03-01,579.0
NCT00877383,4.55434916,Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,April 2009,February 2010,Treatment,Anniston,Alabama,36207-5710,All,40 Years,,2010-02-01,2009-04-01,306.0
NCT00880100,8.333333333,Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF),Completed,Phase 3,,April 2009,November 2009,Treatment,Aurora,Colorado,80045,All,2 Years,6 Years,2009-11-01,2009-04-01,214.0
NCT00883779,25.72271386,A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,April 2009,December 2014,Treatment,Beijing,,100021,All,18 Years,,2014-12-01,2009-04-01,2070.0
NCT00885365,3.067765568,A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®,Completed,Phase 3,Randomized,April 2009,May 2010,Treatment,Praha,,150 06,All,6 Years,,2010-05-01,2009-04-01,395.0
NCT00887159,31.41025641,A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage,Completed,Phase 2,Randomized,"July 16, 2009","November 15, 2016",Treatment,Scottsdale,Arizona,85259,All,18 Years,,2016-11-01,2009-07-01,2680.0
NCT00887549,37.14285714,A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer,Completed,Phase 2,,April 2009,June 2011,Treatment,Dublin,Derbyshire,DE22 3NE,All,18 Years,,2011-06-01,2009-04-01,791.0
NCT00887978,8.665334499,Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,June 2009,July 2011,Treatment,Birmingham,Alabama,35294-0006,All,18 Years,75 Years,2011-07-01,2009-06-01,760.0
NCT00890825,1.136363636,AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients,Completed,Phase 2,Randomized,"April 20, 2009","November 2, 2016",Treatment,Los Angeles,California,90095,All,18 Years,130 Years,2016-11-01,2009-04-01,2771.0
NCT00891462,13.23306513,Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33),Completed,Phase 3,Randomized,April 2009,November 2009,Treatment,Birmingham,Alabama,35209,All,40 Years,,2009-11-01,2009-04-01,214.0
NCT00893763,0.0,Strategies To Prevent Pneumonia 2 (SToPP2),Completed,Phase 2,Randomized,September 2008,June 2012,Prevention,Richmond,Virginia,23298-0567,All,18 Years,,2012-06-01,2008-09-01,1369.0
NCT00895947,11.0,Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu,Completed,Phase 2,Randomized,April 2009,March 2010,Prevention,Nedlands,Western Australia,6009,All,18 Years,75 Years,2010-03-01,2009-04-01,334.0
NCT00896454,39.39393939,Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium,Completed,Phase 2,,"November 16, 2009","August 21, 2013",Treatment,Encinitas,California,92024,All,18 Years,,2013-08-01,2009-11-01,1369.0
NCT00900731,5.462432575,A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,June 2009,March 2010,Treatment,Birmingham,Alabama,35209,All,40 Years,,2010-03-01,2009-06-01,273.0
NCT00902174,19.61361185,Imatinib (QTI571) in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,September 2009,May 2011,Treatment,Birmingham,Alabama,35294,All,18 Years,,2011-05-01,2009-09-01,607.0
NCT00903201,7.544255025,28 Day Repeat Dose in Cystic Fibrosis Patients,Completed,Phase 2,Randomized,"September 28, 2009","December 29, 2010",Treatment,Birmingham,Alabama,35233,All,18 Years,,2010-12-01,2009-09-01,456.0
NCT00903331,4.208802165,Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study,Completed,Phase 2,Randomized,May 2009,August 2011,Treatment,Birmingham,Alabama,35294,All,18 Years,,2011-08-01,2009-05-01,822.0
NCT00906282,6.52173913,"Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",Completed,Phase 2,,June 2009,September 2015,Treatment,Fort Myers,Florida,33901,All,18 Years,,2015-09-01,2009-06-01,2283.0
NCT00909532,8.74266296,Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation,Completed,Phase 3,Randomized,June 2009,November 2012,Treatment,Birmingham,Alabama,35233-1711,All,12 Years,,2012-11-01,2009-06-01,1249.0
NCT00909727,5.769230769,Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation,Completed,Phase 3,Randomized,August 2009,April 2011,Treatment,Birmingham,Alabama,35233-1711,All,6 Years,11 Years,2011-04-01,2009-08-01,608.0
NCT00909779,41.96895148,Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects,Completed,Phase 3,Randomized,June 2009,June 2012,Treatment,Birmingham,Alabama,25233,All,40 Years,,2012-06-01,2009-06-01,1096.0
NCT00918203,9.27005597,A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,January 2010,"November 17, 2017",Treatment,Birmingham,Alabama,35294,All,18 Years,,2017-11-01,2010-01-01,2861.0
NCT00918957,5.0,A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo,Completed,Phase 3,Randomized,June 2009,May 2011,Treatment,Pleven,,,All,6 Years,21 Years,2011-05-01,2009-06-01,699.0
NCT00923273,22.22222222,Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer,Terminated,Phase 1/Phase 2,Randomized,"February 29, 2008","March 10, 2013",Treatment,Bethesda,Maryland,20892,All,18 Years,,2013-03-01,2008-02-01,1855.0
NCT00927901,2.5,"Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma",Completed,Phase 2,Randomized,June 2009,November 2009,Treatment,Poitiers,,,All,18 Years,75 Years,2009-11-01,2009-06-01,153.0
NCT00928668,3.225806452,Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma,Completed,Phase 2,Randomized,January 2006,,Treatment,Vancouver,British Columbia,,All,18 Years,,,2006-01-01,
NCT00928746,4.225352113,Actuation Indicator Trial in Patients With COPD,Completed,Phase 3,,June 2009,,Treatment,Lafayette,Louisiana,,All,40 Years,,,2009-06-01,
NCT00929110,19.48219576,"1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,June 2009,April 2011,Treatment,Birmingham,Alabama,35249,All,40 Years,,2011-04-01,2009-06-01,669.0
NCT00929708,4.609648049,Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 2,Randomized,June 2009,March 2010,Treatment,Blagoevgrad,New Brunswick,,All,40 Years,,2010-03-01,2009-06-01,273.0
NCT00929734,5.319148936,Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,March 2010,January 2014,Treatment,Lørenskog,Akershus,1478,All,40 Years,80 Years,2014-01-01,2010-03-01,1402.0
NCT00930982,40.15625,Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis,Completed,Phase 2,Randomized,June 2009,September 2010,Treatment,Little Rock,Arkansas,72205,All,18 Years,,2010-09-01,2009-06-01,457.0
NCT00931385,2.525252525,Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,June 2009,,Treatment,Tampa,Florida,,All,40 Years,,,2009-06-01,
NCT00932451,9.005628518,"An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene",Completed,Phase 2,Non-Randomized,January 2010,December 2015,Treatment,Birmingham,Alabama,35233,All,18 Years,,2015-12-01,2010-01-01,2160.0
NCT00932646,3.25,Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,June 2009,,Treatment,Jasper,Alabama,,All,40 Years,,,2009-06-01,
NCT00932893,10.40462428,"An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene",Completed,Phase 3,Randomized,September 2009,January 2016,Treatment,Little Rock,Arkansas,72205,All,18 Years,,2016-01-01,2009-09-01,2313.0
NCT00938392,0.8287292818,Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly,Completed,Phase 3,Randomized,"July 30, 2009","October 5, 2009",Prevention,Tallinn,,50106,All,65 Years,,2009-10-01,2009-07-01,92.0
NCT00938639,2.916666667,A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults,Completed,Phase 2,Randomized,July 2009,March 2010,Prevention,Adelaide,South Australia,5000,All,18 Years,64 Years,2010-03-01,2009-07-01,243.0
NCT00939341,7.656612529,Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia,Completed,Phase 4,,July 2009,August 2010,Treatment,Guangzhou,Guangdong,,All,18 Years,,2010-08-01,2009-07-01,396.0
NCT00939627,45.37037037,Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab,Completed,Phase 2,Randomized,July 2009,January 2014,Treatment,Tampa,Florida,33612,All,18 Years,,2014-01-01,2009-07-01,1645.0
NCT00940108,5.409205996,A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children,Completed,Phase 2,Randomized,August 2009,April 2010,Prevention,Westmead,New South Wales,2145,All,6 Months,8 Years,2010-04-01,2009-08-01,243.0
NCT00941798,22.81971043,Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma,Completed,Phase 2,Randomized,July 2009,May 2011,Treatment,Birmingham,Alabama,35209,All,12 Years,70 Years,2011-05-01,2009-07-01,669.0
NCT00949650,18.26086957,BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation,Completed,Phase 3,Randomized,"August 14, 2009","March 16, 2017",Treatment,Fayetteville,Arkansas,72703,All,18 Years,,2017-03-01,2009-08-01,2769.0
NCT00949910,32.91831157,An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 4,,November 2004,April 2009,Treatment,Tirana,,1000,All,18 Years,,2009-04-01,2004-11-01,1612.0
NCT00949975,12.02075246,A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium,Completed,Phase 2,Randomized,July 2009,August 2010,Basic Science,Fullerton,California,,All,40 Years,80 Years,2010-08-01,2009-07-01,396.0
NCT00950807,1.363636364,GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,"September 1, 2009","March 15, 2010",Treatment,Phoenix,Arizona,85013,All,40 Years,80 Years,2010-03-01,2009-09-01,181.0
NCT00951041,4.663825758,Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults,Completed,Phase 2,Randomized,"August 11, 2009","August 30, 2010",Prevention,Dresden,Sachsen,01097,All,18 Years,60 Years,2010-08-01,2009-08-01,365.0
NCT00952276,0.3227695712,A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly,Completed,Phase 2,Randomized,October 2009,March 2011,Prevention,Anaheim,California,92801,All,18 Years,,2011-03-01,2009-10-01,516.0
NCT00952419,2.532796661,A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years,Completed,Phase 2,Randomized,August 2009,June 2010,Prevention,Miami Beach,Florida,33141,All,6 Months,9 Years,2010-06-01,2009-08-01,304.0
NCT00953147,12.04390594,A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older,Completed,Phase 3,Randomized,August 2009,May 2010,Treatment,Huntington Beach,California,92647,All,12 Years,,2010-05-01,2009-08-01,273.0
NCT00953524,7.122419363,A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly,Completed,Phase 2,Randomized,August 2009,December 2010,Prevention,Hoover,Alabama,35216,All,18 Years,,2010-12-01,2009-08-01,487.0
NCT00955825,9.918546366,Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis,Completed,Phase 3,Randomized,October 2008,August 2009,Treatment,Normal,Illinois,61761,All,18 Years,65 Years,2009-08-01,2008-10-01,304.0
NCT00957996,5.769230769,Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza,Completed,Phase 3,Randomized,October 2009,August 2011,Treatment,Dothan,Alabama,,All,6 Years,,2011-08-01,2009-10-01,669.0
NCT00958126,2.165612977,A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA,Completed,Phase 2,Randomized,August 2009,April 2010,Prevention,Huntsville,Alabama,35802,All,18 Years,,2010-04-01,2009-08-01,243.0
NCT00958243,9.355900852,A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA,Completed,Phase 2,Randomized,August 2009,April 2010,Prevention,Chandler,Arizona,85224,All,6 Months,9 Years,2010-04-01,2009-08-01,243.0
NCT00959049,3.278053503,A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population,Completed,Phase 3,Randomized,September 2009,May 2010,Prevention,Chandler,Arizona,85224,All,6 Months,17 Years,2010-05-01,2009-09-01,242.0
NCT00960115,0.0,Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy,Completed,Phase 1/Phase 2,Randomized,December 2008,June 2015,Treatment,Darmstadt,,,All,20 Years,,2015-06-01,2008-12-01,2373.0
NCT00961415,8.59375,AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,August 2009,May 2011,Treatment,Beziers,Campania,34500,All,18 Years,,2011-05-01,2009-08-01,638.0
NCT00963469,4.18686722,Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240),Completed,Phase 3,Randomized,August 2001,November 2001,Treatment,,,,All,15 Years,85 Years,2001-11-01,2001-08-01,92.0
NCT00963599,3.144139096,Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117),Completed,Phase 3,Randomized,September 1999,November 1999,Treatment,,,,All,15 Years,85 Years,1999-11-01,1999-09-01,61.0
NCT00964158,3.251461988,Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A),Completed,Phase 3,,"September 10, 2009","November 27, 2010",Prevention,Bilbao,,48013,All,3 Years,17 Years,2010-11-01,2009-09-01,426.0
NCT00965848,1.893939394,"A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections",Completed,Phase 4,Non-Randomized,June 2009,July 2010,Treatment,Bangkok,,,All,18 Years,,2010-07-01,2009-06-01,395.0
NCT00968149,2.716165414,A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED),Completed,Phase 3,Randomized,March 2001,July 2001,Treatment,,,,All,2 Years,14 Years,2001-07-01,2001-03-01,122.0
NCT00968526,1.086956522,Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults,Completed,Phase 3,Randomized,"September 8, 2009","September 23, 2010",Prevention,Wilrijk,,2610,All,18 Years,,2010-09-01,2009-09-01,365.0
NCT00968539,0.78125,Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults,Completed,Phase 3,Randomized,"September 8, 2009","September 28, 2010",Prevention,Gent,,9000,All,18 Years,60 Years,2010-09-01,2009-09-01,365.0
NCT00968669,15.60991028,A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults,Completed,Phase 2,Randomized,December 2009,January 2012,Treatment,Pell City,Alabama,35128,All,18 Years,65 Years,2012-01-01,2009-12-01,761.0
NCT00971425,2.064307458,Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1),Completed,Phase 3,Randomized,"September 8, 2009","October 8, 2010",Prevention,Rednitzhembach,Bayern,91126,All,61 Years,,2010-10-01,2009-09-01,395.0
NCT00972517,0.3415300546,Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children,Completed,Phase 3,,"September 29, 2009","November 22, 2010",Prevention,Kehl,Baden-Wuerttemberg,77694,All,3 Years,17 Years,2010-11-01,2009-09-01,426.0
NCT00972738,3.148001714,Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235),Completed,Phase 3,Randomized,April 2001,July 2001,Treatment,,,,All,15 Years,85 Years,2001-07-01,2001-04-01,91.0
NCT00972816,6.401922725,Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years),Completed,Phase 2/Phase 3,Randomized,September 2009,October 2010,Prevention,Downey,California,90241-4982,All,3 Years,8 Years,2010-10-01,2009-09-01,395.0
NCT00973349,0.1157407407,Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults,Completed,Phase 2/Phase 3,Randomized,September 2009,December 2010,Prevention,Miami,Florida,33143,All,18 Years,,2010-12-01,2009-09-01,456.0
NCT00974571,11.2882161,Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246),Completed,Phase 3,Randomized,November 2001,May 2002,Treatment,,,,All,15 Years,85 Years,2002-05-01,2001-11-01,181.0
NCT00975195,18.06849436,Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,February 2009,July 2013,Treatment,Concord,New South Wales,,All,40 Years,,2013-07-01,2009-02-01,1611.0
NCT00975780,5.299539171,A Trial to Reduce Pneumonia in Nursing Home Residents,Completed,Phase 3,Randomized,October 2009,December 2012,Prevention,New Haven,Connecticut,06520,All,65 Years,,2012-12-01,2009-10-01,1157.0
NCT00976456,16.9854509,Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer,Completed,Phase 3,Randomized,September 2009,October 2014,Treatment,Halle,,06120,All,65 Years,,2014-10-01,2009-09-01,1856.0
NCT00976820,11.2316024,Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age,Completed,Phase 2,Randomized,"October 20, 2009","March 21, 2011",Prevention,Conway,Arkansas,72034,All,6 Months,8 Years,2011-03-01,2009-10-01,516.0
NCT00978029,5.104895105,Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081),Completed,Phase 2,Randomized,November 2009,February 2010,Treatment,,,,All,50 Years,,2010-02-01,2009-11-01,92.0
NCT00978120,1.607312094,Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma,Completed,Phase 2,Randomized,October 2009,September 2010,Prevention,Atlanta,Georgia,,All,12 Years,,2010-09-01,2009-10-01,335.0
NCT00979407,3.892215569,Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1),Completed,Phase 3,Randomized,"October 12, 2009","November 4, 2010",Prevention,Caen cedex 9,Bayern,14033,All,18 Years,60 Years,2010-11-01,2009-10-01,396.0
NCT00979602,6.867444145,"Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older",Completed,Phase 3,Randomized,"November 9, 2009","February 1, 2011",Prevention,Mesa,Arizona,85213,All,18 Years,,2011-02-01,2009-11-01,457.0
NCT00980005,5.196385418,Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children,Completed,Phase 3,Randomized,"October 13, 2009","June 17, 2010",Prevention,Birmingham,Alabama,35205,All,3 Years,17 Years,2010-06-01,2009-10-01,243.0
NCT00980200,0.2666666667,Efficacy and Safety Study in Subjects With Asthma,Completed,Phase 2,Randomized,September 2009,January 2010,Treatment,Cypress,California,90630,All,18 Years,,2010-01-01,2009-09-01,122.0
NCT00981409,21.42857143,The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients,Completed,Phase 3,Randomized,July 2007,December 2008,Treatment,Aichi,,440-8510,All,20 Years,,2008-12-01,2007-07-01,519.0
NCT00984542,26.0,Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer,Completed,Phase 2,,September 2009,September 2012,Treatment,Elizabethtown,Kentucky,42701,All,18 Years,,2012-09-01,2009-09-01,1096.0
NCT00985088,3.734665947,Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older,Completed,Phase 2,Randomized,"October 11, 2009","December 16, 2010",Prevention,Huntsville,Alabama,35802,All,18 Years,,2010-12-01,2009-10-01,426.0
NCT00985673,9.167919846,Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults,Completed,Phase 2,Randomized,"October 1, 2009","December 29, 2010",Prevention,Stockbridge,Georgia,30281,All,19 Years,40 Years,2010-12-01,2009-10-01,426.0
NCT00985790,2.503400299,Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children,Completed,Phase 2,Randomized,"October 8, 2009","May 21, 2010",Prevention,Ecatepec de Morelos,Estado De México,55075,All,18 Months,47 Months,2010-05-01,2009-10-01,212.0
NCT00986102,1.992244121,PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region,Completed,Phase 4,,July 2009,September 2011,Treatment,Hk,,,All,18 Years,,2011-09-01,2009-07-01,792.0
NCT00986154,1.553398424,Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).,Completed,Phase 3,Randomized,October 2009,April 2013,Treatment,Mobile,Alabama,36608,All,18 Years,,2013-04-01,2009-10-01,1278.0
NCT00986674,42.41037173,Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,September 2009,December 2013,Treatment,Stanford,California,94305,All,18 Years,,2013-12-01,2009-09-01,1552.0
NCT00988247,21.02547211,Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis,Completed,Phase 3,Randomized,"October 31, 2009","February 28, 2011",Treatment,Oxford,Alabama,36203,All,12 Years,,2011-02-01,2009-10-01,488.0
NCT00988858,12.72727273,A Study of Advanced or Metastatic Non-small Cell Lung Cancer,Completed,Phase 2,,November 2009,November 2014,Treatment,Tucson,Arizona,85704,All,18 Years,,2014-11-01,2009-11-01,1826.0
NCT00989287,1.526806527,Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults,Completed,Phase 3,Randomized,"October 7, 2009","October 26, 2010",Prevention,Gent,,9000,All,18 Years,60 Years,2010-10-01,2009-10-01,365.0
NCT00989833,10.61860844,Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients,Completed,Phase 2,Randomized,September 2009,July 2010,Treatment,Oslo,,,All,12 Years,,2010-07-01,2009-09-01,303.0
NCT00992017,7.8125,Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women,Completed,Phase 2,,October 2009,November 2010,Prevention,Alhambra,California,91803,Female,18 Years,39 Years,2010-11-01,2009-10-01,396.0
NCT00992784,1.584178096,Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People,Completed,Phase 3,Randomized,"October 15, 2009","May 27, 2010",Prevention,Gueglingen,Baden-Wuerttemberg,74363,All,19 Years,,2010-05-01,2009-10-01,212.0
NCT00992836,3.225806452,Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth,Completed,Phase 2,,October 2009,August 2010,Prevention,Birmingham,Alabama,35233,All,4 Years,25 Years,2010-08-01,2009-10-01,304.0
NCT00996307,10.99385625,"Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months",Completed,Phase 2/Phase 3,Randomized,October 2009,December 2010,Prevention,Bentonville,Arkansas,72712,All,6 Months,35 Months,2010-12-01,2009-10-01,426.0
NCT00997334,15.0,Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC,Completed,Phase 2,,February 2010,January 2017,Treatment,Boston,Massachusetts,02115,All,18 Years,,2017-01-01,2010-02-01,2526.0
NCT00999466,14.83516484,The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen,Completed,Phase 2,Randomized,October 2009,December 2011,Treatment,London,,,All,18 Years,55 Years,2011-12-01,2009-10-01,791.0
NCT00999908,1.851851852,Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity,Completed,Phase 3,Randomized,October 2009,March 2010,Treatment,Bergamo,,,All,40 Years,,2010-03-01,2009-10-01,151.0
NCT00999921,11.30134896,Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer,Completed,Phase 4,Randomized,January 2008,January 2015,Treatment,Kolkata,West Bengal,700073,Female,16 Years,,2015-01-01,2008-01-01,2557.0
NCT01000025,12.08333333,PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer,Completed,Phase 3,Randomized,"December 23, 2009","November 27, 2015",Treatment,Arcadia,California,91007,All,18 Years,,2015-11-01,2009-12-01,2161.0
NCT01000480,13.33333333,"A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer",Completed,Phase 2,,October 2009,July 2013,Treatment,Le Mans,,72000,All,18 Years,,2013-07-01,2009-10-01,1369.0
NCT01000506,10.38223066,Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma,Completed,Phase 2,Randomized,"November 1, 2009","March 23, 2012",Treatment,Long Beach,California,90808,All,12 Years,65 Years,2012-03-01,2009-11-01,851.0
NCT01001169,5.0,Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children,Completed,Phase 2,Non-Randomized,"October 1, 2009","May 17, 2010",Prevention,Tokyo,,157-8535,All,6 Months,17 Years,2010-05-01,2009-10-01,212.0
NCT01001325,5.982905983,Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?,Completed,Phase 3,Randomized,October 2009,July 2010,Health Services Research,North York,Ontario,M2K 1E1,All,18 Years,60 Years,2010-07-01,2009-10-01,273.0
NCT01001494,8.783284319,Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 3,Randomized,October 2009,November 2010,Treatment,Benesov,,256 01,All,40 Years,,2010-11-01,2009-10-01,396.0
NCT01003899,30.95238095,A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR],Completed,Phase 2,Non-Randomized,October 2009,,Treatment,Seoul,,,All,18 Years,80 Years,,2009-10-01,
NCT01005680,5.83028083,A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer,Completed,Phase 3,Randomized,November 2009,November 2012,Treatment,Beijing,,100730,All,18 Years,,2012-11-01,2009-11-01,1096.0
NCT01005901,17.8123936,"A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo",Completed,Phase 3,Randomized,October 2009,December 2010,Treatment,Birmingham,Alabama,,All,40 Years,,2010-12-01,2009-10-01,426.0
NCT01006629,6.0,Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children,Completed,Phase 2/Phase 3,Non-Randomized,November 2009,July 2010,Prevention,Ivanovo,,153731,All,,2 Years,2010-07-01,2009-11-01,242.0
NCT01007149,4.761904762,Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma,Completed,Phase 3,Randomized,September 2009,February 2011,Basic Science,Arnaud de Villeneuve,,,All,18 Years,70 Years,2011-02-01,2009-09-01,518.0
NCT01007253,0.0,Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms,Completed,Phase 4,Randomized,November 2009,August 2011,,Chicago,Illinois,60637,All,18 Years,45 Years,2011-08-01,2009-11-01,638.0
NCT01009099,1.260504202,Reducing Dynamic Hyperinflation Through Breathing Retraining,Completed,Phase 2/Phase 3,Randomized,July 2009,January 2015,Treatment,Hines,Illinois,60141-5000,All,21 Years,85 Years,2015-01-01,2009-07-01,2010.0
NCT01009463,15.84137206,A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"September 25, 2009","October 31, 2011",Treatment,Birmingham,Alabama,35235,All,40 Years,,2011-10-01,2009-09-01,760.0
NCT01010971,3.594082417,Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older,Completed,Phase 3,Randomized,December 2009,February 2010,Treatment,Austin,Texas,78731,All,12 Years,,2010-02-01,2009-12-01,62.0
NCT01011049,0.6592449969,Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM,Completed,Phase 2,Randomized,September 2009,October 2010,Prevention,Hoover,Alabama,35216,All,18 Years,64 Years,2010-10-01,2009-09-01,395.0
NCT01014988,10.31339031,Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital,Completed,Phase 2,,November 2009,February 2015,Treatment,Birmingham,Alabama,35233,All,6 Months,,2015-02-01,2009-11-01,1918.0
NCT01017874,20.33898305,A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer,Completed,Phase 3,Randomized,November 2009,October 2014,Treatment,Kowloon,,405-760,All,18 Years,,2014-10-01,2009-11-01,1795.0
NCT01017952,17.70079902,A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"September 25, 2009","October 17, 2011",Treatment,Birmingham,Alabama,35215,All,40 Years,,2011-10-01,2009-09-01,760.0
NCT01018030,5.428004535,Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis,Completed,Phase 2,Randomized,"January 6, 2010","July 16, 2010",Treatment,Ruse,British Columbia,7000,All,12 Years,,2010-07-01,2010-01-01,181.0
NCT01018186,11.16816906,Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study,Completed,Phase 3,Randomized,"October 19, 2009","May 12, 2011",Treatment,Oxford,Alabama,36203,All,12 Years,,2011-05-01,2009-10-01,577.0
NCT01018862,7.373162614,A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,November 2009,April 2011,Treatment,Costa Mesa,California,92626,All,6 Years,12 Years,2011-04-01,2009-11-01,516.0
NCT01019694,23.4938098,Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,November 2009,,Treatment,Jasper,Alabama,,All,40 Years,,,2009-11-01,
NCT01020786,26.60550459,A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients,Completed,Phase 4,,November 2009,June 2012,Treatment,Aichi,,460-0001,All,20 Years,,2012-06-01,2009-11-01,943.0
NCT01023516,5.843894801,Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol,Completed,Phase 2,Randomized,November 2009,August 2010,Treatment,Lovech,Hunedoara,,All,40 Years,80 Years,2010-08-01,2009-11-01,273.0
NCT01024608,2.367195434,Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR),Completed,Phase 3,Randomized,"December 31, 2009","February 28, 2010",Treatment,Austin,Texas,78731,All,12 Years,,2010-02-01,2009-12-01,62.0
NCT01025284,0.0,A Study for Participants With Small-Cell Lung Cancer,Completed,Phase 2,Non-Randomized,December 2009,July 2012,Treatment,Torrington,Connecticut,06790,All,18 Years,,2012-07-01,2009-12-01,943.0
NCT01030965,3.858568075,28-day Repeat Dose Study of GSK573719,Completed,Phase 2,Randomized,"December 15, 2009","July 4, 2010",Treatment,Madisonville,Kentucky,42431,All,40 Years,80 Years,2010-07-01,2009-12-01,212.0
NCT01033825,4.40121348,Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis,Completed,Phase 3,Randomized,January 2010,May 2010,Treatment,Stockbridge,Georgia,30281,All,12 Years,,2010-05-01,2010-01-01,120.0
NCT01039675,9.523809524,"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD",Completed,Phase 2,Randomized,"January 1, 2010","April 20, 2010",Treatment,Chester,South Carolina,29706,All,40 Years,,2010-04-01,2010-01-01,90.0
NCT01040689,2.777777778,Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,January 2010,,Treatment,Genk,,,All,40 Years,,,2010-01-01,
NCT01040728,4.098360656,"A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease",Completed,Phase 3,Randomized,January 2010,,Treatment,Jasper,Alabama,,All,40 Years,,,2010-01-01,
NCT01040780,1.003768844,Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients,Completed,Phase 3,Randomized,February 2009,December 2011,Treatment,Beijing,Beijing,100020,All,18 Years,75 Years,2011-12-01,2009-02-01,1033.0
NCT01042158,0.0,A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis,Completed,Phase 4,,January 2010,November 2014,Treatment,Baltimore,Maryland,21287,All,18 Years,,2014-11-01,2010-01-01,1765.0
NCT01044459,30.98639794,"Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)",Completed,Phase 3,Randomized,November 2009,April 2011,Treatment,Birmingham,Alabama,35209,All,40 Years,,2011-04-01,2009-11-01,516.0
NCT01045421,1.424242424,"Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies",Completed,Phase 1/Phase 2,Randomized,February 2010,April 2014,Treatment,Houston,Texas,,All,18 Years,,2014-04-01,2010-02-01,1520.0
NCT01046136,2.639977604,Mucinex Exploratory Cold Study,Completed,Phase 2,Randomized,December 2009,,Treatment,Bellevue,Nebraska,68005,All,12 Years,,,2009-12-01,
NCT01047553,9.177777778,Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 3,Randomized,December 2009,July 2011,Treatment,Nagoya,Aichi,,All,40 Years,,2011-07-01,2009-12-01,577.0
NCT01048866,4.062468102,A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis,Completed,Phase 3,Randomized,November 2009,March 2011,Treatment,New York,New York,10010,All,18 Years,,2011-03-01,2009-11-01,485.0
NCT01049334,6.862745098,A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis,Completed,Phase 3,Randomized,November 2009,March 2011,Treatment,Storrs,Connecticut,06268,All,18 Years,,2011-03-01,2009-11-01,485.0
NCT01050257,23.26415094,A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza,Completed,Phase 3,Randomized,January 2010,September 2012,Treatment,Birmingham,Alabama,35233,All,13 Years,,2012-09-01,2010-01-01,974.0
NCT01052038,11.66666667,Post Operative Sore Throat and Dexamethasone,Completed,Phase 4,Randomized,January 2010,September 2010,Prevention,Chicago,Illinois,60611,Female,18 Years,64 Years,2010-09-01,2010-01-01,243.0
NCT01052116,10.62176166,The Study of Soy Isoflavones in Asthma,Completed,Phase 4,Randomized,March 2010,August 2012,Treatment,Tucson,Arizona,85724,All,12 Years,,2012-08-01,2010-03-01,884.0
NCT01052480,17.34693878,Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza,Completed,Phase 2,Randomized,December 2010,November 2015,Treatment,Los Angeles,California,90095-1752,All,,,2015-11-01,2010-12-01,1796.0
NCT01053988,15.82634091,A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"October 5, 2009","April 14, 2011",Treatment,Mobile,Alabama,36608,All,40 Years,,2011-04-01,2009-10-01,547.0
NCT01054170,19.11111111,"Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients",Completed,Phase 2,Randomized,January 2010,November 2010,Treatment,Kingston,Ontario,,All,50 Years,80 Years,2010-11-01,2010-01-01,304.0
NCT01054885,14.12738855,Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"October 19, 2009","February 8, 2011",Treatment,Birmingham,Alabama,35235,All,40 Years,,2011-02-01,2009-10-01,488.0
NCT01055197,12.98701299,Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,March 2010,December 2016,Treatment,Tucson,Arizona,85704,All,18 Years,,2016-12-01,2010-03-01,2467.0
NCT01059565,25.24038462,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection,Completed,Phase 3,Randomized,February 2010,January 2012,Treatment,Mobile,Alabama,36608,All,6 Years,,2012-01-01,2010-02-01,699.0
NCT01059643,4.854368932,"A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck",Completed,Phase 2,,April 2011,December 2012,Treatment,Jonesboro,Arkansas,72401,All,18 Years,,2012-12-01,2011-04-01,610.0
NCT01067105,16.38349515,A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older,Completed,Phase 3,,February 2010,November 2010,Treatment,Huntington Beach,California,92647,All,12 Years,,2010-11-01,2010-02-01,273.0
NCT01068600,6.603773585,Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks,Completed,Phase 3,Randomized,January 2010,,Treatment,Anniston,Alabama,36207-5710,All,40 Years,,,2010-01-01,
NCT01068912,8.597822557,Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza,Completed,Phase 2,Randomized,February 2010,May 2012,Treatment,Birmingham,Alabama,,All,20 Years,80 Years,2012-05-01,2010-02-01,820.0
NCT01069289,7.406450131,Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 3,Randomized,January 2010,March 2011,Treatment,New Delhi,Delhi,,All,40 Years,,2011-03-01,2010-01-01,424.0
NCT01070784,14.61538462,A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan,Completed,Phase 3,Randomized,January 2010,October 2011,Treatment,Nagoya,Aichi,,All,40 Years,,2011-10-01,2010-01-01,638.0
NCT01072396,9.523809524,Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,February 2010,November 2011,Treatment,Birmingham,Alabama,,All,40 Years,,2011-11-01,2010-02-01,638.0
NCT01072448,10.54447853,12-week Efficacy of Indacaterol,Completed,Phase 3,Randomized,January 2010,July 2010,Treatment,Peoria,Arizona,85381,All,40 Years,,2010-07-01,2010-01-01,181.0
NCT01077713,16.23376623,A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,February 2010,July 2014,Treatment,Rionero in Vulture,Basilicata,85028,All,70 Years,,2014-07-01,2010-02-01,1611.0
NCT01079130,4.002662794,Efficacy and Safety of Different Doses of Indacaterol,Completed,Phase 3,Randomized,February 2010,,Treatment,Glendale,Arizona,85306,All,18 Years,,,2010-02-01,
NCT01085136,27.98960139,LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib,Completed,Phase 3,Randomized,February 2010,January 2016,Treatment,Ciudad Autonoma de Buenos Aires,New South Wales,,All,18 Years,,2016-01-01,2010-02-01,2160.0
NCT01086384,10.20272989,Asthma Exacerbation Study,Completed,Phase 3,Randomized,"February 22, 2010","September 15, 2011",Treatment,Birmingham,Alabama,35209,All,12 Years,,2011-09-01,2010-02-01,577.0
NCT01089127,2.947521143,Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,March 2010,July 2010,Treatment,Florence,Alabama,35630,All,40 Years,,2010-07-01,2010-03-01,122.0
NCT01096017,0.0,To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study,Completed,Phase 3,Randomized,March 2010,April 2010,Treatment,Tokyo,,,All,16 Years,,2010-04-01,2010-03-01,31.0
NCT01097694,19.16666667,Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA),Completed,Phase 2,Randomized,November 2010,August 2016,Treatment,Birmingham,Alabama,35294,All,18 Years,65 Years,2016-08-01,2010-11-01,2100.0
NCT01102374,12.13286713,Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents,Completed,Phase 2,Randomized,May 2010,July 2016,Prevention,Aurora,Colorado,80045,All,60 Years,,2016-07-01,2010-05-01,2253.0
NCT01104155,34.84126984,"Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,"February 22, 2010","January 18, 2017",Treatment,Bessemer,Alabama,,All,18 Years,,2017-01-01,2010-02-01,2526.0
NCT01106014,18.88417927,Selexipag (ACT-293987) in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,"December 1, 2009","October 1, 2014",Treatment,Mobile,Alabama,36617,All,18 Years,75 Years,2014-10-01,2009-12-01,1765.0
NCT01109524,35.0,Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer,Completed,Phase 2,,July 2010,September 2012,Treatment,Casa Grande,Arizona,85122,All,18 Years,,2012-09-01,2010-07-01,793.0
NCT01110200,24.41499265,Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study,Completed,Phase 4,Randomized,"April 30, 2010","May 8, 2012",Treatment,Birmingham,Alabama,35233,All,40 Years,85 Years,2012-05-01,2010-04-01,761.0
NCT01118312,17.78867884,Study of Asthma and Nasal Steroids,Completed,Phase 4,Randomized,September 2010,June 2015,Treatment,Tucson,Arizona,85724,All,6 Years,,2015-06-01,2010-09-01,1734.0
NCT01119937,12.78455285,Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients,Completed,Phase 3,Randomized,May 2010,,Treatment,Iizuka,Fukuoka,820-8505,All,40 Years,,,2010-05-01,
NCT01120093,2.53164557,Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.,Completed,Phase 2,Randomized,May 2010,August 2010,Treatment,Gent,,B-9000,All,40 Years,,2010-08-01,2010-05-01,92.0
NCT01120691,15.90804467,Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations,Completed,Phase 3,Randomized,April 2010,July 2012,Treatment,Birmingham,Alabama,35233,All,40 Years,,2012-07-01,2010-04-01,822.0
NCT01120717,11.74827925,A Study to Assess the Long-term Safety of QVA149,Completed,Phase 3,Randomized,April 2010,December 2011,Treatment,Toronto,Ontario,M3H 5S4,All,40 Years,,2011-12-01,2010-04-01,609.0
NCT01121393,33.04769001,BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,"April 19, 2010","November 26, 2017",Treatment,Beijing,,100020,All,18 Years,,2017-11-01,2010-04-01,2771.0
NCT01122680,1.904761905,Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma,Completed,Phase 2,Randomized,May 2010,,Treatment,Denver,Colorado,,All,12 Years,17 Years,,2010-05-01,
NCT01124422,5.112656981,Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,"July 19, 2010","May 2, 2011",Treatment,Birmingham,Alabama,35294,All,40 Years,,2011-05-01,2010-07-01,304.0
NCT01124864,10.3403731,A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.,Completed,Phase 2,Non-Randomized,October 2010,August 2014,Treatment,Los Angeles,California,90095,All,18 Years,,2014-08-01,2010-10-01,1400.0
NCT01126437,22.20118932,Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,May 2010,May 2013,Treatment,Athens,Alabama,,All,40 Years,,2013-05-01,2010-05-01,1096.0
NCT01128595,0.9259259259,"Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response",Completed,Phase 2,Randomized,May 2010,May 2011,Treatment,Randwick,New South Wales,2031,All,18 Years,65 Years,2011-05-01,2010-05-01,365.0
NCT01133626,7.139227642,Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,June 2010,September 2010,Treatment,North Dartmouth,Massachusetts,02747,All,12 Years,45 Years,2010-09-01,2010-06-01,92.0
NCT01134042,8.884858927,Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics,Completed,Phase 3,Randomized,June 2010,October 2011,Treatment,Bell Gardens,California,90201,All,12 Years,,2011-10-01,2010-06-01,487.0
NCT01134705,7.933613322,Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis),Completed,Phase 3,Randomized,May 2010,October 2010,Treatment,Los Angeles,California,90025,All,12 Years,,2010-10-01,2010-05-01,153.0
NCT01135134,0.6697506034,"Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)",Completed,Phase 3,Randomized,June 2010,October 2010,Treatment,,,,All,5 Years,15 Years,2010-10-01,2010-06-01,122.0
NCT01136174,16.66666667,Safety and PK Study of BIBF 1120 in Japanese Patients With IPF,Completed,Phase 2,Randomized,May 2010,,,"Bunkyo-ku,Tokyo",,,All,40 Years,,,2010-05-01,
NCT01136382,5.921052632,A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo,Completed,Phase 2,Randomized,July 2010,April 2013,Treatment,Scottsdale,Arizona,,All,6 Years,11 Years,2013-04-01,2010-07-01,1005.0
NCT01137435,3.641881639,Post Marketing Surveillance for ADACEL™ in South Korea,Completed,Phase 4,,June 2010,September 2016,Prevention,Jung-gu,Incheon,,All,11 Years,64 Years,2016-09-01,2010-06-01,2284.0
NCT01139775,22.79821628,A Study in Non Small Cell Lung Cancer,Completed,Phase 1/Phase 2,Randomized,February 2011,August 2014,Treatment,Mannheim,Baden-Wurttemberg,68167,All,18 Years,,2014-08-01,2011-02-01,1277.0
NCT01144299,1.666666667,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults,Completed,Phase 3,Non-Randomized,"June 17, 2010","July 10, 2010",Prevention,Dresden,Sachsen,01067,All,18 Years,,2010-07-01,2010-06-01,30.0
NCT01146860,0.2604166667,Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis,Completed,Phase 3,Randomized,January 2010,April 2010,Treatment,Puchheim,,82178,All,18 Years,75 Years,2010-04-01,2010-01-01,90.0
NCT01147068,4.09158924,Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults,Completed,Phase 1/Phase 2,Randomized,June 2010,October 2011,Prevention,Overland Park,Kansas,66210,All,18 Years,49 Years,2011-10-01,2010-06-01,487.0
NCT01147744,9.368932039,Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily,Completed,Phase 2,Randomized,"June 28, 2010","October 6, 2011",Treatment,Birmingham,Alabama,35209,Female,12 Years,,2011-10-01,2010-06-01,487.0
NCT01147848,7.320099256,HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents,Completed,Phase 3,Randomized,June 2010,July 2011,Treatment,Huntington Beach,California,92647,All,12 Years,,2011-07-01,2010-06-01,395.0
NCT01152814,3.125,"Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011",Completed,Phase 2,,June 2010,July 2010,Prevention,Chieti,,66100,All,65 Years,,2010-07-01,2010-06-01,30.0
NCT01153321,6.818181818,Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,October 2010,July 2011,Basic Science,Hannover,,,All,40 Years,,2011-07-01,2010-10-01,273.0
NCT01153984,8.695652174,A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations,Completed,Phase 2,,June 2011,July 2015,Treatment,Alba Iulia,,510073,All,18 Years,,2015-07-01,2011-06-01,1491.0
NCT01154127,10.2058319,Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,June 2010,February 2011,Treatment,Spartanburg,South Carolina,29303,All,40 Years,,2011-02-01,2010-06-01,245.0
NCT01154153,5.695039804,Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis,Completed,Phase 4,Randomized,June 2010,October 2010,Treatment,Cypress,California,90630,All,2 Years,12 Years,2010-10-01,2010-06-01,122.0
NCT01156844,4.78916127,"Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol",Completed,Phase 2,Randomized,March 2010,,Treatment,Anniston,Alabama,36207,All,18 Years,,,2010-03-01,
NCT01159912,9.605898805,Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents,Completed,Phase 3,Randomized,"June 30, 2010","January 16, 2012",Treatment,Birmingham,Alabama,35209,All,12 Years,,2012-01-01,2010-06-01,579.0
NCT01160744,15.74811186,A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,September 2010,April 2018,Treatment,Scottsdale,Arizona,85258,All,18 Years,,2018-04-01,2010-09-01,2769.0
NCT01162122,4.095053181,Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects,Completed,Phase 3,Randomized,August 2010,November 2011,Prevention,Phoenix,Arizona,85253,All,65 Years,,2011-11-01,2010-08-01,457.0
NCT01165138,4.92959927,Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics,Completed,Phase 3,Randomized,"August 20, 2010","October 19, 2011",Treatment,Bell Gardens,California,90201,All,12 Years,,2011-10-01,2010-08-01,426.0
NCT01165424,3.75,A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1),Completed,Phase 3,,April 2010,December 2010,Treatment,,,,All,3 Years,15 Years,2010-12-01,2010-04-01,244.0
NCT01168973,24.56700637,A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy,Completed,Phase 3,Randomized,December 2010,August 2016,Treatment,Phoenix,Arizona,85016,All,18 Years,,2016-08-01,2010-12-01,2070.0
NCT01172808,6.640860741,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I,Completed,Phase 3,Randomized,August 2010,November 2012,Treatment,Huntington Beach,California,,All,18 Years,75 Years,2012-11-01,2010-08-01,823.0
NCT01172821,5.427597272,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II,Completed,Phase 3,Randomized,August 2010,November 2012,Treatment,Los Angeles,California,,All,18 Years,75 Years,2012-11-01,2010-08-01,823.0
NCT01174563,6.666666667,A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy,Completed,Phase 2,,"May 23, 2011","December 20, 2016",Treatment,Afula,,18101,All,18 Years,,2016-12-01,2011-05-01,2041.0
NCT01177722,2.836652742,A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants,Completed,Phase 3,Randomized,August 2010,December 2011,Prevention,Cali,,,All,55 Days,65 Days,2011-12-01,2010-08-01,487.0
NCT01178073,20.70117346,A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH),Completed,Phase 3,Randomized,"October 1, 2010","July 31, 2014",Treatment,Birmingham,Alabama,35294,All,18 Years,75 Years,2014-07-01,2010-10-01,1369.0
NCT01181895,5.467266367,Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma,Completed,Phase 3,Randomized,"September 1, 2010","August 26, 2011",Treatment,Huntington Beach,California,92647,All,12 Years,,2011-08-01,2010-09-01,334.0
NCT01183858,20.45250347,A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS),Completed,Phase 3,Randomized,October 2010,February 2014,Treatment,Beijing,Barcelona,100071,All,18 Years,,2014-02-01,2010-10-01,1219.0
NCT01185080,2.0,Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848,Completed,Phase 2,Randomized,September 2010,January 2012,Treatment,Lund,Malmohus Lan,,All,18 Years,55 Years,2012-01-01,2010-09-01,487.0
NCT01189487,2.127659574,The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP),Completed,Phase 3,Non-Randomized,October 2010,April 2011,Treatment,Seto-shi,Aichi-ken,,All,16 Years,79 Years,2011-04-01,2010-10-01,182.0
NCT01190215,2.631578947,Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM,Completed,Phase 4,Randomized,"October 4, 2010","July 7, 2011",Prevention,Tampere,,33100,All,10 Years,18 Years,2011-07-01,2010-10-01,273.0
NCT01192191,14.14698163,A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD,Completed,Phase 3,Randomized,August 2010,January 2012,Treatment,Fukuoka,,811-2201,All,40 Years,,2012-01-01,2010-08-01,518.0
NCT01196026,5.126849894,Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™,Completed,Phase 4,Randomized,"September 15, 2010","May 26, 2011",Prevention,Rotterdam,,3011 EN,All,1 Year,10 Years,2011-05-01,2010-09-01,242.0
NCT01196078,17.70050125,A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 4,Randomized,February 2007,December 2010,Treatment,Taipei,,,All,70 Years,,2010-12-01,2007-02-01,1399.0
NCT01196975,3.12508311,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults,Completed,Phase 3,Randomized,"October 1, 2010","June 24, 2011",Prevention,Mesa,Arizona,85213,All,18 Years,,2011-06-01,2010-10-01,243.0
NCT01196988,2.30924267,Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children,Completed,Phase 3,Randomized,"October 4, 2010","June 15, 2011",Prevention,Sacramento,California,95816,All,6 Months,17 Years,2011-06-01,2010-10-01,243.0
NCT01198756,5.059929038,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children,Completed,Phase 3,Randomized,"October 1, 2010","July 1, 2011",Prevention,Chandler,Arizona,85224,All,6 Months,17 Years,2011-07-01,2010-10-01,273.0
NCT01202188,7.371642787,"A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,September 2010,March 2012,Treatment,Fullerton,California,92835,All,40 Years,,2012-03-01,2010-09-01,547.0
NCT01202903,3.625525947,Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy,Completed,Phase 3,Randomized,September 2010,October 2013,Treatment,Beijing,Beijing,100023,All,18 Years,75 Years,2013-10-01,2010-09-01,1126.0
NCT01204671,1.198772312,Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A),Completed,Phase 3,Randomized,"October 4, 2010","June 6, 2011",Prevention,Chandler,Arizona,85224,All,18 Years,,2011-06-01,2010-10-01,243.0
NCT01204697,19.10660661,A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN),Completed,Phase 2,Randomized,November 2010,July 2014,Treatment,Avellino,Campania,83100,All,18 Years,,2014-07-01,2010-11-01,1338.0
NCT01214187,18.96551724,Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis,Completed,Phase 2,Randomized,July 2011,April 2015,Treatment,San Francisco,California,94143,All,18 Years,85 Years,2015-04-01,2011-07-01,1370.0
NCT01218126,12.81366318,"Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).",Completed,Phase 2,Randomized,"November 4, 2010","December 21, 2011",Treatment,Birmingham,Alabama,35294,All,40 Years,,2011-12-01,2010-11-01,395.0
NCT01218308,4.31501548,A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children,Completed,Phase 3,Randomized,"December 9, 2010","January 9, 2012",Prevention,Dhaka,,1000,All,3 Years,8 Years,2012-01-01,2010-12-01,396.0
NCT01218646,0.7239583333,Study of Quadrivalent Influenza Vaccine Among Adults,Completed,Phase 3,Randomized,October 2010,April 2011,Prevention,Hoover,Alabama,35216,All,18 Years,,2011-04-01,2010-10-01,182.0
NCT01222403,0.2638522427,A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older,Completed,Phase 4,Non-Randomized,October 2010,October 2014,Prevention,Gimpo-si,Gyeonggi-do,415-040,All,65 Years,,2014-10-01,2010-10-01,1461.0
NCT01225211,4.825908858,Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation,Completed,Phase 2,Randomized,October 2010,April 2014,Treatment,Birmingham,Alabama,,All,18 Years,,2014-04-01,2010-10-01,1278.0
NCT01227278,10.88235294,A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,November 2010,July 2013,Treatment,Los Angeles,California,,All,40 Years,85 Years,2013-07-01,2010-11-01,973.0
NCT01227421,6.068342303,Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza,Completed,Phase 2/Phase 3,Randomized,December 2010,May 2011,Treatment,Elmira,New York,14901,All,12 Years,65 Years,2011-05-01,2010-12-01,151.0
NCT01227967,4.310591213,"Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications",Completed,Phase 2,Randomized,September 2010,"March 30, 2017",Treatment,Birmingham,Alabama,35211,All,18 Years,,2017-03-01,2010-09-01,2373.0
NCT01229150,6.666666667,Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...,Completed,Phase 2,Randomized,"October 26, 2010","November 21, 2015",Treatment,Davis,California,95616,All,18 Years,,2015-11-01,2010-10-01,1857.0
NCT01229371,0.2252252252,Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers,Completed,Phase 3,Randomized,October 2010,December 2010,Prevention,Allschwil,,4123,All,18 Years,,2010-12-01,2010-10-01,61.0
NCT01230710,7.843137255,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression,Completed,Phase 4,Non-Randomized,March 2011,September 2013,Treatment,Bangalore,,560027,All,18 Years,,2013-09-01,2011-03-01,915.0
NCT01231464,3.304292393,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis",Completed,Phase 3,Randomized,September 2009,July 2010,Treatment,Nanjing,Jiangsu,210029,All,12 Years,65 Years,2010-07-01,2009-09-01,303.0
NCT01231620,6.664917138,A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza,Completed,Phase 3,Randomized,"January 15, 2011","March 18, 2015",Treatment,Birmingham,Alabama,35249,All,16 Years,,2015-03-01,2011-01-01,1520.0
NCT01232452,30.20960108,A Study in Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,April 2011,June 2016,Treatment,Chicago,Illinois,60611,All,18 Years,,2016-06-01,2011-04-01,1888.0
NCT01232894,19.16666667,12-week Open-label Evaluation of Efficacy and Safety of Indacaterol,Completed,Phase 3,Randomized,March 2011,May 2012,Treatment,Afula,,,All,40 Years,,2012-05-01,2011-03-01,427.0
NCT01233232,1.149425287,A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,November 2010,March 2011,Treatment,Sofia,,,All,40 Years,80 Years,2011-03-01,2010-11-01,120.0
NCT01233687,2.222222222,AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer,Completed,Phase 1/Phase 2,,August 2011,November 2014,Treatment,Pittsburgh,Pennsylvania,15232,All,18 Years,,2014-11-01,2011-08-01,1188.0
NCT01238861,11.50951213,Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma,Completed,Phase 2,Randomized,December 2010,August 2013,Treatment,Birmingham,Alabama,,All,18 Years,75 Years,2013-08-01,2010-12-01,974.0
NCT01240746,7.670176499,Study of Quadrivalent Influenza Vaccine Among Children,Completed,Phase 3,Randomized,November 2010,February 2012,Prevention,Dothan,Alabama,36305,All,6 Months,8 Years,2012-02-01,2010-11-01,457.0
NCT01243775,6.060606061,BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC,Completed,Phase 2,,November 2010,January 2013,Treatment,Hwasun,Jeonnam,519-809,All,18 Years,,2013-01-01,2010-11-01,792.0
NCT01244984,8.363201912,A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma,Completed,Phase 3,Non-Randomized,July 2010,January 2012,Treatment,Chiba,,277-0863,All,18 Years,,2012-01-01,2010-07-01,549.0
NCT01248065,10.77943615,Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma,Completed,Phase 3,Randomized,April 2011,January 2014,Treatment,San Francisco,California,94143,All,18 Years,,2014-01-01,2011-04-01,1006.0
NCT01248715,0.0,Rapid Empiric Treatment With Oseltamivir Study (RETOS),Completed,Phase 4,Randomized,November 2010,May 2016,Treatment,Louisville,Kentucky,40202,All,18 Years,,2016-05-01,2010-11-01,2008.0
NCT01249833,0.7936507937,Effect of Oseltamivir on Cognitive Function in Subjects With Influenza,Completed,Phase 4,Randomized,November 2010,April 2012,Treatment,Vancouver,British Columbia,L1V 2A6,All,18 Years,65 Years,2012-04-01,2010-11-01,517.0
NCT01253369,27.27272727,Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer,Completed,Phase 2,,June 2010,December 2014,Treatment,Boston,Massachusetts,02114,All,18 Years,,2014-12-01,2010-06-01,1644.0
NCT01253577,2.857142857,A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis,Completed,Phase 3,Randomized,December 2009,October 2010,Treatment,Fresno,California,93720,All,18 Years,,2010-10-01,2009-12-01,304.0
NCT01255592,13.46153846,Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis,Completed,Phase 2,Randomized,February 2011,February 2012,Treatment,Ostrava,East Yorkshire,,All,18 Years,80 Years,2012-02-01,2011-02-01,365.0
NCT01257230,5.341812676,Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma,Completed,Phase 3,Randomized,December 2010,December 2013,Treatment,Plymouth,Minnesota,,All,12 Years,17 Years,2013-12-01,2010-12-01,1096.0
NCT01258595,0.6667852063,A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age,Completed,Phase 2,Randomized,November 2010,April 2011,Prevention,Idaho Falls,Idaho,83404,All,50 Years,64 Years,2011-04-01,2010-11-01,151.0
NCT01260181,0.0,A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations,Completed,Phase 2,,"March 31, 2011","September 29, 2017",Treatment,Aveiro,,3814-501,All,18 Years,,2017-09-01,2011-03-01,2376.0
NCT01262560,1.863498719,Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer,Completed,Phase 2,Randomized,February 2012,November 2014,Supportive Care,Mobile,Alabama,36608,All,18 Years,,2014-11-01,2012-02-01,1004.0
NCT01270464,13.94481305,A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma,Completed,Phase 3,Randomized,February 2011,September 2013,Treatment,Anaheim,California,,All,12 Years,75 Years,2013-09-01,2011-02-01,943.0
NCT01270958,3.333333333,"A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis",Completed,Phase 4,,August 2009,February 2010,,Ha Noi,,084,All,18 Years,,2010-02-01,2009-08-01,184.0
NCT01277523,1.003207932,Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma,Completed,Phase 3,Randomized,January 2011,October 2013,Treatment,Stockton,California,,All,12 Years,17 Years,2013-10-01,2011-01-01,1004.0
NCT01285323,12.28448276,A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma,Completed,Phase 3,Randomized,March 2011,April 2014,Treatment,Mobile,Alabama,,All,12 Years,75 Years,2014-04-01,2011-03-01,1127.0
NCT01285492,8.004740358,Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,January 2011,September 2012,Treatment,Anjo,Aichi,446-8602,All,40 Years,,2012-09-01,2011-01-01,609.0
NCT01285609,36.53439758,Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin,Completed,Phase 3,Randomized,"January 16, 2011","August 22, 2017",Treatment,San Diego,California,92123,All,18 Years,,2017-08-01,2011-01-01,2404.0
NCT01287039,11.247909,A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma,Completed,Phase 3,Randomized,April 2011,March 2014,Treatment,Scottsdale,Arizona,,All,12 Years,75 Years,2014-03-01,2011-04-01,1065.0
NCT01287364,10.28173954,Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis,Completed,Phase 3,Randomized,February 2011,April 2011,,Mission Viejo,California,92691,All,12 Years,,2011-04-01,2011-02-01,59.0
NCT01297491,38.48484848,Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,May 2011,October 2014,Treatment,Chandler,Arizona,85224,All,18 Years,,2014-10-01,2011-05-01,1249.0
NCT01303510,0.9090909091,A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere,Completed,Phase 4,Randomized,July 2008,July 2008,Treatment,Allschwil,,4123,All,18 Years,,2008-07-01,2008-07-01,0.0
NCT01306253,1.754385965,A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere,Completed,Phase 4,Non-Randomized,June 2009,June 2009,Treatment,Allschwil,,4123,All,18 Years,,2009-06-01,2009-06-01,0.0
NCT01306305,1.818181818,A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere,Completed,Phase 4,Non-Randomized,June 2010,July 2010,Treatment,Allschwil,,4123,All,18 Years,,2010-07-01,2010-06-01,30.0
NCT01307319,2.661531745,Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies,Completed,Phase 3,Randomized,March 2011,August 2011,Treatment,Oxford,Alabama,36203,All,6 Years,11 Years,2011-08-01,2011-03-01,153.0
NCT01310036,17.87439614,A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations,Completed,Phase 2,,"April 30, 2011","December 30, 2016",Treatment,Hong Kong,,13620,All,18 Years,,2016-12-01,2011-04-01,2071.0
NCT01311557,0.8448540707,Study of Adacel® Vaccine Administered to Persons 10 Years of Age,Completed,Phase 4,Non-Randomized,March 2011,January 2012,Prevention,Chandler,Arizona,85224,All,10 Years,11 Years,2012-01-01,2011-03-01,306.0
NCT01312961,11.53846154,"Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma",Completed,Phase 2,Randomized,March 2011,October 2012,Treatment,Anaheim,California,92804,All,18 Years,65 Years,2012-10-01,2011-03-01,580.0
NCT01313637,11.43583315,A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD,Completed,Phase 3,Randomized,"March 1, 2011","April 19, 2012",Treatment,Jasper,Alabama,35501,All,40 Years,,2012-04-01,2011-03-01,397.0
NCT01313650,11.90237429,A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD,Completed,Phase 3,Randomized,"March 1, 2011","April 5, 2012",Treatment,Tucson,Arizona,85723,All,40 Years,,2012-04-01,2011-03-01,397.0
NCT01313676,23.33027498,Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"January 25, 2011","July 15, 2015",Treatment,Andalusia,Alabama,36420,All,40 Years,80 Years,2015-07-01,2011-01-01,1642.0
NCT01315249,16.47727273,QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,March 2011,March 2012,Treatment,Aalst,CZE,9300,All,40 Years,,2012-03-01,2011-03-01,366.0
NCT01316380,2.157519899,Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma,Completed,Phase 3,Randomized,March 2011,April 2012,Treatment,Capital Federal,,,All,18 Years,75 Years,2012-04-01,2011-03-01,397.0
NCT01316887,21.02377634,"A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"January 1, 2011","July 21, 2012",Other,Mobile,Alabama,36608,All,40 Years,120 Years,2012-07-01,2011-01-01,547.0
NCT01316900,11.02450645,24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"March 1, 2011","April 24, 2012",Treatment,Birmingham,Alabama,35216,All,40 Years,,2012-04-01,2011-03-01,397.0
NCT01316913,12.76787826,24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,March 2011,April 2012,Treatment,Jasper,Alabama,35501,All,40 Years,,2012-04-01,2011-03-01,397.0
NCT01317615,24.48979592,RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation,Completed,Phase 4,,April 2011,March 2015,Treatment,Berlin,,13125,All,18 Years,,2015-03-01,2011-04-01,1430.0
NCT01323621,4.692192192,Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"March 18, 2011","January 24, 2012",Treatment,Jasper,Alabama,35501,All,40 Years,,2012-01-01,2011-03-01,306.0
NCT01323634,7.709385209,Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"March 18, 2011","December 14, 2011",Treatment,Los Angeles,California,90048,All,40 Years,,2011-12-01,2011-03-01,275.0
NCT01323660,2.660152009,An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B,Completed,Phase 3,Randomized,"March 16, 2011","July 16, 2012",Treatment,Jasper,Alabama,35501,Male,40 Years,,2012-07-01,2011-03-01,488.0
NCT01327703,1.724137931,Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency,Completed,Phase 4,Randomized,April 2011,May 2012,Treatment,Bochum,,,All,7 Years,,2012-05-01,2011-04-01,396.0
NCT01328444,2.442528736,An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A,Completed,Phase 3,Randomized,"March 1, 2011","June 14, 2012",Treatment,Phoenix,Arizona,85006,All,40 Years,,2012-06-01,2011-03-01,458.0
NCT01329029,20.2009179,Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS),Completed,Phase 4,Randomized,May 2011,May 2014,Treatment,Box Hill,,3128,All,40 Years,,2014-05-01,2011-05-01,1096.0
NCT01330017,5.878880451,Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed),Completed,Phase 2,Randomized,March 2011,June 2011,Treatment,,,,All,18 Years,,2011-06-01,2011-03-01,92.0
NCT01330108,14.28571429,Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension,Completed,Phase 4,,May 2011,June 2012,Treatment,Birmingham,Alabama,35249,All,19 Years,,2012-06-01,2011-05-01,397.0
NCT01332292,5.555555556,Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients,Completed,Phase 2,Randomized,May 2010,January 2011,Treatment,Cypress,California,90630,All,5 Years,11 Years,2011-01-01,2010-05-01,245.0
NCT01335464,15.77193984,Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients,Completed,Phase 3,Randomized,April 2011,October 2013,Treatment,Birmingham,Alabama,,All,40 Years,,2013-10-01,2011-04-01,914.0
NCT01335477,18.32729594,Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II,Completed,Phase 3,Randomized,May 2011,October 2013,Treatment,Scottsdale,Arizona,,All,40 Years,,2013-10-01,2011-05-01,884.0
NCT01336608,10.73084782,A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD,Completed,Phase 3,Randomized,"March 4, 2011","November 4, 2014",Treatment,Birmingham,Alabama,35294,All,40 Years,,2014-11-01,2011-03-01,1341.0
NCT01338415,29.66764418,FUTURE 3 Study Extension,Completed,Phase 3,Non-Randomized,"March 8, 2011","May 29, 2020",Treatment,Aurora,Colorado,80045,All,3 Months,12 Years,2020-05-01,2011-03-01,3349.0
NCT01338636,0.0,An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH),Completed,Phase 4,,September 2008,May 2016,Treatment,Boston,Massachusetts,02115,All,18 Years,,2016-05-01,2008-09-01,2799.0
NCT01340209,7.602339181,Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma,Completed,Phase 3,Randomized,April 2011,April 2013,Treatment,"Asahikawa, Hokkaido",,,All,18 Years,75 Years,2013-04-01,2011-04-01,731.0
NCT01342913,6.049474832,A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP)),Completed,Phase 3,Randomized,"February 1, 2011","October 19, 2011",Treatment,Bouge,Bayern,5004,All,40 Years,,2011-10-01,2011-02-01,242.0
NCT01342965,46.54630416,A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations,Completed,Phase 3,Randomized,March 2011,April 2014,Treatment,Beijing,,100071,All,18 Years,,2014-04-01,2011-03-01,1127.0
NCT01344057,1.587301587,"Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012",Completed,Phase 2,,May 2011,June 2011,Prevention,Via Dei Vestini,Chieti,66100,All,65 Years,,2011-06-01,2011-05-01,31.0
NCT01344759,3.333333333,Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea,Completed,Phase 4,Randomized,June 2009,November 2011,Treatment,Cincinnati,Ohio,45229,All,12 Months,25 Years,2011-11-01,2009-06-01,883.0
NCT01344824,57.89473684,"Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers",Completed,Phase 2,,March 2010,"July 20, 2016",Treatment,Asheville,North Carolina,28801,All,18 Years,,2016-07-01,2010-03-01,2314.0
NCT01346293,2.890606933,Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age,Completed,Phase 3,Randomized,April 2011,September 2013,Prevention,Birmingham,Alabama,35205,All,4 Years,6 Years,2013-09-01,2011-04-01,884.0
NCT01346592,5.215141411,"Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age",Completed,Phase 3,Randomized,April 2011,July 2012,Prevention,Buenos Aires,,1406,All,6 Months,72 Months,2012-07-01,2011-04-01,457.0
NCT01348139,0.641025641,Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma,Completed,Phase 2,Randomized,May 2011,February 2012,Treatment,Göteborg,,,All,18 Years,,2012-02-01,2011-05-01,276.0
NCT01349803,1.264124294,PT003 MDI Cardiovascular Safety Study,Completed,Phase 2,Randomized,May 2011,November 2011,Treatment,Glendale,Arizona,,All,40 Years,80 Years,2011-11-01,2011-05-01,184.0
NCT01351415,11.56037415,A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,"June 25, 2011","June 25, 2016",Treatment,Mobile,Alabama,36688,All,18 Years,,2016-06-01,2011-06-01,1827.0
NCT01360554,7.110091743,ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,"June 16, 2011","September 14, 2015",Treatment,Birmingham,Alabama,35233,All,18 Years,,2015-09-01,2011-06-01,1553.0
NCT01362244,18.08278867,Mepolizumab in Nasal Polyposis,Completed,Phase 2,Randomized,"May 12, 2009","December 5, 2014",Treatment,Gent,,9000,All,18 Years,70 Years,2014-12-01,2009-05-01,2040.0
NCT01366209,5.585279069,Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 3,Randomized,June 2011,February 2014,Treatment,Brisbane,California,94005,All,40 Years,80 Years,2014-02-01,2011-06-01,976.0
NCT01366521,4.554865424,Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils,Completed,Phase 2,Randomized,February 2011,March 2012,Treatment,Winston-Salem,North Carolina,27103,All,18 Years,65 Years,2012-03-01,2011-02-01,394.0
NCT01371838,12.58021739,A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia,Completed,Phase 3,Randomized,December 2011,May 2013,Treatment,Beijing,,,All,18 Years,150 Years,2013-05-01,2011-12-01,517.0
NCT01372410,0.8435582822,"A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 2,Randomized,"July 1, 2011","October 27, 2011",Treatment,Costa Mesa,California,92626,All,40 Years,80 Years,2011-10-01,2011-07-01,92.0
NCT01375049,4.761904762,Aztreonam Lysine for Pseudomonas Infection Eradication Study,Completed,Phase 2,,August 2011,May 2013,Treatment,Phoenix,Arizona,85016,All,3 Months,17 Years,2013-05-01,2011-08-01,639.0
NCT01376245,13.66112964,A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD,Completed,Phase 3,Randomized,April 2011,September 2012,Treatment,Guangzhou,Guangdong,510120,All,40 Years,,2012-09-01,2011-04-01,519.0
NCT01376388,12.30769231,Long-term Safety Study for GSK573719/GW642444 in Japanese,Completed,Phase 3,,August 2011,December 2012,Treatment,Fukuoka,,802-0083,All,40 Years,,2012-12-01,2011-08-01,488.0
NCT01378429,2.380952381,Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,July 2011,November 2011,Treatment,Costa Mesa,California,92626,All,6 Years,11 Years,2011-11-01,2011-07-01,123.0
NCT01378962,6.0,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER),Completed,Phase 2,,"March 31, 2011","January 31, 2017",Treatment,Napoli,Campania,80131,All,18 Years,,2017-01-01,2011-03-01,2133.0
NCT01379937,1.362179487,A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children,Completed,Phase 3,Randomized,"July 28, 2011","October 5, 2012",Prevention,"Alabang, Muntinlupa",,1781,All,3 Years,17 Years,2012-10-01,2011-07-01,458.0
NCT01380327,14.89247312,Biomarkers of Cockroach Sublingual Immunotherapy 2,Completed,Phase 1/Phase 2,Randomized,May 2011,June 2012,Treatment,Chicago,Illinois,60614,All,5 Years,17 Years,2012-06-01,2011-05-01,397.0
NCT01380769,17.12371134,A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,June 2011,October 2014,Treatment,Saransk,Republic Of Mordovia,430032,All,18 Years,,2014-10-01,2011-06-01,1218.0
NCT01383499,0.2475247525,A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma,Completed,Phase 2,Randomized,August 2011,September 2012,Treatment,Bochum,,,All,6 Years,11 Years,2012-09-01,2011-08-01,397.0
NCT01385371,16.38221529,"A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)",Completed,Phase 3,Randomized,June 2011,August 2012,Treatment,,,,All,5 Years,65 Years,2012-08-01,2011-06-01,427.0
NCT01387230,4.859335038,Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD,Completed,Phase 3,Randomized,"July 1, 2011","February 13, 2012",Treatment,Sunset,Louisiana,70584,All,40 Years,,2012-02-01,2011-07-01,215.0
NCT01387269,14.57031325,Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1),Completed,Phase 3,Randomized,July 2011,February 2015,Treatment,Fullerton,California,,All,18 Years,,2015-02-01,2011-07-01,1311.0
NCT01387282,16.96969697,Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2),Completed,Phase 3,Randomized,July 2011,February 2015,Treatment,Corona,California,,All,18 Years,,2015-02-01,2011-07-01,1311.0
NCT01395758,3.921568627,Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,July 2011,August 2016,Treatment,Stanford,California,94305,All,18 Years,,2016-08-01,2011-07-01,1858.0
NCT01395888,9.321623259,A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD,Completed,Phase 3,Randomized,"June 30, 2011","August 6, 2012",Treatment,Ciudad Autonoma de Buenos Aires,Buenos Aires,C1056ABJ,All,40 Years,80 Years,2012-08-01,2011-06-01,427.0
NCT01395914,13.05383023,Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3),Completed,Phase 3,Randomized,July 2011,February 2015,Treatment,Corona,California,,All,18 Years,,2015-02-01,2011-07-01,1311.0
NCT01397890,5.540670431,Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,July 2011,June 2013,Treatment,Beijing,Beijing,,All,40 Years,,2013-06-01,2011-07-01,701.0
NCT01399723,0.0,Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia,Completed,Phase 3,Randomized,September 2011,September 2013,Treatment,Kerugoya,Central,,All,2 Months,59 Months,2013-09-01,2011-09-01,731.0
NCT01401465,3.211009174,"Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray",Completed,Phase 3,Randomized,July 2011,November 2011,Treatment,Huntington Beach,California,92647,All,12 Years,,2011-11-01,2011-07-01,123.0
NCT01404234,3.278688525,Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways,Completed,Phase 3,,December 2011,April 2013,Treatment,Aurora,Colorado,80045,All,,12 Years,2013-04-01,2011-12-01,487.0
NCT01413958,0.1742160279,Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1),Completed,Phase 3,Randomized,August 2011,October 2011,Treatment,,,,All,18 Years,,2011-10-01,2011-08-01,61.0
NCT01415518,7.379546528,Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 4,Randomized,"September 1, 2011","December 1, 2012",Treatment,Beijing,Beijing,,All,40 Years,,2012-12-01,2011-09-01,457.0
NCT01416571,2.564102564,Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults,Completed,Phase 2,,"August 12, 2011","September 28, 2012",Prevention,Mesa,Arizona,85213,All,18 Years,64 Years,2012-09-01,2011-08-01,397.0
NCT01424514,3.75,SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis,Completed,Phase 2,Randomized,"December 1, 2010","April 18, 2011",Treatment,Mississauga,Ontario,L4W 1N2,All,18 Years,65 Years,2011-04-01,2010-12-01,121.0
NCT01424813,4.430379747,A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma,Completed,Phase 3,Randomized,December 2012,November 2013,Treatment,Birmingham,Alabama,,All,12 Years,,2013-11-01,2012-12-01,335.0
NCT01425632,1.018799123,A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,August 2011,December 2011,Treatment,Chubu,,,All,7 Years,15 Years,2011-12-01,2011-08-01,122.0
NCT01425801,0.8064516129,"Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.",Completed,Phase 2,Randomized,"August 1, 2011","February 1, 2012",Treatment,Berlin,,10117,All,18 Years,70 Years,2012-02-01,2011-08-01,184.0
NCT01425814,0.7142857143,Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population,Completed,Phase 2,Randomized,August 2011,March 2012,Treatment,Berlin,,14050,All,40 Years,,2012-03-01,2011-08-01,213.0
NCT01427309,4.794210519,A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults,Completed,Phase 4,Randomized,September 2011,November 2013,Prevention,Mobile,Alabama,36608,All,65 Years,,2013-11-01,2011-09-01,792.0
NCT01431274,13.78446802,Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,September 2011,September 2013,Treatment,Jasper,Alabama,,All,40 Years,,2013-09-01,2011-09-01,731.0
NCT01431287,17.06079737,Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,September 2011,November 2013,Treatment,Greer,California,,All,40 Years,,2013-11-01,2011-09-01,792.0
NCT01431716,2.43902439,Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension,Completed,Phase 3,,March 2011,July 2012,Treatment,Leuven,Ontario,3000,All,18 Years,,2012-07-01,2011-03-01,488.0
NCT01431950,11.34453782,Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents,Completed,Phase 3,Randomized,September 2011,October 2012,Treatment,Long Beach,California,90808,All,12 Years,100 Years,2012-10-01,2011-09-01,396.0
NCT01436071,6.611570248,Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma,Completed,Phase 3,Randomized,September 2011,August 2012,Treatment,Long Beach,California,90808,All,12 Years,,2012-08-01,2011-09-01,335.0
NCT01436110,10.67013502,Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma,Completed,Phase 3,Randomized,September 2011,September 2012,Treatment,Los Angeles,California,90025,All,12 Years,,2012-09-01,2011-09-01,366.0
NCT01437397,19.35722905,"Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,September 2011,February 2013,Treatment,Anniston,Alabama,36207,All,40 Years,,2013-02-01,2011-09-01,519.0
NCT01437423,1.854714065,Regulatory Post-Marketing Surveillance Study for TETRAXIM™,Completed,Phase 4,,June 2011,November 2015,Prevention,Seoul,,,All,2 Months,6 Years,2015-11-01,2011-06-01,1614.0
NCT01437540,26.90166976,Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"September 19, 2011","April 30, 2013",Treatment,Birmingham,Alabama,35209,All,40 Years,,2013-04-01,2011-09-01,578.0
NCT01438307,0.0,Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,September 2011,September 2015,Treatment,Birmingham,Alabama,35294,All,19 Years,,2015-09-01,2011-09-01,1461.0
NCT01439165,1.35278224,Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose,Completed,Phase 4,Randomized,November 2011,February 2017,Prevention,Huntsville,Alabama,35802,All,18 Years,64 Years,2017-02-01,2011-11-01,1919.0
NCT01439360,3.378225235,An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children,Completed,Phase 3,Randomized,"October 1, 2011","December 31, 2014",Prevention,Dhaka,Cornwall,1000,All,6 Months,35 Months,2014-12-01,2011-10-01,1157.0
NCT01443078,4.761904762,"Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",Completed,Phase 2,,October 2011,April 2015,Treatment,Basking Ridge,New Jersey,11725,All,18 Years,,2015-04-01,2011-10-01,1278.0
NCT01443845,20.74199622,Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS),Completed,Phase 4,Randomized,"September 30, 2011","January 31, 2016",Treatment,Anniston,Alabama,36207,All,40 Years,,2016-01-01,2011-09-01,1583.0
NCT01444430,1.094658869,A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents,Completed,Phase 3,Randomized,December 2011,October 2015,Treatment,Birmingham,Alabama,,All,12 Years,130 Years,2015-10-01,2011-12-01,1400.0
NCT01444781,0.3013863773,Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants,Completed,Phase 3,Randomized,September 2011,October 2013,Prevention,Cali,,,All,12 Months,24 Months,2013-10-01,2011-09-01,761.0
NCT01448057,3.52253182,"Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu",Completed,Phase 3,Randomized,July 2013,August 2015,Treatment,Belo Horizonte/MG,,30150-221,All,18 Years,65 Years,2015-08-01,2013-07-01,761.0
NCT01448850,20.07621951,A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,November 2011,February 2014,Treatment,Peoria,Arizona,,All,45 Years,75 Years,2014-02-01,2011-11-01,823.0
NCT01450761,30.47976513,Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone,Completed,Phase 3,Randomized,"December 13, 2011","May 17, 2017",Treatment,Hot Springs,Arkansas,71913,All,18 Years,,2017-05-01,2011-12-01,1978.0
NCT01451541,10.16264114,A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).,Completed,Phase 3,Randomized,October 2011,December 2012,Treatment,Hot Springs,Arkansas,71913,All,6 Years,11 Years,2012-12-01,2011-10-01,427.0
NCT01453023,3.846153846,"Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study",Completed,Phase 2,Randomized,October 2011,June 2012,Treatment,Huntington Beach,California,92647,All,5 Years,11 Years,2012-06-01,2011-10-01,244.0
NCT01453296,5.357142857,Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects,Completed,Phase 2,Randomized,August 2010,April 2011,Treatment,Cypress,California,90630,All,5 Years,11 Years,2011-04-01,2010-08-01,243.0
NCT01454934,20.37037037,"A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer",Completed,Phase 3,Randomized,"December 9, 2011","May 2, 2016",Treatment,Los Angeles,California,,All,18 Years,,2016-05-01,2011-12-01,1613.0
NCT01455194,15.29380692,Effect of High Dose Ciclesonide on Asthma Control,Completed,Phase 3,Randomized,November 2011,August 2014,Treatment,"Capital Federal, Buenos Aires",,,All,12 Years,70 Years,2014-08-01,2011-11-01,1004.0
NCT01458275,4.249471635,A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR),Completed,Phase 3,Randomized,November 2011,March 2013,Treatment,Little Rock,Arkansas,72205,All,6 Years,11 Years,2013-03-01,2011-11-01,486.0
NCT01462344,10.51815049,6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old,Completed,Phase 4,Randomized,"November 17, 2011","November 3, 2015",Treatment,Birmingham,Alabama,35209,All,4 Years,11 Years,2015-11-01,2011-11-01,1461.0
NCT01462929,3.387168177,Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,November 2011,May 2012,Treatment,Humpolec,,396 26,All,40 Years,,2012-05-01,2011-11-01,182.0
NCT01462942,9.717751252,Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination,Completed,Phase 3,Randomized,October 2011,January 2013,Treatment,Graz,,8036,All,40 Years,,2013-01-01,2011-10-01,458.0
NCT01465802,20.7012664,Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO,Completed,Phase 2,Non-Randomized,"December 26, 2011","May 18, 2015",Treatment,Duarte,California,91010,All,18 Years,,2015-05-01,2011-12-01,1247.0
NCT01466062,7.142857143,"Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions",Completed,Phase 3,Non-Randomized,August 2011,April 2012,Prevention,Hyogo,,,All,,24 Months,2012-04-01,2011-08-01,244.0
NCT01466348,0.7042253521,Effects of a Common Cold Treatment on Cognitive Function,Completed,Phase 4,Randomized,February 2011,April 2011,Treatment,Cardiff,Wales,,All,18 Years,,2011-04-01,2011-02-01,59.0
NCT01469000,4.340659341,A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,February 2012,November 2017,Treatment,Beijing,,100036,All,18 Years,,2017-11-01,2012-02-01,2100.0
NCT01470144,4.87804878,Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension,Completed,Phase 3,,"June 1, 2011","July 1, 2015",Treatment,Leuven,Ontario,3000,All,,,2015-07-01,2011-06-01,1491.0
NCT01471171,2.678571429,Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,November 2011,June 2012,Treatment,Berlin,,10117,All,40 Years,,2012-06-01,2011-11-01,213.0
NCT01471340,0.02558272555,A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241),Completed,Phase 4,Randomized,"January 9, 2012","November 30, 2016",Treatment,,,,All,12 Years,,2016-11-01,2012-01-01,1766.0
NCT01473563,1.923076923,A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,,December 2011,September 2013,,Linkoping,Greater London,58185,All,18 Years,,2013-09-01,2011-12-01,640.0
NCT01475721,0.1369981522,SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.,Completed,Phase 4,Randomized,"November 18, 2011","June 23, 2015",Treatment,Athens,Alabama,35611,All,12 Years,,2015-06-01,2011-11-01,1308.0
NCT01479595,4.653679654,A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma,Completed,Phase 2,Randomized,February 2012,February 2015,Treatment,Anaheim,California,92801,All,18 Years,65 Years,2015-02-01,2012-02-01,1096.0
NCT01479621,11.57580284,A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids,Completed,Phase 2,Randomized,January 2012,July 2013,Treatment,Homewood,Alabama,,All,12 Years,,2013-07-01,2012-01-01,547.0
NCT01483625,5.555555556,Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection,Completed,Phase 4,Randomized,November 2011,December 2012,Treatment,Tucson,Arizona,,All,40 Years,,2012-12-01,2011-11-01,396.0
NCT01484197,1.388888889,A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device,Completed,Phase 2,Randomized,November 2011,May 2012,Treatment,Wiesbaden,,65187,All,18 Years,,2012-05-01,2011-11-01,182.0
NCT01498653,5.844155844,Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry,Completed,Phase 3,Randomized,January 2012,February 2013,Treatment,Guangzhou,Guangdong,510120,All,12 Years,100 Years,2013-02-01,2012-01-01,397.0
NCT01498679,8.133859604,Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.,Completed,Phase 3,Randomized,January 2012,July 2013,Treatment,Shenzhen,Guangdong,518020,All,12 Years,100 Years,2013-07-01,2012-01-01,547.0
NCT01500720,7.833957553,Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer,Completed,Phase 2,Randomized,March 2012,April 2014,Treatment,Muscle Shoals,Alabama,35661,All,18 Years,,2014-04-01,2012-03-01,761.0
NCT01502371,11.39233834,A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223),Completed,Phase 2,Randomized,"January 25, 2012","January 29, 2015",Treatment,,,,All,5 Years,11 Years,2015-01-01,2012-01-01,1096.0
NCT01504867,1.538461538,LIPS-A: Lung Injury Prevention Study With Aspirin,Completed,Phase 2,Randomized,January 2012,September 2015,Prevention,Stanford,California,94305,All,18 Years,,2015-09-01,2012-01-01,1339.0
NCT01508936,21.53368885,Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma,Completed,Phase 3,Randomized,February 2012,August 2013,Treatment,Birmingham,Alabama,,All,18 Years,65 Years,2013-08-01,2012-02-01,547.0
NCT01513460,12.30858947,"Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease",Completed,Phase 3,Randomized,April 2012,December 2013,Treatment,Baulkham Hills,New South Wales,2153,All,40 Years,,2013-12-01,2012-04-01,609.0
NCT01519661,31.21019108,Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis,Completed,Phase 4,Non-Randomized,January 2012,January 2014,Treatment,Little Rock,Arkansas,72205,All,6 Years,,2014-01-01,2012-01-01,731.0
NCT01523587,21.06890696,LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy,Completed,Phase 3,Randomized,"March 5, 2012","December 27, 2017",Treatment,Chandler,Arizona,85224,All,18 Years,,2017-12-01,2012-03-01,2101.0
NCT01524198,4.313689177,The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room,Completed,Phase 2/Phase 3,Randomized,November 2010,April 2012,Treatment,Riyadh,,11525,All,2 Years,12 Years,2012-04-01,2010-11-01,517.0
NCT01525615,6.728588421,A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD,Completed,Phase 3,Randomized,February 2012,September 2013,Treatment,Torrance,California,,All,40 Years,75 Years,2013-09-01,2012-02-01,578.0
NCT01527110,4.761904762,A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection,Completed,Phase 3,,"January 1, 2012","March 29, 2013",Treatment,Fukuoka,,816-0864,All,16 Years,,2013-03-01,2012-01-01,425.0
NCT01529112,8.878847093,"A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments",Completed,Phase 2,Randomized,November 2011,"June 27, 2015",Treatment,Casa Grande,Arizona,85122,All,18 Years,,2015-06-01,2011-11-01,1308.0
NCT01529632,3.122977346,"Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,May 2012,December 2012,Treatment,Feldbach,,8330,All,,,2012-12-01,2012-05-01,214.0
NCT01530334,6.557377049,Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment,Completed,Phase 2,,July 2012,July 2014,Treatment,Alessandria,,,All,18 Years,130 Years,2014-07-01,2012-07-01,730.0
NCT01531673,0.0,Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation,Completed,Phase 2,Randomized,February 2012,March 2014,Treatment,Birmingham,Alabama,,All,12 Years,,2014-03-01,2012-02-01,759.0
NCT01533181,0.0,Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer,Completed,Phase 2,Randomized,February 2012,November 2014,Treatment,Scottsdale,Arizona,85259,All,18 Years,,2014-11-01,2012-02-01,1004.0
NCT01533922,2.847457627,Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients,Completed,Phase 3,Randomized,March 2012,November 2013,Treatment,Torrance,California,,All,40 Years,75 Years,2013-11-01,2012-03-01,610.0
NCT01533935,2.886597938,Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.,Completed,Phase 3,Randomized,February 2012,November 2013,Treatment,Phoenix,Arizona,,All,40 Years,75 Years,2013-11-01,2012-02-01,639.0
NCT01535040,38.46153846,Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking,Completed,Phase 2,Randomized,"August 1, 2012","February 1, 2014",Supportive Care,Winston-Salem,North Carolina,27157,All,18 Years,,2014-02-01,2012-08-01,549.0
NCT01536262,9.796747967,Japan Long-term Safety for Tiotropium Plus Olodaterol,Completed,Phase 3,Randomized,February 2012,September 2013,Treatment,"Chiyoda-ku, Tokyo",,,All,40 Years,,2013-09-01,2012-02-01,578.0
NCT01536587,6.25,Effects of Salmeterol on Autonomic Nervous System,Completed,Phase 4,,July 2012,November 2012,Treatment,Goettingen,Niedersachsen,37075,All,41 Years,79 Years,2012-11-01,2012-07-01,123.0
NCT01537081,2.792632204,Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections,Completed,Phase 2/Phase 3,Randomized,September 2011,July 2012,Treatment,Hoover,Alabama,35216,All,12 Years,,2012-07-01,2011-09-01,304.0
NCT01551758,6.003432064,"A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"March 13, 2012","November 24, 2015",Treatment,Altrincham,Cheshire,WA14 2NW,All,40 Years,,2015-11-01,2012-03-01,1340.0
NCT01555138,13.06408798,Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.),Completed,Phase 4,Randomized,February 2012,February 2014,Treatment,C A B A,Buenos Aires,1028,All,40 Years,,2014-02-01,2012-02-01,731.0
NCT01555151,4.992999193,Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma,Completed,Phase 2,Randomized,July 2012,July 2013,Treatment,Kortrijk,Ontario,8500,All,12 Years,,2013-07-01,2012-07-01,365.0
NCT01557166,22.27808814,Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea,Completed,Phase 3,Randomized,"June 7, 2012","June 17, 2013",Treatment,Glendale,California,91206,All,18 Years,64 Years,2013-06-01,2012-06-01,365.0
NCT01560988,14.51612903,Borage and Echium Seed Oils for Asthma,Completed,Phase 3,Randomized,February 2013,May 2015,Treatment,Boston,Massachusetts,02115,All,18 Years,65 Years,2015-05-01,2013-02-01,819.0
NCT01563029,5.730142905,A Dose-ranging Study of Fluticasone Furoate (FF),Completed,Phase 2,Randomized,"March 28, 2012","September 24, 2014",Treatment,Little Rock,Arkansas,72205,All,5 Years,11 Years,2014-09-01,2012-03-01,914.0
NCT01566149,10.25,Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212),Completed,Phase 3,Non-Randomized,March 2012,September 2012,Treatment,,,,All,12 Years,,2012-09-01,2012-03-01,184.0
NCT01566604,5.056418991,"Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease",Completed,Phase 3,Randomized,March 2012,June 2013,Treatment,Beijing,Beijing,100023,All,40 Years,,2013-06-01,2012-03-01,457.0
NCT01572792,45.19236583,"Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,April 2012,June 2013,Treatment,Anniston,Alabama,36207,All,40 Years,,2013-06-01,2012-04-01,426.0
NCT01573624,1.153715643,"Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma",Completed,Phase 2,Randomized,"April 3, 2012","February 4, 2013",Diagnostic,Saint Louis,Missouri,63141,All,18 Years,,2013-02-01,2012-04-01,306.0
NCT01573767,3.068336,Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children,Completed,Phase 2,Randomized,April 2012,April 2014,Treatment,Birmingham,Alabama,35209,All,5 Years,11 Years,2014-04-01,2012-04-01,730.0
NCT01574651,10.49227551,The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,May 2012,April 2013,Treatment,Koblenz,NRW,56068,All,40 Years,,2013-04-01,2012-05-01,335.0
NCT01576718,9.016046553,A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications,Completed,Phase 2,Randomized,April 2012,October 2013,Treatment,Birmingham,Alabama,,All,12 Years,,2013-10-01,2012-04-01,548.0
NCT01579916,3.085625254,A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults,Completed,Phase 4,Randomized,May 2012,November 2012,Prevention,Miami,Florida,33143,All,18 Years,49 Years,2012-11-01,2012-05-01,184.0
NCT01588405,3.03030303,Remodulin® to Oral Treprostinil Transition,Completed,Phase 2,,April 2012,December 2014,Treatment,Phoenix,Arizona,85013,All,15 Years,80 Years,2014-12-01,2012-04-01,974.0
NCT01597375,4.678848283,Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin),Completed,Phase 2,Randomized,"August 31, 2012","December 14, 2016",Supportive Care,Boston,Massachusetts,02115,All,18 Years,65 Years,2016-12-01,2012-08-01,1583.0
NCT01603277,19.34021263,Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids,Completed,Phase 2,Randomized,July 2012,January 2014,Treatment,Birmingham,Alabama,35216,All,16 Years,75 Years,2014-01-01,2012-07-01,549.0
NCT01604278,4.027349538,"Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,May 2012,January 2013,Treatment,Brussel,GR,1090,All,40 Years,,2013-01-01,2012-05-01,245.0
NCT01606319,19.0,Acetaminophen Versus Ibuprofen in Children With Asthma,Completed,Phase 3,Randomized,February 2013,April 2015,Treatment,Tucson,Arizona,85724,All,12 Months,59 Months,2015-04-01,2013-02-01,789.0
NCT01607398,7.692307692,ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,May 2012,July 2013,Treatment,Osaka,,530-0001,All,40 Years,,2013-07-01,2012-05-01,426.0
NCT01609478,4.12193803,"Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma",Completed,Phase 2,Randomized,August 2012,July 2013,Treatment,Lovech,Ontario,5500,All,18 Years,,2013-07-01,2012-08-01,334.0
NCT01609543,11.29032258,A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations,Completed,Phase 4,,May 2012,January 2015,Treatment,Budapest,,1125,All,18 Years,,2015-01-01,2012-05-01,975.0
NCT01610037,15.38296572,Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation,Completed,Phase 3,Randomized,October 2012,February 2015,Treatment,Caba,Buenos Aires,1028,All,40 Years,,2015-02-01,2012-10-01,853.0
NCT01612000,8.803742427,Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults,Completed,Phase 1/Phase 2,Randomized,May 2012,December 2013,Prevention,Omaha,Nebraska,68134,All,18 Years,49 Years,2013-12-01,2012-05-01,579.0
NCT01613326,3.651654156,"Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,June 2012,January 2013,Treatment,Toronto,Ontario,M5G1N8,All,40 Years,,2013-01-01,2012-06-01,214.0
NCT01614457,2.941176471,Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT),Completed,Phase 3,Randomized,July 2012,October 2013,Treatment,Birmingham,Alabama,,All,6 Years,,2013-10-01,2012-07-01,457.0
NCT01622231,1.639344262,"Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis",Completed,Phase 3,,June 2012,November 2012,Treatment,Chiba,,272-0143,All,2 Years,14 Years,2012-11-01,2012-06-01,153.0
NCT01623310,32.28699552,12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device,Completed,Phase 3,,September 2013,October 2015,Treatment,Birmingham,Alabama,35216,All,18 Years,,2015-10-01,2013-09-01,760.0
NCT01624974,4.672897196,Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011),Completed,Phase 2,Randomized,"August 9, 2012","May 5, 2014",Treatment,,,,All,18 Years,65 Years,2014-05-01,2012-08-01,638.0
NCT01625689,1.0,Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine,Completed,Phase 2,Randomized,June 2012,February 2013,Prevention,Dhaka,,,All,24 Months,59 Months,2013-02-01,2012-06-01,245.0
NCT01627327,6.730907967,Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease,Completed,Phase 3,Randomized,"April 1, 2012","December 21, 2012",Treatment,Newport Beach,California,92663,All,40 Years,,2012-12-01,2012-04-01,244.0
NCT01629589,3.545560225,Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents,Completed,Phase 4,Randomized,June 2012,June 2013,Prevention,Sacramento,California,95816,All,11 Years,12 Years,2013-06-01,2012-06-01,365.0
NCT01630135,0.0,"Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis",Completed,Phase 3,Randomized,June 2012,August 2012,Treatment,Chiba,,261-0004,All,6 Years,14 Years,2012-08-01,2012-06-01,61.0
NCT01634113,1.075268817,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma,Completed,Phase 2,Randomized,July 2012,December 2014,Treatment,Columbia,Missouri,,All,1 Year,5 Years,2014-12-01,2012-07-01,883.0
NCT01634139,5.260578645,Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma,Completed,Phase 3,Randomized,July 2012,December 2015,Treatment,Columbia,Missouri,,All,6 Years,11 Years,2015-12-01,2012-07-01,1248.0
NCT01634152,2.26576394,Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma,Completed,Phase 3,Randomized,July 2012,May 2015,Treatment,Rolling Hills Estates,California,,All,6 Years,11 Years,2015-05-01,2012-07-01,1034.0
NCT01636076,5.887794718,Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,November 2012,September 2013,Treatment,Concord,New South Wales,2139,All,40 Years,,2013-09-01,2012-11-01,304.0
NCT01636713,10.51760056,A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD,Completed,Phase 3,Randomized,July 2012,October 2013,Treatment,Gaungzhou,Guangdong,510120,All,40 Years,,2013-10-01,2012-07-01,457.0
NCT01638546,4.294871795,Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer,Completed,Phase 2,Randomized,June 2012,January 2017,Treatment,Tampa,Florida,33612,All,18 Years,,2017-01-01,2012-06-01,1675.0
NCT01640314,0.7936507937,Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above,Completed,Phase 3,,July 2012,August 2012,Prevention,Bernhard-Nocht-Strasse 74,Hamburg,D-20359,All,18 Years,,2012-08-01,2012-07-01,31.0
NCT01641692,0.9642857143,A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma,Completed,Phase 2,Randomized,May 2012,February 2013,Treatment,Newport Beach,California,92663,All,18 Years,,2013-02-01,2012-05-01,276.0
NCT01641822,14.32459179,Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF,Completed,Phase 3,Randomized,December 2012,January 2015,Treatment,Birmingham,Alabama,35233,All,6 Years,,2015-01-01,2012-12-01,761.0
NCT01644617,14.51800232,A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627),Completed,Phase 2,Randomized,October 2012,August 2013,Treatment,,,,All,18 Years,,2013-08-01,2012-10-01,304.0
NCT01644734,20.74882995,Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test,Completed,Phase 4,,November 2011,March 2013,,Andrychow,,,All,,,2013-03-01,2011-11-01,486.0
NCT01645735,6.25,Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus,Completed,Phase 4,Randomized,October 2012,December 2013,Treatment,Phoenix,Arizona,85008,All,18 Years,,2013-12-01,2012-10-01,426.0
NCT01654224,6.787434075,Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting,Completed,Phase 4,Randomized,November 2011,June 2014,Prevention,Pittsburgh,Pennsylvania,15213,All,65 Years,,2014-06-01,2011-11-01,943.0
NCT01654289,14.54212067,University of Wisconsin Meditation & Exercise Cold Study,Completed,Phase 2,Randomized,July 2012,June 2016,Prevention,Madison,Wisconsin,53715,All,30 Years,69 Years,2016-06-01,2012-07-01,1431.0
NCT01654536,8.412866737,A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR),Completed,Phase 4,Randomized,September 2012,July 2013,Treatment,Mission Viejo,California,92691,All,12 Years,,2013-07-01,2012-09-01,303.0
NCT01658020,4.980325064,A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg,Completed,Phase 3,Randomized,August 2012,August 2014,Treatment,Seoul,,,All,40 Years,,2014-08-01,2012-08-01,730.0
NCT01659996,2.000965968,Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age,Completed,Phase 4,Randomized,July 2012,September 2015,Prevention,Birmingham,Alabama,35235,All,9 Months,18 Months,2015-09-01,2012-07-01,1157.0
NCT01661790,2.941176471,Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer,Completed,Phase 3,Randomized,August 2009,October 2012,Treatment,Beijing,Beijing,100048,All,18 Years,85 Years,2012-10-01,2009-08-01,1157.0
NCT01662986,39.74358974,Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2,Completed,Phase 4,Randomized,"August 1, 2012","April 1, 2014",Treatment,Montgomery,Alabama,,All,40 Years,,2014-04-01,2012-08-01,608.0
NCT01663987,24.16666667,Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1,Completed,Phase 4,Randomized,"August 1, 2012","May 1, 2014",Treatment,Birmingham,Alabama,,All,40 Years,,2014-05-01,2012-08-01,638.0
NCT01665807,0.3676871119,A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine,Completed,Phase 4,Randomized,September 2012,December 2012,Health Services Research,Halifax,Nova Scotia,M5G1X5,All,18 Years,69 Years,2012-12-01,2012-09-01,91.0
NCT01666782,1.0,Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy,Completed,Phase 2,Randomized,August 2012,December 2015,Prevention,Rochester,New York,14621,All,18 Years,64 Years,2015-12-01,2012-08-01,1217.0
NCT01669174,17.9144385,BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia,Completed,Phase 2,Randomized,September 2012,December 2014,Supportive Care,Torrance,California,90502,All,40 Years,80 Years,2014-12-01,2012-09-01,821.0
NCT01673620,1.063829787,A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484),Completed,Phase 3,Randomized,"July 4, 2012","October 10, 2012",Treatment,,,,All,15 Years,65 Years,2012-10-01,2012-07-01,92.0
NCT01682863,9.271099744,A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation,Completed,Phase 3,Randomized,October 2012,June 2014,Treatment,Vestavia,Alabama,35216,All,40 Years,,2014-06-01,2012-10-01,608.0
NCT01685060,23.57142857,LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib,Completed,Phase 2,,"November 26, 2012","March 29, 2016",Treatment,Fayetteville,Arkansas,72703,All,18 Years,,2016-03-01,2012-11-01,1216.0
NCT01686633,3.656999439,"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.",Completed,Phase 3,Randomized,"September 20, 2012","October 15, 2013",Treatment,Little Rock,Arkansas,72205,All,12 Years,,2013-10-01,2012-09-01,395.0
NCT01687283,12.05756672,Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma,Completed,Phase 3,Randomized,"September 27, 2012","November 7, 2013",Treatment,Guangzhou,Guangdong,510080,All,17 Years,70 Years,2013-11-01,2012-09-01,426.0
NCT01687296,4.00152439,Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma,Completed,Phase 3,Randomized,"November 12, 2012","June 21, 2013",Treatment,Changsha,Hunan,410005,All,4 Years,16 Years,2013-06-01,2012-11-01,212.0
NCT01688921,1.924877557,Jet Injection for Influenza,Completed,Phase 4,Randomized,October 2012,March 2013,Prevention,Fort Collins,Colorado,80524,All,18 Years,64 Years,2013-03-01,2012-10-01,151.0
NCT01691508,5.204216074,Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma,Completed,Phase 3,Randomized,October 2012,December 2013,Treatment,Long Beach,California,90808,All,12 Years,,2013-12-01,2012-10-01,426.0
NCT01691521,5.216710746,Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma,Completed,Phase 3,Randomized,"October 8, 2012","January 18, 2014",Treatment,Birmingham,Alabama,35294,All,12 Years,,2014-01-01,2012-10-01,457.0
NCT01691885,3.333333333,RELOVAIR® Lung Deflation Study,Completed,Phase 3,Randomized,November 2012,August 2014,Treatment,London,,E2 9JX,All,40 Years,,2014-08-01,2012-11-01,638.0
NCT01694771,6.978976448,Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®,Completed,Phase 3,Randomized,September 2012,August 2013,Treatment,Florence,Alabama,,All,40 Years,,2013-08-01,2012-09-01,334.0
NCT01696058,6.082365069,Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®,Completed,Phase 3,Randomized,September 2012,October 2013,Treatment,Anniston,Alabama,,All,40 Years,,2013-10-01,2012-09-01,395.0
NCT01696071,0.5102040816,Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication,Completed,Phase 2,Randomized,September 2012,June 2013,Treatment,Grieskirchen,,,All,18 Years,75 Years,2013-06-01,2012-09-01,273.0
NCT01697696,16.37045568,Long Term Safety Study of NVA237 vs QAB149 in COPD Patients,Completed,Phase 3,Randomized,October 2012,November 2014,Treatment,Gulf Shores,Alabama,36547,All,40 Years,,2014-11-01,2012-10-01,761.0
NCT01697956,2.370478983,Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,October 2012,February 2013,Treatment,Long Beach,California,,All,6 Years,11 Years,2013-02-01,2012-10-01,123.0
NCT01699685,9.075573549,Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.,Completed,Phase 3,Randomized,November 2012,June 2014,Treatment,Faltigberg-Wald,ZH,8639,All,40 Years,,2014-06-01,2012-11-01,577.0
NCT01700192,20.31039136,Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607),Completed,Phase 3,Randomized,January 2013,April 2015,Treatment,,,,All,12 Years,,2015-04-01,2013-01-01,820.0
NCT01702363,12.21374046,Long-term Safety Study for GSK573719 in Japanese,Completed,Phase 3,,August 2012,December 2013,Treatment,Fukuoka,,811-1347,All,40 Years,,2013-12-01,2012-08-01,487.0
NCT01702454,2.36913153,Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345,Completed,Phase 3,Non-Randomized,"October 6, 2012","June 5, 2013",Prevention,Decin,Cornwall,405 01,All,17 Months,48 Months,2013-06-01,2012-10-01,243.0
NCT01703091,4.722101607,A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,December 2012,July 2016,Treatment,Aichi,,464-8681,All,20 Years,,2016-07-01,2012-12-01,1308.0
NCT01704495,27.34048552,"A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.",Completed,Phase 2,Randomized,November 2012,August 2014,Treatment,Gotse Delchev,Newfoundland and Labrador,,All,18 Years,150 Years,2014-08-01,2012-11-01,638.0
NCT01706328,7.125186706,A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"October 15, 2012","June 17, 2013",Treatment,Clearwater,Florida,33765,All,40 Years,,2013-06-01,2012-10-01,243.0
NCT01706536,6.089626566,A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,October 2012,April 2013,Treatment,Jasper,Alabama,35501,All,35 Years,75 Years,2013-04-01,2012-10-01,182.0
NCT01707290,20.66115702,Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation,Completed,Phase 3,Non-Randomized,February 2013,April 2016,Treatment,Birmingham,Alabama,,All,6 Years,,2016-04-01,2013-02-01,1155.0
NCT01709864,3.631371097,NVA237 Versus Placebo 12-week Efficacy Study,Completed,Phase 3,Randomized,November 2012,October 2013,Treatment,Homewood,Alabama,35209-6870,All,40 Years,,2013-10-01,2012-11-01,334.0
NCT01709903,7.833945275,"A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149",Completed,Phase 3,Randomized,November 2012,February 2014,Treatment,Caba,Buenos Aires,1122,All,40 Years,,2014-02-01,2012-11-01,457.0
NCT01711645,25.45454545,Tdap Vaccine in Post-Partum Women,Completed,Phase 4,,"October 26, 2012","August 28, 2015",Prevention,Nashville,Tennessee,37232-2573,Female,18 Years,45 Years,2015-08-01,2012-10-01,1034.0
NCT01711736,3.331192274,Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age,Completed,Phase 3,Randomized,"November 1, 2012","June 19, 2013",Prevention,Halifax,Nova Scotia,B3K 6R8,All,6 Months,35 Months,2013-06-01,2012-11-01,212.0
NCT01712334,1.176470588,A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis,Completed,Phase 4,Randomized,December 2012,June 2013,Treatment,Phoenix,Arizona,85016,All,6 Years,,2013-06-01,2012-12-01,182.0
NCT01712516,2.899241588,"A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation",Completed,Phase 3,Randomized,December 2012,February 2014,Treatment,Huntsville,Alabama,35801,All,40 Years,,2014-02-01,2012-12-01,427.0
NCT01712984,1.350186635,Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years,Completed,Phase 3,Randomized,October 2012,October 2013,Prevention,Hoover,Alabama,35216,All,18 Years,64 Years,2013-10-01,2012-10-01,365.0
NCT01715298,4.166666667,NVA237 BID Versus Placebo Twelve-week Efficacy Study,Completed,Phase 3,Randomized,November 2012,December 2013,Treatment,*See Various Dept.'s*,Arizona,85224,All,40 Years,,2013-12-01,2012-11-01,395.0
NCT01716754,5.091237497,Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma,Completed,Phase 2,Randomized,December 2012,January 2016,Treatment,Fresno,California,93720,All,18 Years,75 Years,2016-01-01,2012-12-01,1126.0
NCT01726049,13.46153846,Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH,Completed,Phase 3,Randomized,October 2011,December 2014,Treatment,Groningen,,9700 RB,All,18 Years,,2014-12-01,2011-10-01,1157.0
NCT01727024,2.5,"Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients",Completed,Phase 4,Randomized,April 2013,November 2015,Treatment,Goiania,GO,74110-030,All,40 Years,,2015-11-01,2013-04-01,944.0
NCT01727141,2.20674919,"A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.",Completed,Phase 3,Randomized,November 2012,February 2014,Treatment,Birmingham,Alabama,35205,All,40 Years,,2014-02-01,2012-11-01,457.0
NCT01729559,13.52693603,Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin,Completed,Phase 4,Randomized,November 2012,October 2014,Prevention,San Diego,California,92103,All,18 Years,,2014-10-01,2012-11-01,699.0
NCT01730378,0.5952380952,Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old,Completed,Phase 4,Randomized,"December 5, 2012","December 17, 2013",Prevention,Guro Gu,,152703,All,18 Years,60 Years,2013-12-01,2012-12-01,365.0
NCT01732536,2.007226014,Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps,Completed,Phase 2/Phase 3,Randomized,January 2013,May 2014,Treatment,Atherton,California,94027,All,18 Years,,2014-05-01,2013-01-01,485.0
NCT01743001,0.4385964912,Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome,Completed,Phase 3,Randomized,"May 21, 2013","December 1, 2016",Treatment,Los Angeles,California,90095,All,12 Years,,2016-12-01,2013-05-01,1310.0
NCT01745848,23.07692308,Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD,Completed,Phase 4,,February 2013,"June 30, 2016",Treatment,Pittsburgh,Pennsylvania,15213,All,50 Years,75 Years,2016-06-01,2013-02-01,1216.0
NCT01747629,8.117647059,Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics,Completed,Phase 3,Randomized,December 2012,November 2013,Treatment,Costa Mesa,California,,All,12 Years,,2013-11-01,2012-12-01,335.0
NCT01755091,19.45955279,Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea,Completed,Phase 2,Randomized,February 2013,"December 31, 2016",Treatment,Chicago,Illinois,60611,All,21 Years,64 Years,2016-12-01,2013-02-01,1399.0
NCT01764841,17.24464264,Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE),Completed,Phase 3,Randomized,"May 2, 2013","March 9, 2016",Treatment,Jasper,Alabama,35501,All,18 Years,,2016-03-01,2013-05-01,1035.0
NCT01765192,10.9375,Roflumilast Plus Montelukast in Adults With Severe Asthma,Completed,Phase 2,Randomized,February 2013,October 2013,Treatment,Berlin,,,All,18 Years,,2013-10-01,2013-02-01,242.0
NCT01766921,2.797258297,Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects,Completed,Phase 2,Randomized,January 2013,July 2014,Prevention,Phoenix,Arizona,85253,All,65 Years,,2014-07-01,2013-01-01,546.0
NCT01769391,7.081339713,A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,January 2013,July 2017,Treatment,Jonesboro,Arkansas,72401,All,18 Years,,2017-07-01,2013-01-01,1642.0
NCT01772134,5.695839311,Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks,Completed,Phase 3,Randomized,"January 1, 2013","July 22, 2013",Treatment,Jasper,Alabama,35501,All,40 Years,,2013-07-01,2013-01-01,181.0
NCT01772147,8.253433607,Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.,Completed,Phase 3,Randomized,January 2013,August 2013,Treatment,Mobile,Alabama,36608,All,40 Years,,2013-08-01,2013-01-01,212.0
NCT01776541,12.96534339,Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults,Completed,Phase 2,Randomized,January 2013,May 2014,Prevention,Miami,Florida,33143,All,18 Years,64 Years,2014-05-01,2013-01-01,485.0
NCT01776554,6.045089449,Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children,Completed,Phase 2,Randomized,January 2013,June 2014,Prevention,Miami,Florida,68005,All,6 Months,17 Years,2014-06-01,2013-01-01,516.0
NCT01777334,7.954423357,The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD,Completed,Phase 3,Randomized,"January 23, 2013","September 24, 2013",Treatment,Tucson,Arizona,85723,All,40 Years,,2013-09-01,2013-01-01,243.0
NCT01780987,11.25,AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients,Completed,Phase 3,Randomized,January 2013,September 2014,Treatment,Nagakute,Aichi,480-1195,All,20 Years,,2014-09-01,2013-01-01,608.0
NCT01782326,24.59773654,"QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)",Completed,Phase 3,Randomized,July 2013,September 2015,Treatment,Caba,Buenos Aires,1122,All,40 Years,,2015-09-01,2013-07-01,792.0
NCT01783548,9.152605644,Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,January 2013,October 2013,Treatment,Hot Springs,Arkansas,,All,4 Years,11 Years,2013-10-01,2013-01-01,273.0
NCT01788228,2.040816327,Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure,Completed,Phase 3,Non-Randomized,"March 22, 2013","February 25, 2015",Prevention,Stockbridge,Georgia,30281,All,18 Years,,2015-02-01,2013-03-01,702.0
NCT01788566,1.639344262,A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer,Completed,Phase 2,,March 2013,December 2015,Treatment,Birmingham,Alabama,35294,All,18 Years,,2015-12-01,2013-03-01,1005.0
NCT01793883,4.536933784,Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza,Completed,Phase 2,Randomized,May 2013,May 2014,Treatment,Scottsboro,Alabama,35768,All,18 Years,64 Years,2014-05-01,2013-05-01,365.0
NCT01799993,20.7808604,Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia,Completed,Phase 3,Randomized,"April 13, 2013","April 7, 2017",Treatment,Birmingham,Alabama,35233,All,18 Years,,2017-04-01,2013-04-01,1461.0
NCT01801111,12.31884058,A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment,Completed,Phase 1/Phase 2,,"June 20, 2013","October 27, 2017",Treatment,Birmingham,Alabama,35233,All,18 Years,,2017-10-01,2013-06-01,1583.0
NCT01804946,1.867283951,Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza,Completed,Phase 4,Randomized,February 2011,October 2014,Treatment,Moscow,,105064,All,18 Years,60 Years,2014-10-01,2011-02-01,1338.0
NCT01807923,3.647044925,A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation,Completed,Phase 3,Randomized,May 2013,April 2014,Treatment,Birmingham,Alabama,,All,12 Years,,2014-04-01,2013-05-01,335.0
NCT01807949,3.222045575,A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation,Completed,Phase 3,Randomized,April 2013,April 2014,Treatment,Oakland,California,,All,12 Years,65 Years,2014-04-01,2013-04-01,365.0
NCT01808092,3.836963514,A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia,Completed,Phase 3,Randomized,April 2013,January 2016,Treatment,Buenos Aires,,,All,18 Years,90 Years,2016-01-01,2013-04-01,1005.0
NCT01808313,6.015037594,Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH),Completed,Phase 3,,"December 1, 2012","August 15, 2014",Treatment,Harbin,Heilongjiang,150001,All,18 Years,75 Years,2014-08-01,2012-12-01,608.0
NCT01817764,7.932011331,A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"March 1, 2013","October 25, 2013",Treatment,Jasper,Alabama,35501,All,40 Years,,2013-10-01,2013-03-01,214.0
NCT01817790,1.918993957,Assessment of Fluticasone Propionate on Ocular Allergy Symptoms,Completed,Phase 3,Randomized,December 2012,February 2013,,Wilmington,North Carolina,28401-3331,All,12 Years,,2013-02-01,2012-12-01,62.0
NCT01822899,4.608938547,A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"April 4, 2013","October 7, 2013",Treatment,Benesov,Bayern,256 30,All,40 Years,,2013-10-01,2013-04-01,183.0
NCT01825200,0.45682387,"Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age",Completed,Phase 3,Randomized,March 2013,May 2013,Prevention,Tucson,Arizona,85704-1152,All,50 Years,,2013-05-01,2013-03-01,61.0
NCT01827267,2.325581395,Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,"July 1, 2013","October 6, 2017",Treatment,Duarte,California,91010,All,18 Years,,2017-10-01,2013-07-01,1553.0
NCT01829113,36.18048618,Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer,Completed,Phase 2,Randomized,July 2013,"April 19, 2017",Treatment,Denver,Colorado,80218,All,18 Years,,2017-04-01,2013-07-01,1370.0
NCT01841762,33.09859155,Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument,Completed,Phase 3,,"April 1, 2013","November 1, 2015",Treatment,Birmingham,Alabama,35243,All,18 Years,,2015-11-01,2013-04-01,944.0
NCT01843842,0.0,Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children,Completed,Phase 3,Randomized,April 2013,March 2015,Treatment,Ekaterinburg,,620028,All,3 Years,18 Years,2015-03-01,2013-04-01,699.0
NCT01846416,6.451612903,A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR],Completed,Phase 2,Non-Randomized,"May 30, 2013","December 18, 2017",Treatment,Scottsdale,Arizona,85258,All,18 Years,,2017-12-01,2013-05-01,1675.0
NCT01852812,0.0,Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520),Completed,Phase 3,Non-Randomized,"June 7, 2013","December 24, 2013",Treatment,,,,All,1 Year,15 Years,2013-12-01,2013-06-01,183.0
NCT01854047,8.52320717,An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma,Completed,Phase 2,Randomized,June 2013,April 2015,Treatment,Fullerton,California,92835,All,18 Years,,2015-04-01,2013-06-01,669.0
NCT01854645,14.83341148,"Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)",Completed,Phase 3,Randomized,May 2013,February 2015,Treatment,Andalusia,Alabama,,All,40 Years,80 Years,2015-02-01,2013-05-01,641.0
NCT01854658,14.30036523,"Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)",Completed,Phase 3,Randomized,July 2013,March 2015,Treatment,Birmingham,Alabama,u,All,40 Years,80 Years,2015-03-01,2013-07-01,608.0
NCT01857063,4.090909091,Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519),Completed,Phase 3,Randomized,"June 10, 2013","September 1, 2013",Treatment,,,,All,10 Years,15 Years,2013-09-01,2013-06-01,92.0
NCT01857323,20.18927445,Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI),Completed,Phase 3,,May 2013,September 2013,Treatment,Phoenix,Arizona,,All,4 Years,,2013-09-01,2013-05-01,123.0
NCT01858389,40.90909091,A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,July 2013,September 2015,Treatment,Beverly Hills,California,90211,All,18 Years,,2015-09-01,2013-07-01,792.0
NCT01859143,0.4166666667,Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults,Completed,Phase 4,Randomized,May 2013,December 2013,Prevention,Miami,Florida,,All,18 Years,49 Years,2013-12-01,2013-05-01,214.0
NCT01859390,5.405405405,Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis,Completed,Phase 2,Randomized,June 2013,July 2016,Treatment,Tucson,Arizona,85724,All,10 Years,,2016-07-01,2013-06-01,1126.0
NCT01861522,0.625,The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,April 2013,December 2013,Treatment,Fukuoka,,,All,7 Years,15 Years,2013-12-01,2013-04-01,244.0
NCT01863433,0.8333333333,A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers,Completed,Phase 4,,May 2013,June 2013,Prevention,London,,NW10 7EW,All,18 Years,59 Years,2013-06-01,2013-05-01,31.0
NCT01867021,0.3447800893,"Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above",Completed,Phase 4,Randomized,May 2013,December 2013,Prevention,Kbel 163,Benátky nad Jizerou,294 71,All,50 Years,,2013-12-01,2013-05-01,214.0
NCT01868009,0.5226480836,DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,May 2013,July 2013,Treatment,Jasper,Alabama,35501,All,40 Years,,2013-07-01,2013-05-01,61.0
NCT01871805,14.94252874,A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 1/Phase 2,Non-Randomized,"September 30, 2013","August 31, 2017",Treatment,Birmingham,Alabama,35233,All,18 Years,,2017-08-01,2013-09-01,1430.0
NCT01872689,29.19268017,A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 2,Randomized,"October 13, 2013","November 6, 2017",Treatment,Birmingham,Alabama,35294,All,40 Years,,2017-11-01,2013-10-01,1492.0
NCT01879410,7.463030662,A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"June 13, 2013","January 9, 2014",Treatment,Tucson,Arizona,85723,All,40 Years,,2014-01-01,2013-06-01,214.0
NCT01879553,0.7936507937,"Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above",Completed,Phase 2,Non-Randomized,July 2013,August 2013,Prevention,Ghent,,9000,All,18 Years,,2013-08-01,2013-07-01,31.0
NCT01883453,0.0,A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold,Completed,Phase 2,Randomized,January 2013,September 2013,Treatment,Boden,,,All,18 Years,,2013-09-01,2013-01-01,243.0
NCT01899742,5.465587045,The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium,Completed,Phase 3,Randomized,"September 15, 2014","July 22, 2015",Treatment,Medford,Oregon,97504,All,40 Years,,2015-07-01,2014-09-01,303.0
NCT01900054,1.724137931,A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis,Completed,Phase 3,,June 2013,November 2013,Treatment,Kanagawa,,,All,7 Years,15 Years,2013-11-01,2013-06-01,153.0
NCT01900652,5.378657487,A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants,Completed,Phase 2,Randomized,August 2013,March 2016,Treatment,Birmingham,Alabama,35294,All,18 Years,,2016-03-01,2013-08-01,943.0
NCT01903993,7.328088578,"A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - ""POPLAR""",Completed,Phase 2,Randomized,"August 6, 2013","September 6, 2018",Treatment,Tucson,Arizona,85704,All,18 Years,,2018-09-01,2013-08-01,1857.0
NCT01908140,12.4339451,Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,September 2013,August 2014,Treatment,Feldbach,Alberta,8330,All,40 Years,,2014-08-01,2013-09-01,334.0
NCT01914757,8.789436987,Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist,Completed,Phase 3,Randomized,August 2013,March 2016,Treatment,Andalusia,Alabama,,All,12 Years,75 Years,2016-03-01,2013-08-01,943.0
NCT01916226,0.7327141383,A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis,Completed,Phase 4,Randomized,"August 1, 2013","October 17, 2013",Treatment,Little Rock,Arkansas,72205,All,18 Years,,2013-10-01,2013-08-01,61.0
NCT01918033,1.644474792,A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200),Completed,Phase 3,Randomized,"August 20, 2013","January 26, 2014",Treatment,,,,All,12 Years,,2014-01-01,2013-08-01,153.0
NCT01920893,11.66666667,An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis,Completed,Phase 2,Randomized,August 2013,November 2014,Treatment,Rolling Hills Estates,California,90274,All,18 Years,65 Years,2014-11-01,2013-08-01,457.0
NCT01922037,17.71576898,A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair),Completed,Phase 4,,"June 19, 2013","March 31, 2016",Treatment,Birmingham,Alabama,35209,All,12 Years,,2016-03-01,2013-06-01,1004.0
NCT01922271,0.6578947368,Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,August 2013,January 2014,Treatment,Berlin,,12043,All,40 Years,,2014-01-01,2013-08-01,153.0
NCT01928771,9.804986808,Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma,Completed,Phase 3,Randomized,"September 19, 2013","April 5, 2016",Treatment,Foley,Alabama,,All,12 Years,75 Years,2016-04-01,2013-09-01,943.0
NCT01931839,8.914797669,A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis,Completed,Phase 3,Randomized,October 2013,April 2016,Treatment,Birmingham,Alabama,,All,12 Years,,2016-04-01,2013-10-01,913.0
NCT01933048,5.088866245,Self-Administered Nasal Influenza Feasibility Study,Completed,Phase 4,Randomized,September 2012,October 2013,Other,San Diego,California,92134,All,18 Years,49 Years,2013-10-01,2012-09-01,395.0
NCT01943552,26.31870567,Ipratropium Bromide in Peri-Operative COPD,Completed,Phase 4,Randomized,October 2013,August 2015,Treatment,Chengdu,,,All,50 Years,75 Years,2015-08-01,2013-10-01,669.0
NCT01944631,3.0,Iota-Carrageenan Nasal Spray in Common Cold,Completed,Phase 4,Randomized,September 2013,March 2014,Treatment,Cardiff,,,All,18 Years,64 Years,2014-03-01,2013-09-01,181.0
NCT01944774,8.737562189,Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride,Completed,Phase 2,Randomized,March 2013,December 2013,Treatment,Shanghai,,200040,All,18 Years,75 Years,2013-12-01,2013-03-01,275.0
NCT01946425,1.666666667,Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine,Completed,Phase 4,Non-Randomized,September 2013,July 2014,Prevention,Bardstown,Kentucky,40040,All,6 Months,8 Years,2014-07-01,2013-09-01,303.0
NCT01946438,1.923076923,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults",Completed,Phase 4,Randomized,September 2013,July 2014,Prevention,Santa Rosa,California,95405,All,18 Years,,2014-07-01,2013-09-01,303.0
NCT01948193,5.084745763,Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth,Completed,Phase 3,,February 2014,June 2015,Prevention,Ludhiana,Punjab,141008,All,6 Weeks,8 Weeks,2015-06-01,2014-02-01,485.0
NCT01949090,3.666666667,Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older,Completed,Phase 2,Randomized,"September 25, 2013","October 23, 2014",Prevention,Hollywood,Florida,33024,All,65 Years,,2014-10-01,2013-09-01,395.0
NCT01951586,8.879071379,Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,"December 31, 2013","November 28, 2017",Treatment,Goodyear,Arizona,85338,All,18 Years,100 Years,2017-11-01,2013-12-01,1431.0
NCT01957163,4.039053828,"Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"October 1, 2013","April 1, 2014",Treatment,Jasper,Alabama,35501,All,40 Years,,2014-04-01,2013-10-01,182.0
NCT01959412,0.1831501832,"Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma",Completed,Phase 2,Randomized,November 2013,March 2014,Treatment,Huntington Beach,California,92647,All,18 Years,,2014-03-01,2013-11-01,120.0
NCT01964352,5.533456127,Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1),Completed,Phase 3,Randomized,November 2013,November 2014,Treatment,Wheat Ridge,Colorado,,All,40 Years,,2014-11-01,2013-11-01,365.0
NCT01966003,10.39692403,Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,"November 11, 2013","July 23, 2015",Treatment,Bismarck,North Dakota,58501,All,18 Years,80 Years,2015-07-01,2013-11-01,607.0
NCT01966107,37.13830865,Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.,Completed,Phase 4,Randomized,"October 16, 2013","September 21, 2017",Treatment,Birmingham,Alabama,35209,All,40 Years,130 Years,2017-09-01,2013-10-01,1431.0
NCT01967173,23.68730324,Best African American Response to Asthma Drugs,Completed,Phase 3,Randomized,February 2014,"July 1, 2017",Treatment,Tucson,Arizona,85724,All,5 Years,,2017-07-01,2014-02-01,1246.0
NCT01967628,16.25,Human Lung Responses to Respiratory Pathogens,Completed,Phase 1/Phase 2,Randomized,June 2007,October 2010,Basic Science,Iowa City,Iowa,52242,All,18 Years,60 Years,2010-10-01,2007-06-01,1218.0
NCT01968434,6.08974359,Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.,Completed,Phase 4,Randomized,December 2013,April 2014,Treatment,Bat Yam,,,All,2 Years,5 Years,2014-04-01,2013-12-01,121.0
NCT01969721,2.401746725,Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients,Completed,Phase 3,Randomized,October 2013,February 2015,Treatment,Genk,,,All,40 Years,,2015-02-01,2013-10-01,488.0
NCT01969799,2.083333333,Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia,Completed,Phase 2,Randomized,December 2013,April 2016,Treatment,Los Angeles,California,90033,All,18 Years,80 Years,2016-04-01,2013-12-01,852.0
NCT01970371,1.666666667,A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE),Completed,Phase 3,Randomized,"September 16, 2014","September 15, 2016",Treatment,,,,All,18 Years,85 Years,2016-09-01,2014-09-01,731.0
NCT01970878,2.76069181,"Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)",Completed,Phase 3,Randomized,November 2013,March 2015,Treatment,Andalusia,Alabama,,All,40 Years,80 Years,2015-03-01,2013-11-01,485.0
NCT01974895,9.554527751,Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age,Completed,Phase 2,Randomized,"October 23, 2013","July 3, 2014",Prevention,Sacramento,California,95822,All,6 Months,35 Months,2014-07-01,2013-10-01,273.0
NCT01978119,1.829268293,"A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma",Completed,Phase 3,Randomized,"November 6, 2013","January 28, 2015",Treatment,Nizhniy Novgorod,,603011,All,12 Years,80 Years,2015-01-01,2013-11-01,426.0
NCT01978145,4.929577465,"A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"November 14, 2013","April 16, 2015",Treatment,Florencio Varela,Buenos Aires,1888,All,40 Years,80 Years,2015-04-01,2013-11-01,516.0
NCT01978262,11.95652174,Immune and Hormone Response to Influenza Vaccine,Completed,Phase 4,,October 2013,August 2017,Other,Baltimore,Maryland,21205,Female,18 Years,39 Years,2017-08-01,2013-10-01,1400.0
NCT01979952,12.40601504,Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 3,Randomized,"November 26, 2013","October 27, 2016",Treatment,Danbury,Connecticut,06810,All,40 Years,,2016-10-01,2013-11-01,1065.0
NCT01992094,3.007165732,Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older,Completed,Phase 3,Randomized,November 2013,July 2014,Prevention,Huntsville,Alabama,35802,All,18 Years,,2014-07-01,2013-11-01,242.0
NCT01992107,5.876088124,Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old,Completed,Phase 3,Randomized,November 2013,August 2014,Prevention,Huntsville,Alabama,35802,All,4 Years,18 Years,2014-08-01,2013-11-01,273.0
NCT01996319,5.697278912,"Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.",Completed,Phase 3,Randomized,April 2014,February 2015,Treatment,Koblenz,NRW,56068,All,40 Years,,2015-02-01,2014-04-01,306.0
NCT01996332,13.90581717,A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Non-Randomized,April 2004,October 2012,Treatment,Alcoy,Alicante,03804,All,18 Years,,2012-10-01,2004-04-01,3105.0
NCT01998477,3.462238835,A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications,Completed,Phase 3,Randomized,October 2013,July 2014,Prevention,Firenze,Barcelona,50139,All,3 Years,17 Years,2014-07-01,2013-10-01,273.0
NCT01998919,13.00607287,A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.,Completed,Phase 2,Randomized,August 2006,November 2011,Treatment,Campbelltown,,2560,All,18 Years,,2011-11-01,2006-08-01,1918.0
NCT02000531,2.380952381,Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population,Completed,Phase 4,Randomized,January 2014,December 2014,Treatment,Beijing,,101149,All,18 Years,,2014-12-01,2014-01-01,334.0
NCT02006732,4.20243379,Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2),Completed,Phase 3,Randomized,November 2013,November 2014,Treatment,Jasper,Alabama,,All,40 Years,,2014-11-01,2013-11-01,365.0
NCT02013206,27.2113943,A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy,Completed,Phase 2,Non-Randomized,September 2006,October 2010,Treatment,Marseille,,13274,All,18 Years,,2010-10-01,2006-09-01,1491.0
NCT02020889,5.147058824,A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis,Completed,Phase 3,Randomized,"February 5, 2014","September 5, 2016",Treatment,Denver,Colorado,80206,All,18 Years,,2016-09-01,2014-02-01,943.0
NCT02021292,1.25,"Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension",Completed,Phase 2,Randomized,"August 20, 2014","September 28, 2016",Treatment,Leuven,,3000,All,18 Years,84 Years,2016-09-01,2014-08-01,762.0
NCT02031640,4.245283019,A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma,Completed,Phase 3,Randomized,December 2013,December 2014,Treatment,Costa Mesa,California,,All,12 Years,,2014-12-01,2013-12-01,365.0
NCT02034877,0.3003003003,13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India,Completed,Phase 4,,August 2014,July 2015,Prevention,Visakhapatnam,Andhra Pradesh,530002,All,6 Years,65 Years,2015-07-01,2014-08-01,334.0
NCT02035696,1.789260581,Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old,Completed,Phase 1/Phase 2,Randomized,December 2013,December 2014,Prevention,Phoenix,Arizona,,All,6 Months,48 Months,2014-12-01,2013-12-01,365.0
NCT02040766,6.680874891,A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma,Completed,Phase 3,Randomized,December 2013,March 2016,Treatment,Hoover,Alabama,,All,4 Years,11 Years,2016-03-01,2013-12-01,821.0
NCT02040779,6.231530145,A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma,Completed,Phase 3,Randomized,"December 26, 2013","December 24, 2014",Treatment,Huntington Beach,California,,All,12 Years,,2014-12-01,2013-12-01,365.0
NCT02054130,10.01269438,"Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma",Completed,Phase 2,Randomized,"December 13, 2013","March 1, 2017",Treatment,Los Angeles,California,90025,All,18 Years,75 Years,2017-03-01,2013-12-01,1186.0
NCT02055352,8.488268247,Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD,Completed,Phase 4,Randomized,"May 30, 2014","January 26, 2016",Treatment,Caba,Buenos Aires,C1056ABJ,All,40 Years,,2016-01-01,2014-05-01,610.0
NCT02061280,40.66666667,Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial,Completed,Phase 4,Randomized,October 2013,"February 17, 2017",Other,Wilmington,Delaware,19803,All,12 Years,17 Years,2017-02-01,2013-10-01,1219.0
NCT02064439,9.594677461,Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism),Completed,Phase 3,Randomized,"March 5, 2014","November 4, 2016",Prevention,Beverly Hills,California,90211,All,18 Years,,2016-11-01,2014-03-01,976.0
NCT02073682,26.85684829,Cancer Venous Thromboembolism (VTE),Completed,Phase 3,Randomized,"July 16, 2015","September 15, 2017",Treatment,Brandon,Florida,,All,18 Years,,2017-09-01,2015-07-01,793.0
NCT02075255,3.197361745,Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy,Completed,Phase 3,Randomized,"April 28, 2014","August 8, 2016",Treatment,Los Angeles,California,90025,All,18 Years,75 Years,2016-08-01,2014-04-01,853.0
NCT02075541,7.600837139,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.",Completed,Phase 2,Randomized,"July 8, 2014","April 19, 2017",Prevention,Eskilstuna,Carmarthenshire,SE-631 88,All,40 Years,80 Years,2017-04-01,2014-07-01,1005.0
NCT02085161,12.22368421,To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways,Completed,Phase 3,Randomized,March 2014,October 2015,Treatment,San Diego,California,,All,40 Years,75 Years,2015-10-01,2014-03-01,579.0
NCT02089347,0.1404494382,Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old,Completed,Phase 3,Randomized,March 2014,March 2015,Prevention,Aichi,,451 8511,All,11 Years,12 Years,2015-03-01,2014-03-01,365.0
NCT02091986,9.294431732,"A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg",Completed,Phase 3,Randomized,April 2014,April 2016,Treatment,Hoover,Alabama,,All,6 Years,11 Years,2016-04-01,2014-04-01,731.0
NCT02097472,0.4,Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers,Completed,Phase 1/Phase 2,Randomized,April 2014,December 2015,Prevention,Kisumu,Nyanza,PO Box 54-40100,All,12 Months,45 Years,2015-12-01,2014-04-01,609.0
NCT02098369,4.040953337,Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers,Completed,Phase 4,Randomized,April 2015,October 2016,Treatment,Lake Forest,California,92630,All,18 Years,,2016-10-01,2015-04-01,549.0
NCT02105948,10.70460777,Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 3,Randomized,"April 15, 2014","January 17, 2017",Treatment,Newport Beach,California,92663,All,40 Years,,2017-01-01,2014-04-01,1006.0
NCT02105961,10.95862123,Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"April 24, 2014","January 16, 2017",Treatment,Birmingham,Alabama,35294,All,40 Years,,2017-01-01,2014-04-01,1006.0
NCT02105974,3.885630499,Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"April 7, 2014","July 8, 2015",Treatment,Riverside,California,92506,All,40 Years,,2015-07-01,2014-04-01,456.0
NCT02106832,13.29999815,Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE),Completed,Phase 3,Randomized,"April 30, 2014","October 19, 2016",Treatment,Peoria,Arizona,85381,All,18 Years,,2016-10-01,2014-04-01,914.0
NCT02107274,11.77489177,Efficacy of Azithromycin in Treatment of Bronchiectasis,Completed,Phase 4,Randomized,November 2011,December 2013,Treatment,Taiping,Perak,34000,All,18 Years,,2013-12-01,2011-11-01,761.0
NCT02118961,0.2232142857,Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents,Completed,Phase 3,Randomized,April 2014,August 2014,Prevention,Fukuoka-shi,Fukuoka,,All,11 Years,12 Years,2014-08-01,2014-04-01,122.0
NCT02119286,4.204774635,"Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2",Completed,Phase 3,Randomized,October 2013,April 2014,Treatment,Mobile,Alabama,36608,All,40 Years,,2014-04-01,2013-10-01,182.0
NCT02125734,1.041666667,Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients,Completed,Phase 4,,April 2014,January 2015,Treatment,Ibbenbüren,Rheinland Pfalz,49477,All,40 Years,,2015-01-01,2014-04-01,275.0
NCT02130193,18.19444444,"Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations",Completed,Phase 2,Randomized,"February 13, 2014","August 29, 2016",Treatment,Birmingham,Alabama,35294,All,40 Years,70 Years,2016-08-01,2014-02-01,912.0
NCT02135692,7.079646018,"A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects",Completed,Phase 3,,"May 29, 2014","October 5, 2017",Treatment,Newport Beach,California,92663,All,12 Years,,2017-10-01,2014-05-01,1249.0
NCT02139644,5.403697078,Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma,Completed,Phase 3,Randomized,June 2014,September 2015,Treatment,Birmingham,Alabama,,All,12 Years,,2015-09-01,2014-06-01,457.0
NCT02141854,5.479452055,Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma,Completed,Phase 3,Randomized,June 2014,September 2015,Treatment,Birmingham,Alabama,,All,12 Years,,2015-09-01,2014-06-01,457.0
NCT02148445,0.0,Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers,Completed,Phase 3,Randomized,May 2014,December 2016,Treatment,Kansas City,Kansas,66160,All,18 Years,,2016-12-01,2014-05-01,945.0
NCT02152605,4.233870968,A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"September 1, 2014","March 5, 2015",Treatment,Phoenix,Arizona,85006,All,40 Years,,2015-03-01,2014-09-01,181.0
NCT02155881,7.5,Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia,Completed,Phase 3,Randomized,August 2014,November 2014,Treatment,Kazan,,,All,18 Years,,2014-11-01,2014-08-01,92.0
NCT02157935,7.372980365,Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"June 27, 2014","February 8, 2016",Treatment,Andalusia,Alabama,36420,All,40 Years,95 Years,2016-02-01,2014-06-01,610.0
NCT02161757,11.65465114,A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma,Completed,Phase 3,Randomized,"June 13, 2014","July 18, 2017",Treatment,Birmingham,Alabama,35209,All,12 Years,75 Years,2017-07-01,2014-06-01,1126.0
NCT02164513,11.17288302,"A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"June 30, 2014","July 17, 2017",Treatment,Athens,Alabama,35611,All,40 Years,,2017-07-01,2014-06-01,1126.0
NCT02164539,3.539621398,Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component,Completed,Phase 2,Randomized,"July 1, 2014","July 18, 2015",Treatment,Newport Beach,California,92663,All,18 Years,,2015-07-01,2014-07-01,365.0
NCT02175771,11.95443444,Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma,Completed,Phase 3,Randomized,July 2014,July 2015,Treatment,Birmingham,Alabama,,All,12 Years,,2015-07-01,2014-07-01,365.0
NCT02191137,12.0,Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION),Completed,Phase 4,,"September 23, 2014","July 16, 2016",Treatment,Tucson,Arizona,85724,All,18 Years,80 Years,2016-07-01,2014-09-01,669.0
NCT02194699,12.78520041,A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma,Completed,Phase 3,Randomized,"October 30, 2014","September 21, 2017",Treatment,Birmingham,Alabama,35294,All,12 Years,75 Years,2017-09-01,2014-10-01,1066.0
NCT02207413,1.025789604,A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children,Completed,Phase 3,Randomized,"August 18, 2014","April 18, 2015",Prevention,Wichita,Kansas,67207,All,6 Months,49 Years,2015-04-01,2014-08-01,243.0
NCT02207829,5.407584735,A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"September 1, 2014","June 15, 2015",Treatment,Spartanburg,South Carolina,29303,All,40 Years,,2015-06-01,2014-09-01,273.0
NCT02214225,2.487190088,A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.,Completed,Phase 3,Randomized,August 2014,April 2015,Prevention,Huntsville,Alabama,35802,All,18 Years,,2015-04-01,2014-08-01,243.0
NCT02218697,2.253574472,Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older,Completed,Phase 3,Randomized,"October 1, 2014","May 4, 2015",Prevention,Gent,,9000,All,50 Years,,2015-05-01,2014-10-01,212.0
NCT02228980,5.32781457,"Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China",Completed,Phase 4,Non-Randomized,September 2014,October 2015,Prevention,Nanning,Guangxi,,All,6 Months,,2015-10-01,2014-09-01,395.0
NCT02230332,6.513157895,Alendronate to Prevent Loss of Bronchoprotection in Asthma,Completed,Phase 2/Phase 3,Randomized,January 2015,September 2016,Treatment,Tucson,Arizona,85724,All,18 Years,80 Years,2016-09-01,2015-01-01,609.0
NCT02233543,3.947368421,"A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 4,Randomized,"November 30, 2014","June 26, 2016",Treatment,Aarhus,,8000 C,All,40 Years,,2016-06-01,2014-11-01,578.0
NCT02233803,3.266331658,"A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma",Completed,Phase 4,Randomized,"November 14, 2014","December 11, 2015",Treatment,Ciudad autónoma de Buenos Aires,Buenos Aires,C1028AAP,All,18 Years,80 Years,2015-12-01,2014-11-01,395.0
NCT02236611,3.964637395,A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,"September 26, 2014","June 2, 2015",Treatment,Paraná,Buenos Aires,E3100BHK,All,40 Years,,2015-06-01,2014-09-01,273.0
NCT02238483,13.20872274,A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy,Completed,Phase 2,Randomized,"October 28, 2014","April 4, 2016",Treatment,Los Angeles,California,90036,All,40 Years,85 Years,2016-04-01,2014-10-01,548.0
NCT02242643,6.311478032,Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age,Completed,Phase 3,Randomized,"October 1, 2014","June 23, 2015",Prevention,Birmingham,Alabama,35235,All,6 Months,35 Months,2015-06-01,2014-10-01,243.0
NCT02246166,2.0,"The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.",Completed,Phase 4,Randomized,January 2015,February 2015,Treatment,Shanghai,,200025,All,18 Years,65 Years,2015-02-01,2015-01-01,31.0
NCT02250274,0.0,Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents,Completed,Phase 4,Randomized,September 2014,April 2015,Basic Science,Marshfield,Wisconsin,54449,All,5 Years,17 Years,2015-04-01,2014-09-01,212.0
NCT02256488,1.538461538,Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects,Completed,Phase 3,Randomized,September 2014,December 2014,Other,Anaheim,California,,All,18 Years,49 Years,2014-12-01,2014-09-01,91.0
NCT02257372,5.918264742,A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,"September 30, 2014","March 24, 2015",Treatment,Kurim,Bayern,66434,All,40 Years,,2015-03-01,2014-09-01,181.0
NCT02257385,4.266105909,Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium,Completed,Phase 3,Randomized,"October 15, 2014","May 4, 2015",Treatment,Mar del Plata,Buenos Aires,7600,All,40 Years,,2015-05-01,2014-10-01,212.0
NCT02258334,0.5,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults",Completed,Phase 4,Randomized,October 2014,December 2014,Prevention,Santa Rosa,California,95405,All,18 Years,,2014-12-01,2014-10-01,61.0
NCT02259582,7.305418719,"A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,February 2015,"April 7, 2017",Treatment,Rancho Mirage,California,92270,All,21 Years,,2017-04-01,2015-02-01,790.0
NCT02266875,18.96551724,Nebulized Hypertonic Saline for Inpatient Use in COPD,Completed,Phase 4,Randomized,October 2014,"January 30, 2017",Treatment,Columbus,Ohio,43228,All,18 Years,,2017-01-01,2014-10-01,823.0
NCT02268396,7.246376812,Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD,Completed,Phase 3,,November 2014,May 2015,Treatment,Clearwater,Florida,,All,40 Years,80 Years,2015-05-01,2014-11-01,181.0
NCT02276222,19.15443721,A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD,Completed,Phase 3,Randomized,October 2014,February 2016,Treatment,Andalusia,Alabama,36420,All,40 Years,,2016-02-01,2014-10-01,488.0
NCT02279498,13.94383394,SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis,Completed,Phase 3,Randomized,June 2015,"January 20, 2017",Treatment,Long Beach,California,90806,All,7 Years,,2017-01-01,2015-06-01,580.0
NCT02281318,2.717462911,Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control,Completed,Phase 3,Randomized,"December 11, 2014","June 10, 2016",Treatment,Birmingham,Alabama,35243,All,12 Years,,2016-06-01,2014-12-01,548.0
NCT02281357,7.857142857,Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma,Completed,Phase 3,Randomized,"February 19, 2015","September 7, 2017",Treatment,New Haven,Connecticut,06520,All,12 Years,75 Years,2017-09-01,2015-02-01,943.0
NCT02285998,5.719449012,Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age,Completed,Phase 3,Randomized,October 2014,May 2015,Prevention,Mobile,Alabama,36608,All,50 Years,,2015-05-01,2014-10-01,212.0
NCT02289833,6.896551724,"A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",Completed,Phase 2,,"December 15, 2014","August 20, 2018",Treatment,Jacksonville,Florida,32256,All,18 Years,,2018-08-01,2014-12-01,1339.0
NCT02290691,1.72858276,Inactivated Influenza Via Jet Injection,Completed,Phase 4,Randomized,November 2014,January 2015,Prevention,Huntsville,Alabama,35802,All,18 Years,64 Years,2015-01-01,2014-11-01,61.0
NCT02291549,0.753806724,S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps,Completed,Phase 3,Randomized,December 2014,October 2016,Treatment,Birmingham,Alabama,35233,All,18 Years,,2016-10-01,2014-12-01,670.0
NCT02293863,10.76471401,A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection,Completed,Phase 2,Randomized,"January 14, 2015","May 23, 2017",Treatment,Brussels,MG,1000,All,18 Years,,2017-05-01,2015-01-01,851.0
NCT02294734,14.28571429,An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,"March 31, 2015","April 25, 2016",Treatment,Edegem,,2650,All,40 Years,80 Years,2016-04-01,2015-03-01,397.0
NCT02296138,13.51478159,Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.,Completed,Phase 3,Randomized,"January 13, 2015","March 29, 2017",Treatment,Andalusia,Alabama,,All,40 Years,,2017-03-01,2015-01-01,790.0
NCT02299375,17.5177305,Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,"December 9, 2014","June 30, 2016",Treatment,Ciudad Autónoma de Buenos Aires,Región Del Maule,C1426ABP,All,40 Years,,2016-06-01,2014-12-01,548.0
NCT02301975,4.385720717,"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma",Completed,Phase 3,Randomized,"March 1, 2015","November 25, 2016",Treatment,Huntington Beach,California,92647,All,12 Years,,2016-11-01,2015-03-01,611.0
NCT02320396,1.781746032,Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204),Completed,Phase 3,Randomized,"January 9, 2015","April 27, 2015",Treatment,,,,All,16 Years,,2015-04-01,2015-01-01,90.0
NCT02322775,5.215633423,Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma,Completed,Phase 3,Randomized,"February 2, 2015","October 7, 2015",Treatment,Los Angeles,California,90048,All,18 Years,75 Years,2015-10-01,2015-02-01,242.0
NCT02345161,5.197994112,A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"January 23, 2015","April 7, 2016",Treatment,Dimitrovgrad,Guangdong,6400,All,40 Years,,2016-04-01,2015-01-01,456.0
NCT02347657,6.338205645,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor",Completed,Phase 3,Randomized,January 2015,"January 20, 2017",Treatment,Little Rock,Arkansas,,All,12 Years,,2017-01-01,2015-01-01,731.0
NCT02347774,22.67236819,Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4),Completed,Phase 3,Randomized,February 2015,December 2015,Treatment,Andalusia,Alabama,36420,All,40 Years,,2015-12-01,2015-02-01,303.0
NCT02364999,7.787570219,A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC,Completed,Phase 3,Randomized,April 2015,December 2017,Treatment,Daphne,Alabama,36526,All,18 Years,,2017-12-01,2015-04-01,975.0
NCT02369341,0.7936507937,Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above,Completed,Phase 3,Non-Randomized,"April 29, 2015","June 3, 2015",Prevention,Belo Horizonte,Minas Gerais,30150-221,All,18 Years,,2015-06-01,2015-04-01,61.0
NCT02375724,3.717523494,BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH,Completed,Phase 4,Randomized,March 2015,November 2015,Treatment,Berlin,,,All,40 Years,110 Years,2015-11-01,2015-03-01,245.0
NCT02377427,11.53846154,Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children,Completed,Phase 2,Non-Randomized,"August 25, 2015","January 31, 2018",Other,San Diego,California,92123,All,6 Years,11 Years,2018-01-01,2015-08-01,884.0
NCT02379637,4.285714286,Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough,Completed,Phase 2,Randomized,January 2015,April 2015,Treatment,Chicoutimi,Quebec,,All,18 Years,65 Years,2015-04-01,2015-01-01,90.0
NCT02390219,23.91304348,Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease,Completed,Phase 3,,March 2015,October 2016,Treatment,Denver,Colorado,,All,12 Years,,2016-10-01,2015-03-01,580.0
NCT02394600,6.429232192,The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation,Completed,Phase 4,Randomized,April 2015,June 2016,Treatment,Kingston,Ontario,K7L 2V7,All,18 Years,65 Years,2016-06-01,2015-04-01,427.0
NCT02411292,20.21276596,Enoxaparin Metabolism in Reconstructive Surgery Patients,Completed,Phase 2,,March 2015,June 2016,Other,Salt Lake City,Utah,84132,All,18 Years,,2016-06-01,2015-03-01,458.0
NCT02414854,7.089750492,Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest),Completed,Phase 3,Randomized,"April 27, 2015","November 23, 2017",Treatment,Birmingham,Alabama,35209,All,12 Years,,2017-11-01,2015-04-01,945.0
NCT02416180,0.9009009009,Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® Inhaler,Completed,Phase 4,,"June 18, 2015","August 20, 2015",Treatment,Frankfurt,Hessen,60389,All,18 Years,,2015-08-01,2015-06-01,61.0
NCT02417961,3.448275862,"Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home",Completed,Phase 3,,"April 27, 2015","March 14, 2016",Treatment,Fountain Valley,California,,All,18 Years,75 Years,2016-03-01,2015-04-01,335.0
NCT02424344,5.995398945,"Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients",Completed,Phase 4,Randomized,"April 27, 2015","July 25, 2016",Treatment,Hamilton,Ontario,L8N 3Z5,All,40 Years,130 Years,2016-07-01,2015-04-01,457.0
NCT02438137,20.995671,Dimethyl Fumarate for Obstructive Sleep Apnea,Completed,Phase 2,Randomized,May 2015,May 2016,Treatment,Ann Arbor,Michigan,48109,All,18 Years,65 Years,2016-05-01,2015-05-01,366.0
NCT02449018,3.571428571,"A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251",Completed,Phase 2,Randomized,"April 30, 2015","January 23, 2017",Treatment,Birmingham,Alabama,35294,All,18 Years,75 Years,2017-01-01,2015-04-01,641.0
NCT02451358,1.015254587,Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India,Completed,Phase 3,Randomized,"July 27, 2015","January 28, 2017",Prevention,Vadodara,Gujarat,390001,All,6 Months,,2017-01-01,2015-07-01,550.0
NCT02471183,5.882352941,Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension,Completed,Phase 3,,"October 12, 2015","December 5, 2016",Treatment,La Jolla,California,,All,18 Years,75 Years,2016-12-01,2015-10-01,427.0
NCT02473510,1.25,Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season,Completed,Phase 4,Randomized,June 2015,January 2016,Prevention,South Miami,Florida,,All,18 Years,49 Years,2016-01-01,2015-06-01,214.0
NCT02483975,1.818181818,Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma,Completed,Phase 3,Randomized,"October 9, 2015","June 21, 2016",Treatment,Little Rock,Arkansas,72211,All,5 Years,11 Years,2016-06-01,2015-10-01,244.0
NCT02501629,5.094484168,An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils,Completed,Phase 3,Randomized,"September 29, 2015","December 4, 2017",Treatment,Bakersfield,California,93301,All,12 Years,,2017-12-01,2015-09-01,822.0
NCT02502734,1.666666667,Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma,Completed,Phase 3,Randomized,"September 7, 2015","December 21, 2015",Treatment,Randers,,8900,All,5 Years,11 Years,2015-12-01,2015-09-01,91.0
NCT02513160,10.75452455,Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma,Completed,Phase 3,Randomized,"September 30, 2015","March 31, 2016",Treatment,Peoria,Arizona,,All,12 Years,,2016-03-01,2015-09-01,182.0
NCT02514473,3.912332981,"A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation",Completed,Phase 3,Randomized,July 2015,September 2016,Treatment,Birmingham,Alabama,,All,6 Years,11 Years,2016-09-01,2015-07-01,428.0
NCT02516410,1.204819277,"A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation",Completed,Phase 3,Randomized,August 2015,"June 7, 2016",Treatment,Birmingham,Alabama,,All,12 Years,,2016-06-01,2015-08-01,305.0
NCT02528214,1.45631068,Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma,Completed,Phase 3,Randomized,"October 15, 2015","November 13, 2017",Treatment,Los Angeles,California,90048,All,12 Years,,2017-11-01,2015-10-01,762.0
NCT02531438,5.943859837,Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13),Completed,Phase 3,Randomized,November 2015,"March 10, 2017",Treatment,Birmingham,Alabama,35215,All,18 Years,,2017-03-01,2015-11-01,486.0
NCT02543892,0.0,A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya,Completed,Phase 1/Phase 2,Randomized,"August 10, 2016","January 4, 2018",Prevention,Kilifi,,80108,All,1 Year,40 Years,2018-01-01,2016-08-01,518.0
NCT02545543,5.269733994,A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age,Completed,Phase 3,Randomized,September 2015,June 2016,Prevention,Huntsville,Alabama,35802,All,5 Years,17 Years,2016-06-01,2015-09-01,274.0
NCT02555618,0.0,Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants,Completed,Phase 2,Randomized,September 2015,December 2015,Prevention,,,,All,20 Years,49 Years,2015-12-01,2015-09-01,91.0
NCT02563106,14.32038835,A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI,Completed,Phase 2,Randomized,October 2015,November 2016,Prevention,Little Rock,Arkansas,72205,All,50 Years,,2016-11-01,2015-10-01,397.0
NCT02567708,3.0,"A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma",Completed,Phase 2,Randomized,"October 1, 2015","September 28, 2016",Treatment,Muenchen,Bayern,80539,All,18 Years,70 Years,2016-09-01,2015-10-01,336.0
NCT02570165,2.498568345,Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,"November 6, 2015","July 6, 2016",Treatment,Hialeah,Florida,33013,All,40 Years,,2016-07-01,2015-11-01,243.0
NCT02573870,11.9047619,Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,"December 1, 2015","July 5, 2016",Treatment,Phoenix,Arizona,85006,All,40 Years,,2016-07-01,2015-12-01,213.0
NCT02579603,5.80836108,"Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF",Completed,Phase 4,Randomized,"October 16, 2015","January 31, 2017",Treatment,Danbury,Connecticut,06810,All,40 Years,,2017-01-01,2015-10-01,458.0
NCT02584660,13.21195145,A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department,Completed,Phase 4,Randomized,"October 15, 2015","March 22, 2017",Treatment,Montgomery,Alabama,,All,18 Years,,2017-03-01,2015-10-01,517.0
NCT02586493,4.316546763,Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects,Completed,Phase 4,,"October 1, 2015","March 15, 2016",Other,Jasper,Alabama,35501,All,40 Years,,2016-03-01,2015-10-01,152.0
NCT02586506,3.474903475,Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma,Completed,Phase 4,,"October 1, 2015","February 4, 2016",Other,Mobile,Alabama,36608,All,18 Years,,2016-02-01,2015-10-01,123.0
NCT02596009,0.0,"Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices",Completed,Phase 4,Randomized,"December 16, 2015","April 29, 2016",Treatment,Caba,Buenos Aires,C1426ABP,All,40 Years,,2016-04-01,2015-12-01,122.0
NCT02598193,17.97752809,Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 4,,"January 14, 2016","May 16, 2017",Treatment,Los Angeles,California,90095-1690,All,40 Years,80 Years,2017-05-01,2016-01-01,486.0
NCT02603952,1.5625,A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza,Completed,Phase 1/Phase 2,Randomized,"December 7, 2015","December 9, 2016",Treatment,Canoga Park,California,91303,All,18 Years,65 Years,2016-12-01,2015-12-01,366.0
NCT02604342,6.369047619,Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib,Completed,Phase 3,Randomized,"November 3, 2015","August 13, 2018",Treatment,Charleroi,Campania,6000,All,18 Years,,2018-08-01,2015-11-01,1004.0
NCT02631551,3.475516912,Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR),Completed,Phase 3,Randomized,March 2016,July 2016,Treatment,Mission Viejo,California,,All,12 Years,,2016-07-01,2016-03-01,122.0
NCT02654145,4.137931034,Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients,Completed,Phase 4,,"March 17, 2016","May 31, 2017",Treatment,Birmingham,Alabama,35209,All,12 Years,,2017-05-01,2016-03-01,426.0
NCT02683109,0.4545454545,Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD,Completed,Phase 4,Randomized,"March 8, 2016","January 30, 2017",Treatment,Feldbach,,8330,All,40 Years,,2017-01-01,2016-03-01,306.0
NCT02707640,8.198924731,A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 2,Randomized,August 2013,February 2015,Treatment,Graz,Campania,8036,All,40 Years,80 Years,2015-02-01,2013-08-01,549.0
NCT02709538,21.92791798,Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,April 2016,July 2017,Treatment,Hot Springs,Arkansas,,All,12 Years,,2017-07-01,2016-04-01,456.0
NCT02720081,5.634920635,Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015),Completed,Phase 2,Randomized,"May 11, 2016","September 6, 2017",Treatment,,,,All,18 Years,65 Years,2017-09-01,2016-05-01,488.0
NCT02730351,2.702702703,Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB),Completed,Phase 4,Randomized,"May 25, 2016","February 3, 2017",Treatment,Huntington Beach,California,92647,All,12 Years,50 Years,2017-02-01,2016-05-01,276.0
NCT02743117,1.054926507,Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season,Completed,Phase 4,Randomized,"May 2, 2016","November 30, 2016",Prevention,South Miami,Florida,33143,All,18 Years,49 Years,2016-11-01,2016-05-01,184.0
NCT02774278,13.63636364,A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,,July 2005,June 2009,Treatment,Bruxelles,,B-1200,All,18 Years,,2009-06-01,2005-07-01,1431.0
NCT02794480,0.7258064516,Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use,Completed,Phase 4,Randomized,"August 22, 2016","December 15, 2016",Treatment,Huntington Beach,California,92648,All,18 Years,,2016-12-01,2016-08-01,122.0
NCT02796677,8.501747625,AMPLIFY - D6571C00001 Duaklir USA Phase III Study,Completed,Phase 3,Randomized,"July 5, 2016","June 8, 2017",Treatment,Gulf Shores,Alabama,36542,All,40 Years,130 Years,2017-06-01,2016-07-01,335.0
NCT02799784,2.118644068,An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients,Completed,Phase 4,Randomized,"July 14, 2016","April 27, 2017",Treatment,Clearwater,Florida,33765,All,40 Years,,2017-04-01,2016-07-01,274.0
NCT02805907,5.357142857,Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD),Completed,Phase 4,Randomized,June 2016,January 2017,Treatment,Murcia,,30008,All,18 Years,,2017-01-01,2016-06-01,214.0
NCT02814643,3.865007541,Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma,Completed,Phase 3,Randomized,"July 1, 2016","January 24, 2017",Supportive Care,Birmingham,Alabama,35209,All,12 Years,21 Years,2017-01-01,2016-07-01,184.0
NCT02823964,12.0,EASY: Extended Access to Sollpura Over Years,Completed,Phase 4,,September 2016,March 2018,Treatment,Aurora,Colorado,80045,All,7 Years,,2018-03-01,2016-09-01,546.0
NCT02847260,12.82051282,Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID),Completed,Phase 4,,April 2012,March 2014,Treatment,,,,All,18 Years,,2014-03-01,2012-04-01,699.0
NCT02864342,20.47974414,Adherence Study in COPD Patients,Completed,Phase 4,Randomized,"August 12, 2016","October 31, 2017",,Clearwater,Florida,37765,All,40 Years,130 Years,2017-10-01,2016-08-01,426.0
NCT02894840,0.75,Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults,Completed,Phase 1/Phase 2,Randomized,November 2015,November 2016,Prevention,,,,All,18 Years,49 Years,2016-11-01,2015-11-01,366.0
NCT02915302,7.356109147,Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children,Completed,Phase 4,Randomized,"September 23, 2016","March 6, 2017",Prevention,Birmingham,Alabama,35205,All,6 Months,35 Months,2017-03-01,2016-09-01,181.0
NCT02918071,2.479338843,"Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home",Completed,Phase 3,,"November 10, 2016","August 21, 2017",Treatment,Northridge,California,91324,All,18 Years,75 Years,2017-08-01,2016-11-01,273.0
NCT02948582,2.777777778,"Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 2,Randomized,July 2010,November 2010,Treatment,,,,All,40 Years,75 Years,2010-11-01,2010-07-01,123.0
NCT03005067,10.06811409,To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold,Completed,Phase 2,Randomized,"December 29, 2016","June 7, 2017",Treatment,Birmingham,Alabama,35211,All,18 Years,75 Years,2017-06-01,2016-12-01,182.0
NCT03021304,0.0,Study of Mepolizumab Safety Syringe in Asthmatics,Completed,Phase 3,,"February 1, 2017","August 8, 2017",Treatment,Birmingham,Alabama,35243,All,12 Years,,2017-08-01,2017-02-01,181.0
NCT03022422,13.04347826,"T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011",Completed,Phase 4,Non-Randomized,September 2011,December 2011,Basic Science,,,,All,18 Years,100 Years,2011-12-01,2011-09-01,91.0
NCT03099096,0.6289308176,Study of Mepolizumab Autoinjector in Asthmatics,Completed,Phase 3,,"May 4, 2017","November 30, 2017",Treatment,Birmingham,Alabama,35243,All,12 Years,,2017-11-01,2017-05-01,184.0
